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Abstract 
Redox-active probes are designed and prepared for use in DNA-mediated electron 
transfer studies. These probes consist of ruthenium(II) complexes bound to nucleosides 
that possess metal-binding ligands. Low- and high-potential oxidants are synthesized 
from these modified nucleosides and display reversible one-electron electrochemical 
behavior. The ruthenium-modified nucleosides exhibit distinct charge-transfer transitions 
in the visible region that resemble those of appropriate model complexes. Resonance 
Raman and time-resolved emission spectroscopy are used to characterize the nature of 
these transitions. 
The site-specific incorporation of these redox-active probes into oligonucleotides 
is explored using post-synthetic modification and solid-phase synthetic methods. The 
preparation of the metal-binding nucleosides, their incorporation into oligonucleotides, 
and characterization of the resulting oligonucleotides is described. Because the insertion 
of these probes into modified oligonucleotides using post-synthetic modification is 
unsuccessful, solid-phase synthetic methods are explored. These efforts lead to the first 
report of 3'-metallated oligonucleotides prepared completely by automated solid-phase 
synthesis. Preliminary efforts to prepare a bis-metallated oligonucleotide by automated 
synthesis are described. 
The electrochemical, absorption, and emissive features of the ruthenium-modified 
oligonucleotides are unchanged from those of the precursor metallonucleoside. The 
absence of any change in these properties upon incorporation into oligonucleotides and 
subsequent hybridization suggests that the incorporated ruthenium(ll) complex is a 
valuable probe for DNA-mediated electron transfer studies. 
vii 
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The interaction between ruthenium and nucleic acids is of on-going interest, due 
to the importance of developing agents that inhibit DNA synthesis and tumor growth. I 
Various Ru11 and Rum complexes exhibiting high binding affinities for nucleic acids have 
been investigated for potential antitumor activity.2 Several studies have established that 
Ru(II) and Ru(III) ammine complexes bind DNA at N7 of guanine bases, in addition to 
adenine and cytidine bases.3A This propensity to bind nucleic acids is consistent with the 
observation that many ruthenium complexes inhibit DNA replication, display mutagenic 
activity, and retard RNA synthesis.2,5-7 
A second motivation for investigating the interaction between ruthenium and 
nucleic acids is to assess the ability of DNA to mediate energy- and electron-transfer 
reactions.8,9 Experiments involving ruthenium-modified duplexes have shown that DNA 
can mediate energy transfer.l0-13 Considerably more attention has centered on electron 
transfer (ET) processes in ruthenium-modified DNA assemblies.l4-17 ET reactions 
employing DNA as the intervening mediuml6-22 have generated intense interest due to 
implications regarding the electronic properties of nucleic acids and the role ET plays in 
DNA damage and repair mechanisms.23-29 Debate over the mechanism and distance 
dependence of radical cation migration in DNA underscores the need for DNA 
assemblies modified in specific locations with redox-active probes.30-33 The design, 
synthesis, and subsequent incorporation of such probes into oligonucleotides pose major 
challenges in this area.34 
3 
Designing Donors and Acceptors for DNA-ET Reactions 
Helpful lessons for designing redox-active probes for DNA-ET experiments can 
be derived from studies evaluating proteins as bridging media for ET reactions.35-38 
These studies employ electron donors (D) and acceptors (A) whose orbitals mix relatively 
weakly with those of the surrounding protein; the D and A do not possess redox 
potentials sufficient enough to allow reactions with the bridging medium. As a result, the 
effectiveness of the protein structure in coupling a D/A pair is directly assessed. The 
judicious choice of a D/ A pair that is energetically well-separated from the bridging 
medium facilitates a clear evaluation of the parameters governing ET rates in biological 
settings. 
Understanding the distinctions between protein and nucleic acid structures guides 
the design of D/A pairs suitable for DNA-ET studies (Figure 1.1). For the 
metalloproteins used in ET experiments, either D or A is a redox-active chromophore 
native to the protein; the other probe is incorporated via site-selective surface labeling. 
Since DNA does not contain naturally occurring chromophores nor unique ligands 
suitable for labeling, two redox-active chromophores must be prepared and incorporated 
into the DNA assembly. Unlike proteins, nucleic acids are highly negatively charged, 
and this characteristic strongly influences the association between cationic metal 
complexes and DNA. These considerations present significant obstacles to the design 
and preparation of D/ A pairs. 
Ideal donor and acceptor complexes possess several important characteristics, 
which are numbered here. (1) Each complex displays distinct absorption spectra so that 
the formation of the ET products may be monitored by time-resolved absorption 
4 
Figure 1.1: Three-dimensional structures of (a) the metalloprotein azurin surface-labeled 
with Ru(bpy)2(im)
2
+ at His 83, and (b) an unmodified B-form DNA duplex. Both 




spectroscopy. In such experiments, wavelengths coinciding with the regions of MLCT 
absorption are monitored as the oxidation state of each metal complex changes in the 
course of the electron transfer reaction. Kinetic data are derived from the time-resolved 
changes in these bands. Extraction of the ET rate constant is aided by the use of metal 
complexes that display non-overlapping absorption bands. (2) Each complex exhibits 
reversible, one-electron redox chemistry so that the samples may be studied over several 
cycles without decomposition. The difference in the ground-state reduction potentials of 
the D/A pair provides sufficient thermodynamic driving force for the ET step. The 
complexes contain tunable ligands so that the dependence of ET rates on this value can 
be addressed. However, these probes do not possess reduction potentials strong enough 
to oxidize the DNA bases. (3) Additionally, the donor-acceptor complexes are 
incorporated at fixed locations within the DNA assembly so as to minimize the 
uncertainty in the distance separating these probes, as well as the number of 
conformations the metallated species can adopt. 
With these design considerations in mind, we investigated several ruthenium 
complexes for their suitability as D/A complexes (Table 1.1). This series consists of 
ruthenium(II) complexes that exhibit metal-to-ligand charge-transfer (MLCT) transitions 
that may be easily tracked during transient absorption experiments. These D/A 
candidates possess reversible one-electron reduction potentials. Differences in the 
reduction potentials for this series are large, amounting to substantial thermodynamic 
driving force for ground-state ET reactions. By design, some of these complexes are 
emissive so that the envisioned DNA-ET experiments can employ the bimolecular 
quenching method developed for studying protein-ET.39 While a limited number of 
8 
Table 1.1. Electrochemical and Absorption Data for Donor-Acceptor 
Candidate Complexes.a 
Complex £112, yb Amax, nmb Ref. 
vs. NHE (EX 10-3, M-1 cm-1) 
[Ru(bpy )z(im)(NH2R) ]
2+ -1.2c 480 (1l.O)c 40 
[Ru(bpy )z(impy) ]2+ 1.51c 470 (13.0) 41 
[Ru(NHJ)s(pyr)] 2+ 0.35 407 (7.7) 42 
[Ru(NH3)4(ampy)] 2+ 0.30 414 (6.3) 42 
[Ru(NH3)4(impy)] 2+ 0.56 520 (6.1) 42 
378 (4.4) 
[Ru(acach(impy)] 0.23c 576 (4.6) 43 
[Ru(NHJ)s(N\G))] 2+ 0.15 
402 (4.6) 
565 (0.44) 44 
a Complexes in bold are emissive at room temperature. bRu(IIIIII) potentials measured in 
aqueous solution (unless otherwise noted) . c Measured in CH3CN. 
d Measured in EtOH. 
9 
ruthenium complexes meet the criteria prescribed above for ideal D/A complexes, we 
predicted that the few listed in Table 1.1 could be site-specifically incorporated into 
oligonucleotides. This assessment is based on the available literature for incorporating 
metal complexes into oligonucleotides. 
Methods for Modifying DNA with Ruthenium Complexes 
Incorporating D/ A complexes at specific locations within single- and double-
stranded oligonucleotides is a daunting challenge. The preparation of metal-containing 
oligonucleotides is achieved using the following methods: (a) post-synthetic 
modification,l7,45-59 (b) on-column derivatization,27,60-63 and (c) solid-phase 
synthesis.13,43,64-72 Of the metal complexes that have been introduced into DNA, 
ruthenium is the most widely used. The ruthenium complexes typically contain two types 
of ligands: an unmodified polypyridine ligand (pp) and a substituted polypyridine ligand 
containing a linker required for oligonucleotide attachment (pp'). While each method has 
specific requirements and advantages, the applicability of these methods is limited by the 
substitution chemistry of the individual metal center and stability of the metal complex to 
the conditions required by the method. Examples of the types of ruthenium-modified 
oligonucleotides prepared by each method, as well as an analysis of each method, are 
given below. To provide a clear understanding of how these methods rely on automated 
oligonucleotide synthesis, a description of the procedure is given first. 
Oligonucleotide synthesis proceeds step-wise in a 3' ---t5' direction, beginning with 
the nucleoside pre-derivatized to a solid support (Figure 1.2).73-75 Treatment with mild 
acid removes the DMT group protecting the 5' hydroxyl group on the ribose ring. 
Subsequent activation and coupling of the newly introduced phosphoramidite monomer 
10 
Figure 1.2: Solid-phase oligonucleotide synthesis by the phosphite-triester method.73 
DMT-0 5' B 
~2' 

















yields a dinucleotide derivatized to the solid support. The phosphorus moiety is oxidized 
to form a stable Pv intermediate, and the synthesis cycle repeats until the sequence has 
been completed. The efficiency of each coupling is monitored by the release of the DMf 
cation after the introduction of each monomer. At the end of the cycle, the DMT group 
on the 5' end is removed, and the oligonucleotide is cleaved from the solid support with 
concentrated aqueous ammonia. Prolonged incubation in this solution removes the 
protecting groups on the phosphorus and base moieties, producing the crude 
oligonucleotide in yields determined by the individual step-wise coupling reactions. 
Post-Synthetic Modification. The post-synthetic modification method involves 
the (a) synthesis of nucleosides that possess reactive functional groups or metal-binding 
ligands, (b) incorporation of these modified nucleosides into oligonucleotides by solid-
phase DNA synthesis, and (c) subsequent labeling of the reactive functional groups with 
the desired metal complex (Figure 1.3). This method is attractive because it enables the 
preparation of various metal-containing oligonucleotides from the same precursor strand. 
There are two classes of oligonucleotides used in this method. The first class 
consists of oligonucleotides possessing a reactive functional group to which a metal 
complex can be coupled via an amide bond.46,48,49,51 An example by Bannwarth 
illustrates how this class of oligonucleotides is used for ruthenium complex incorporation 
(Figure 1.4).46 A single primary amine group is introduced at the 5' termini of several 
oligonucleotides using amine-bearing phosphoramidites, with an overall incorporation 
yield of >60%. The ruthenium complexes are prepared in the form of activated N-
succinimidyl esters in good yields (65-100%). Coupling of the ruthenium complexes to 
the amine-bearing oligonucleotides uses 25-fold excess metal reagent in a 
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Figure 1.3: Scheme outlining the steps involved in Post-Synthetic Modification. A 
nucleoside containing a reactive functional group is introduced into a growing 
oligonucleotide using standard phosphoramidite techniques. Upon completion of the 
synthesis, the oligonucleotide is cleaved from the solid support. Incubation of the crude 
mixture in concentrated aqueous ammonia removes the protecting groups on the base and 
phosphate moieties. The oligonucleotide is purified, and subsequently reacted with the 
desired metal complex, leading to the metal-modified oligonucleotide. 
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dioxane/Dl\IIF/water mixture, producing 5' -modified ruthenated oligonucleotides m 
moderate yields (Figure 1.5:A). 
Other examples using this class of oligonucleotides offer minor modifications to 
the above procedure. Barton and coworkers employ oligonucleotides modified with a 
hexylamine linker at the 5' terminal phosphate group.48,49 The ruthenium complexes 
contain a pp' ligand bearing a glutaric acid arm that is subsequently coupled to the 5' 
amine groups of the modified oligonucleotides. The coupling reaction takes place in the 
presence of DCC m a Dl\IIF/dioxane slurry, gtvmg 5'-modified ruthenated 
oligonucleotides in very low yields (<1 %) (Figure 1.5:B). Work by Kirsch-De 
Mesmaeker utilizes a method analogous to that described by Bannwarth, with the 
exception that the ruthenium complex is coupled to an amine-bearing nucleoside placed 
in the middle of the oligonucleotide sequence.51 The amine group is tethered to the base 
of uracil, and the modified nucleoside is introduced into the oligonucleotide by standard 
phosphoramidite coupling chemistry. Following activation, a 150-fold excess of 
ruthenium complex is added to the amino-oligonucleotide, leading to ruthenium-modified 
oligonucleotides in yields of 20% (Figure 1.5:C). 
The second class of oligonucleotides employed in post-synthetic modification 
methods possess metal-binding ligands at either the 5' end or m the middle of the 
strand.l7,47,58 The metal-binding ligands (primary amine or bipyridine groups) are 
introduced into the oligonucleotide via modified nucleosides. Metal complexation occurs 
upon addition of the free metal reagent to the ligand-bearing oligonucleotide. 
Hybridization of the modified oligonucleotide prior to metal complexation reduces the 
number of undesired side-products. I? 
18 
Figure 1.5: Examples of ruthenium-modified oligonucleotides prepared by the Post-
Synthetic Modification method. References for each example: A46, B48, C51, D47, £17, 
p58 . "Ru" represents Ru(II) unless otherwise noted. 
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5'-CAA AAC CCU ACC CAA AC-3' 
5'-TTT TTT TAU TAA A TT TA-3' 
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Netzel and coworkers utilize nucleosides modified at the base with an amine-
bearing linker.47,76 The modified nucleoside is introduced into oligonucleotides using 
standard phosphoramidite techniques; a DMF solution of activated bipyridine ligand is 
added in 100-200-fold excess to the amine-bearing oligonucleotide in a borate buffer 
solution. The yield of bipyridine-containing oligonucleotides produced from this 
coupling reaction is between 40-60%. Complexation of ruthenium reagents with these 
modified oligonucleotides takes place in aqueous ethanol and gives ruthenium-modified 
oligonucleotides in 5-10% yields (Figure 1.5:D). 
Meade employs a multi-step synthetic route to prepare 2'-arnino-modified 
nucleosides that are subsequently introduced into oligonucleotides using standard 
phosphoramidite techniques)? The modified oligonucleotides are hybridized to 
complementary strands, and the ruthenium reagents are added in 10-fold excess to the 
resulting amine-containing duplexes in buffered aqueous solution. The yield of 
ruthenium-modified oligonucleotides obtained by this method ranges from 25-50% 
(Figure 1.5:E). 
McLaughlin incorporates a non-nucleosidic bipyridine linker into the backbone of 
several oligonucleotides using standard phosphoramidite techniques.58 The ruthenium 
reagent is added in slight excess to the bipyridine-containing oligonucleotides in 
refluxing aqueous ethanol. While the yield of ruthenium-modified oligonucleotides was 
not specified, analytical measurements suggest a nearly quantitative complexation 
reaction (Figure 1.5:F). 
Analysis. The types of ruthenium-oligonucleotide conjugates prepared using this 
method include base-, ribose-, and phosphate-modified oligonucleotides (Figure 1.5). 
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The preparation of the first class of oligonucleotides takes advantage of commercially 
available reagents that bear the desired amine group. The ruthenium complexes are 
easily synthesized as activated ester derivatives. However, the coupling reactions involve 
large amounts of ruthenium reagents and lengthy reaction times; the overall yields of 
ruthenium-modified oligonucleotides are poor-to-moderate. The second class of 
oligonucleotides requires multi-step syntheses to obtain the nucleosides containing metal-
binding ligands. Excess unreacted ruthenium reagents likewise complicate isolation of 
the products, since multiple chromatographic separations are necessary for best isolation. 
While these efforts are rewarded in part by the moderate overall yields of ruthenium-
modified oligonucleotides, this method is not an efficient means of incorporating 
ruthenium into DNA relative to the other two methods described below. 
On-Column Derivatization. The method of on-column derivatization exploits 
the step-wise nature of solid-phase DNA synthesis by introducing non-phosphitylated 
ruthenium reagents to the oligonucleotide during or after automated synthesis.27,60-63 
The ruthenium complex is coupled to a reactive functional group positioned in the 
oligonucleotide at 5' -terminal or internal locations of the sequence. This reaction takes 
place prior to cleavage of the oligonucleotide from the solid support. The resulting 
ruthenium-modified oligonucleotide is liberated, deprotected, and isolated. Delivering 
ruthenium reagents in this manner takes advantage of the fact that all of the bases are 
protected; this both eliminates a purification step and minimizes the number of side-
products. A few examples illustrate the utility of this method. 
Recent work by Grinstaff involves the preparation of an iodo-substituted 
nucleoside that is incorporated via phosphoramidite coupling techniques into an 
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oligonucleotide (Figure 1.6).61,62 This modified nucleoside is used in Pd(O) cross-
coupling reactions with an alkynyl-derivatized ruthenium complex. Following 
incorporation of the modified nucleoside into the oligonucleotide, the column is removed 
from the synthesizer and subjected to the cross-coupling reagents. The excess reagents 
are washed away, the column is returned to the DNA synthesizer, and the oligonucleotide 
synthesis is resumed. Subsequent cleavage and deprotection of the ruthenium-containing 
oligonucleotide produces the desired product in 75-92% yields (Figure 1.7:A). 
Barton and coworkers prepare an unmodified oligonucleotide using standard 
solid-phase DNA methodology, introduce an amine-bearing linker to the 5' hydroxyl 
group of the oligonucleotide, and couple the ruthenium complex to the amino-terminated 
strand in organic solvents.60 Treatment of the ruthenium-modified oligonucleotide with 
concentrated aqueous ammonia cleaves the product from the solid support, and 
subsequent purification gives the desired oligonucleotide (Figure 1.7:B). While this 
method has been used extensively by the Barton group, the overall yield of ruthenium-
modified oligonucleotides has not been reported.l5 
Additional work by this group demonstrates the incorporation of two metal 
complexes at the 5' and 3' ends of an oligonucleotide.63 This work is analogous to the 
on-column derivatization chemistry for the 5'-end modifications just described. The 
method uses a commercially available solid support that contains a hydroxy aminoalkane 
masked with Fmoc and DMT protecting groups. Oligonucleotide synthesis proceeds 
from the deprotected DMT hydroxy group. At the conclusion of the oligonucleotide 
synthesis, an osmium complex is coupled to the 5' end as described above. At the 
opposite end, the Fmoc group is removed and a rhodium complex is coupled as an 
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Figure 1.6: Scheme outlining the steps involved in On-Column Derivatization: (a) 
removal of the DMT protecting group followed by introduction of a modified nucleoside 
in phosphoramidite form; (b) removal of reaction column from synthesizer and 
subsequent cross-coupling of alkynyl-derivatized ruthenium complex to the iodo-
substituted nucleoside; (c) return of reaction column to synthesizer and resumption of 
oligonucleotide synthesis; (d) cleavage of the product oligonucleotide from the solid 








Figure 1.7: Examples of ruthenium-modified oligonucleotides prepared by the On-
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activated ester to the newly deprotected amine group. The bis-metallated oligonucleotide 
is cleaved and deprotected completely to give an oligonucleotide bearing an osmium 
complex at the 5' end and a rhodium complex at the 3' end (yield not given) (Figure 
1.7:C). Although this chemistry is performed with rhodium and osmium complexes, it 
could easily be extended to similarly substituted ruthenium complexes. 
Analysis. Base-modified and 5' end-labeled oligonucleotides can be prepared 
using the on-column derivatization method. This method relies on the coupling 
chemistry developed for the first class of oligonucleotides described above in the section 
on post-synthetic modification. Introducing the metal reagents during or following 
oligonucleotide synthesis reduces the number of synthetic steps needed to prepare the 
desired metal-modified oligonucleotide, although the reaction times are lengthy. 
Incorporation yields appear to be higher than those reported for post-synthetic 
modification, although the yield data are incomplete. The absence of side-products 
greatly aids isolation of the product. While this method represents an improvement upon 
the Post-Synthetic Modification method, it is limited by the reliance upon coupling 
chemistries compatible with the conditions of automated oligonucleotide synthesis. 
Additional synthetic constraints are imposed by the requirement that the ruthenium 
complexes be converted into activated esters or alkynyl derivatives to bring about 
coupling. 
Solid-Phase Synthesis. The last method discussed in this section involves the 
preparation of metal-containing monomers that can be incorporated during solid-phase 
DNA synthesis using standard phosphoramidite coupling techniques.l3,43,64,68-72 
Advantages of this method include: rapid preparation of metal-containing 
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oligonucleotides, high yields of metal incorporation, and routine product isolation. 
However, the success of this method depends on the construction of individual metallated 
monomers that are compatible with automated DNA synthesis techniques. 
Ruthenium complexes can be introduced during automated synthesis as either 
metallated phosphoramidite or phosphonate monomers (Figure 1.8). Bannwarth 
describes the preparation of [Ru(bphenh(bphen')]2+, where bphen' is a substituted 
bathophenanthroline ligand bearing a hydroxyl group that is phosphitylated to form the 
ruthenated phosphoramidite monomer (Figure l.8A).64 Because isolating this monomer 
results in moderate yields, it is generated in situ and coupled directly to the growing 
oligonucleotide chain; this procedure leads to a high coupling yield (value not reported). 
Work by Giese provides an example of incorporating ruthenium complexes as 
phosphonate monomers (Figure 1.8B).68 A tris-heteroleptic Ru(II) complex is prepared 
wherein one ligand containing a hydroxyl group is converted to a phosphonate. Again 
the crude monomer is used directly in the coupling reaction, resulting in a high 
incorporation yield (value not reported). 
Additional work by the Tor and Grinstaff groups illustrates the routine nature of 
preparing and incorporating metallated monomers. Tor applies a versatile Pd(O)-
mediated cross-coupling method that enables the selective functionalization of mixed-
chelate complexes.l3 This approach allows the preparation of base-modified nucleosides 
in high yields after a few steps; likewise, high yields are observed for the synthesis of the 
corresponding phosphoramidites of [Ru(bpyh(phen')]2+ (80%) (Figure l.8D). Manual 
coupling of the ruthenated monomers results in coupling yields that are greater than 90%. 
Work by Grinstaff follows similar synthetic procedures for preparing base-modified 
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Figure 1.8: Structures of ruthenium-modified phosphonate (red) and phosphoramidite 
(blue) monomers, and examples of oligonucleotides prepared by Solid-Phase Synthesis. 
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phosphoramidites of the form [Ru(bpyh(bpy')]2+, for which comparable coupling yields 
are observed (Figure 1.8E).69,77 Other phosphoramidite derivatives can be prepared in 
high yields by the methods employed above (Figure 1.8C,F,G).70,71,78 Coupling yields 
for the non-nucleosidic derivative in Figure 1.8F are> 95%, whereas the overall yield of 
ruthenium-modified oligonucleotides is 3-5% after purification. The metallated 
monomers in Figure 1.8F and Figure 1.80 give ruthenium-modified oligonucleotides in 
50-75% yield. 
An attractive approach to introducing metallated monomers during automated 
oligonucleotide synthesis involves the preparation of customized solid supports. 
Oligonucleotide synthesis can be initiated with a DMT -protected nucleoside that is 
derivatized to a silica- or polymer-based solid support. In principle, the solid support 
may contain a metallonucleoside that is stable under the extreme conditions required for 
automated synthesis. Synthesis begins with the metal-containing solid support and yields 
an oligonucleotide modified at the 3' terminus with a metal complex. This approach is 
demonstrated for the first time using a ruthenium(II) polypyridine complex.43 Details of 
this work are described in Chapter 4. 
Analysis. This method is a successful way to prepare several oligonucleotides 
modified with ruthenium(II) polypyridine complexes at the 5' terminus and intervening 
positions. While this method was first demonstrated by Bannwarth in 1989, several years 
elapsed before it was further explored as a general method. Recent advances in 
nucleoside chemistry have facilitated the preparation of several metallated monomers. 
Synthesizing these monomers typically requires several steps and produces metallated 
phosphoramidites that are highly moisture sensitive. Additionally, the extreme 
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conditions routinely encountered during automated synthesis-mild acid and strong 
base-preclude the widespread application of solid-phase synthetic methods to a host of 
ruthenium complexes. However, high coupling yields are observed for the metallated 
monomers; the judicious placement of the ruthenium complex away from the 3' position 
is responsible for this observation in many cases. Additionally, the overall yields of 
ruthenium-containing oligonucleotides are far greater than those achieved via the post-
synthetic modification and on-column derivatization methods, due to the ease of both 
oligonucleotide synthesis and product isolation. 
Characterization of Ruthenium-Modified Oligonucleotides 
Two consequences arise from the incorporation of mixed-chelate ruthenium(II) 
complexes into oligonucleotides. First, the presence of the ruthenium complex influences 
the duplex stability; the extent of structural destabilization caused by the incorporated 
ruthenium complex is evaluated with thermal denaturation studies. Second, the 
oligonucleotide environment alters the properties of the ruthenium complex. Analysis of 
the absorption and emission properties of the ruthenium-modified oligonucleotides 
assesses the impact of oligonucleotide incorporation upon the ruthenium center. Changes 
in these properties are ascribed to (a) the presence of substituted ligands containing 
linkers needed for oligonucleotide attachment (pp'), and (b) the environment typical of a 
DNA duplex. A summary of these consequences is given for the ruthenium-modified 
oligonucleotides presented in the previous section. 
Effect of Ruthenium Complexes on Duplex Stability. Thermal denaturation 
studies serve as a limited evaluation of how the incorporated metal influences the duplex 
stability. In the case of ruthenium-containing duplexes, it is difficult to ascertain from the 
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transition melting temperatures (T m) if the cationic nature of the ruthenium complex 
partially offsets the destabilization caused by the modification. For example, the Tm 
values for duplexes labeled with nonintercalating ruthenium complexes are similar to the 
T m values for the unmodified duplexes. Slight changes in the T m values are dependent on 
the specific placement of the ruthenium complex within the duplex, as well as the nature 
of attachment to the duplex (i.e., base- or phosphate-derivatized). The presence of 
sodium ions has a large stabilizing effect on these duplexes. Examples of these trends are 
summarized below. (The reader is referred to Figures 1.5-1.8 for the structures of the 
metal-containing oligonucleotides. Specific T m values are not quoted in the discussion, 
but rather the specific entry in Table 1.2 is cited in italics so that the reader can consult 
the table for all relevant data.) 
Duplexes end-labeled with nonintercalating ruthenium complexes typically 
display T m values that are essentially unchanged from the values reported for unmodified 
duplexes. For example, a 20-mer duplex containing [Ru(bpy)z(phen')]2+ attached to the 
base of the 5'-terminal nucleoside exhibits a T m only one degree higher than that of the 
unmodified duplex (Table 1.2:1a; Figure 1.8D).13 The Tm values for a 16-mer duplex 
containing [Ru(bpy)z(bpy') f + attached to the base of the 5' -terminal nucleoside and the 
corresponding unmodified duplex are identical (Table 1.2:2a; Figure 1.8E).62 When the 
same metallonucleosides in these two examples are placed mid-way in the duplex 
sequence, the T m values decrease slightly (Table 1.2:1 b-2b; Figure 1.8D,E). 
Interestingly, a dramatic dependence on [Na+] is revealed in the Tm values for one of 
these modified duplexes (Table 1.2:2b-c; Figure 1.8E). 
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10 100 13 
10 100 13 
5 50 62 
5 50 62 
150 77 
5 50 78 
5 50 78 
100 900 17 
10 1000 47 




10 50 68 
10 50 51 
10 50 51 
" Values are reported for solutions containing sodium phosphate and sodium chloride at pH 7.0 (°C) unless 
otherwise noted. Duplexes are formed with the ruthenium-modified oligonucleotide listed and the 
corresponding unmodified complementary strand (not shown), except where noted. X denotes metal 
attachment to oligonucleotide via linker to nucleoside base, ribose, or phosphate. Please see Figure 1.8 for 
details of metal attachment for each system. b Complementary strand contains [Ru(NH3) 4(pyr)] 
3
+ attached 
to a 5' aminoribose. 
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Further changes are observed when similar ruthenium complexes are attached 
directly to the 5' ribose position, as opposed to the base of a terminal nucleoside (Table 
1.2:3a-b; Figure 1.8G). An 8-mer duplex that is labeled with two ruthenium complexes 
at both 5' termini, displays a broad helix-to-coil transition, with aT rn value in the range of 
36-42 oc (Table 1.2:3c; Figure 1.5E). Comparing this value to that obtained for the 
unmodified duplex suggests that the short duplex is reasonably. stable in spite of the 
presence of two ruthenium complexes. 
Attaching non-intercalating ruthenium complexes to duplexes via extended 
linkers leads to mixed results. For example, linking [Ru(bpyh(bpy')f+ to a nucleobase 
using a long tether does not cause large changes in the T rn values of metallated vs. 
unmodified duplexes, provided that the metallonucleoside is incorporated into the middle 
of the duplex (Table 1.2:4a; Figure 1.5D).47 However, when [Ru(bpyh(bpy')]2+ is 
tethered to the 5'-terrninal phosphate group, the difference in the T rn values is dramatic 
(Table 1.2:4b; Figure 1.8C).70 This result suggest that attaching a cationic ruthenium 
complex with a short ethylene spacer to the 5' terminal phosphate has a large 
destabilizing effect on the duplex. The absence of a nucleoside that imparts rigidity to 
the oligonucleotide terminus may be responsible for the lower T rn value. 
For the ruthenium-modified oligonucleotides designed to form hairpins under 
high ionic strength, the T rn values indicate that two 8-mer strands do not adopt well-
defined structures (Table 1.2:5a-c; Figure 1.8F).71 The T rn value for the 16-mer 
oligonucleotide suggests that a stable hairpin is formed in the presence of 1.0 M sodium 
chloride. 
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For intercalating complexes covalently tethered to duplexes, the Tm values are 
higher compared to those for unmodified duplexes. As a result, the extent of 
destabilization appears to be compensated by the insertion of a n-stacking ligand into the 
duplex. However, dramatic structural changes are imposed on the duplex to 
accommodate the inserted ligand. Therefore, thermal denaturation studies of duplexes 
modified with intercalating complexes provide only a preliminary assessment of how the 
incorporated ruthenium influences the duplex stability. For example, a substantial 
increase in the T m value is observed for a duplex end-labeled with an intercalator (Table 
1.2:6a; Figure 1.8B).68 This increase of 7 °C is attributed to the presence of the 
intercalating ruthenium complex. However, the T m values for duplexes containing an 
intercalator conjugated to the middle of the sequence are identical or only slightly 
increased relative to the T m values of unmodified duplexes (Table 1.2:6b-c; Figure 
1.5C).51 In these two examples, tethering the intercalator to the end has a large effect on 
the Tm value. 
Absorption of Ruthenium-Modified Oligonucleotides. The oligonucleotides 
containing non-intercalating ruthenium complexes display electronic spectra that are 
similar to those of the appropriate model complexes. Changes in the absorption 
maximum occur when the model complex is modified to accommodate linkers needed for 
oligonucleotide attachment (Figure 1.9). The resulting monomer complex (i.e., 
[Ru(bpyh(bpy')]2+, where bpy' denotes a substituted bipyridine ligand containing the 
linker) exhibits an absorption maximum that is unchanged or slightly red-shifted from 
Amax for [Ru(bpy)/+].40 Typically, incorporation of the monomer complex into an 
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Figure 1.9: Structures of an octahedral Ru(II) polypyridyl model complex (A), its 
corresponding monomer complex possessing a substituted polypyridyl ligand needed for 
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oligonucleotide does not alter the position of Amax for the ruthenium-containing 
oligonucleotides (Table 1.3). 
Emission of Ruthenium-Modified Oligonucleotides. Comparison of the 
emissive properties of the ruthenium-containing monomers and oligonucleotides with 
those of reference complexes helps in understanding the observed changes in A.(em) 
summarized in Table 1.3. For example, monomer complexes based on [Ru(bpyh]2+ 
display emission maxima that are shifted from 628 nm to lower energy (660-675 nm). 
When these monomer complexes are incorporated into oligonucleotides, the emission 
maxima are unchanged or shifted to lower energy. An exception to this trend is a 16-mer 
oligonucleotide containing a complex attached to the base of a nucleoside located mid-
strand; A.(em) is centered at 660 nm, blue-shifted from the corresponding value of the 
monomer complex (675 nm).62,69 
The excited-state lifetimes of the single-stranded ruthenated oligonucleotides are 
dramatically different from those of the monomer complexes (Table 1.3). This suggests 
that the ruthenium complex is situated in an environment that has different solvation 
characteristics after incorporation into an oligonucleotide. Likewise, hybridization to 
unmodified complementary strands in some cases leads to further alterations in the 
excited-state lifetimes. For example, Grinstaff and coworkers report an increase in the 
lifetime values upon both incorporation and hybridization of three separate 
[Ru(bpy)z(bpy')]2+ derivatives, regardless of the attachment linkage or placement of the 
metal complex within the duplex (Figure 1.7A, 1.8C,E,G).62,70,72 Conversely, Lewis 
and coworkers observe a decrease in the lifetime of single-stranded oligonucleotides 






















Table 1.3. (continued) 
compd Amax (abs) Amax(em) 't (J,tsec) Ref. 
Ru(tap)l(dip) + 418 652 0.58 51 
Ru(phen)z(dppz)2+ 619 0.18 79 
Ru(tap)z(dip')2+ 418 652 0.580 51 
5' -CAAAACCCXACCCAAAC-3' 420 652 0.315 (16%) 
0.707 (84%) 
duplex 420 652 0.046 (71 %) 
0.229 (21 %) 
0.659 (8%) 
5'-TTTTTIT AXTAAA TIT A-3' 420 654 0.721 (58%) 
1.268 (42%) 
duplex 420 654 0.632 (28%) 
1.176 (72%) 
Ru(phen)(phen')(dppz)2+ 447 68 
5'- x AGAGCACAACT AGCA-3' 437 
Ru(phen')(phen")( dppz /+ 482 598 48 
5' -XAGTGCCAAGCTTGCA-3' 482 598 
Duplex 482 598 0.500 (60%) 
0.110 (40%) 
a Values measured in buffered aqueous solution (pH 7.0) at room temperature unless otherwise 
noted. X denotes metal attachment to oligonucleotide via linker to nucleoside base, ribose, or 
phosphate. Please see individual references for details of metal attachment for each system. b 
Measured in dichloromethane. ,. Measured in unbuffered aqueous solution. d Monomer complex 
values measured in acetonitrile. 
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are within 10% of the value for the monomer complex; a third strand forms a hairpin 
structure at high ionic strength and exhibits a lifetime that is 30% shorter compared to the 
lifetime of the monomer complex. 
A rationale for the contrasting changes in the excited-state lifetime values of the 
metal-containing oligonucleotides summarized in Table 1.3 is unclear. The decrease in 
excited-state lifetime reported by Lewis for the single-stranded vs. hairpin 
oligonucleotides could be attributed to structural differences between the conformations 
available to the strands. The two 8-mer strands do not form well-defined hairpin 
structures at high ionic strength; therefore, the emission lifetimes for these 
oligonucleotides are expected to resemble that of the monomer complex.71 The 16-mer 
oligonucleotide forms a stable hairpin structure, and this structural difference may cause 
the observed decrease in the excited-state lifetime. 80 However, the increase in lifetime 
values upon both incorporation and hybridization reported by Grinstaff must be due to 
interactions between the metal complex and the duplex not operative in Lewis' hairpin 
assembly. Subtle factors involving duplex conformation and ionic strength may be 
responsible for these trends. 
An example of how the compositon of the buffer solution impacts the emissive 
properties of a ruthenium-modified oligonucleotide is provided here. Modulations in the 
excited-state lifetime are observed by Bannwarth for the ruthenium-modified 
oligonucleotide shown in Figure 1.5A.46 The addition of detergents, salts, and reducing 
agents to the solution containing the single strand prolongs the lifetime from 2.0 f.!Sec to 
7.5 f.Lsec. This dramatic enhancement illustrates how the surrounding environment 
influences the emissive properties of the metal complex. 
46 
The most striking alteration in the excited-state lifetime observed upon 
incorporation of a monomer complex occurs for oligonucleotides containing intercalating 
ruthenium complexes. Kirsch-De Mesmaeker and coworkers report that the emission of 
two single-stranded oligonucleotides containing [Ru(tap)z(dip)]2+ is characterized by a hi-
exponential decay. This observation is in sharp contrast to the monoexponential behavior 
exhibited by the model complex (Figure 1.5C).51 It appears from close inspection of 
Table 1.3 that the base composition of the two 17 -mer oligonucleotides may influence the 
excited-state behavior of the tethered complexes by dictating the structural conformations 
that the single strands can adopt. Hybridization of [Ru(tap)z(dip)]2+-containing 
oligonucleotides introduces further complexity into the emission decay, as multi-
exponential behavior is observed for the duplexes. 
This unusual excited-state behavior may be a direct manifestation of subtle 
conformational differences between the oligonucleotides. The biexponential decay 
behavior persists for the 17 -mer single-stranded oligonucleotides, despite the fact these 
strands do not support intercalation of the tethered ruthenium complex. The contrasting 
lifetime values observed for these strands ('t1 = 0.315, 't2 = 0.707 vs. 't1' = 0.721, '!2' = 
1.268 JlS) can be attributed to the different conformations dictated by the respective 
oligonucleotide sequence. The extended linker Uoining the metal complex to the base of 
an intervening nucleoside) amplifies the number of conformations adopted by the 
oligonucleotides, leading to multiple components for the excited-state lifetime.51 
Additionally, the excited-state behavior is more complicated for the duplex containing a 
GC-rich strand vs. an AT -rich strand. The presence of a guanine-rich strand may cause 
quenching of the luminescent MLCT state based on the following: (1) guanine is the 
47 
most facile electron donor of the DNA bases (E+•/O = 1.3 V vs. NHE, pH 7),81 and (2) 
photoexcited [Ru(tap)z(dip)]2+ is a powerful oxidant (1.3 V NHE, CH3CN).82 Taken 
together, these results suggest that excited-state lifetimes are diagnostic of different 
conformational states that are populated on the timescale of the emission decay. 
Barton and coworkers likewise report biexponential decay for the emission of 
[Ru(phen')2(dppz)]
2
+ covalently bound to 15-mer duplexes.48 In this setting the tethered 
intercalator displays lifetime values of 500 (60%) and 110 (40%) nsec, whereas minimal 
emission is observed when the ruthenium-containing oligonucleotide is unhybridized. 
When [Ru(phenh(dppz)]2+ is bound noncovalently to DNA duplexes, it also displays 
biexponential decay behavior (-r1 = 420 (35%), -r2 = 90 (65%) nsec).48,83 Complicating a 
thorough understanding of how the emission decay of the metal complex is influenced by 
the presence of DNA is the fact that the model complex possesses a very short emission 
lifetime. The authors propose that intercalation protects the phenazine ring from 
interactions with the surrounding solvent that are responsible for quenching the excited 
state of the ruthenium complex. If the interpretation given above for the Kirsch-De 
Mesmaeker assemblies is applied here, it would appear that the biexponential emission 
decay is suggestive of at least two distinct conformations of the ruthenium-modified 
duplex. Whether these conformations are dictated by the multiple binding modes 
available to the intercalator or by the oligonucleotide sequence remains to be established 
for the covalently tethered ruthenium-oligonucleotide conjugates. 
Additional work involving [Ru(phen)2(dppz)]
2
+ bound noncovalently to DNA 
duplexes has provided insight into this issue. Barton and coworkers have conducted 
several experiments investigating the possible binding modes adopted by 
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[Ru(phenh(dppz)]2+ in the presence of duplex DNAJ9,84,85 These studies provide 
evidence for two different binding interactions between [Ru(phenh(dppz)]2+ and DNA. 
However, results from linear dichroism studies by Norden suggest that one binding mode 
dominates. 86,87 Additional studies probing the emission behavior exhibited by the A and 
D. enantiomers of [Ru(phenh(dppz)]2+ reveal an enantiospecificity of the lifetimes. That 
is, each enantiomer displays two distinct lifetimes when bound to DNA; one of these 
values increases as the concentration of the enantiomer increases. The authors speculate 
that the prolonged lifetime is the direct consequence of the enhanced protection from 
solvent that the clustered intercalators afford one another. Regardless of the validity of 
the models proposed by Barton and by Norden for the interaction between 
[Ru(phenh(dppz)]2+ and duplex DNA, these studies showcase the complexity of 
interpreting emission decay kinetics for intercalating assemblies. 
Summary. Analyzing the methods developed for inserting ruthenium complexes 
into oligonucleotides highlights the importance of selecting ligands that facilitate routine 
incorporation. Likewise, a review of the resulting ruthenium-modified oligonucleotides 
shows how the different ligands used for the purposes of incorporation influence the 
spectroscopic properties of the incorporated metal complex. It is clear from the 
preceding discussion that non-intercalating ruthenium complexes offer distinct 
advantages over intercalating ruthenium complexes since the emissive properties of the 
former are not substantially altered by the presence of oligonucleotides. 
Inspection of the various ruthenium-modified oligonucleotides described above 
reveals that nearly all of these complexes are based on [Ru(bpy)3]2+. This is to be 
expected since [Ru(bpy)3]
2+ has been widely used as a photosensitizer in many different 
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studies.40,88 However, the preceding review uncovers the absence of low-potential 
complexes that can be incorporated into DNA. In an ET reaction scheme, both an 
electron donor and an acceptor are needed; the difference in the reduction potentials of 
these complexes constitutes the overall driving force for the ET reactio. Low-potential 
complexes that are spectroscopically distinct from high-potential complexes are needed 
to facilitate a systematic evaluation DNA-mediated ET processes. The design of a low-
potential complex exhibiting reversible electrochemistry and displaying unique 
absorption bands thus becomes an important endeavor. 
To this end, Meade and coworkers designed a DNA assembly modified with non-
intercalating ruthenium complexes that possess the features discussed above regarding 
ideal D/A complexes (Figure 1.10).17 The high-potential complex 
[Ru(bpyh(im)(NRH2)]
2
+ (where NRH2 represents an amine-bearing oligonucleotide) is 
amenable to the bimolecular quenching method. The low-potential complex 
[Ru(NH3Mpyr)(NH2R)]
2+ displays an absorption maximum at 410 nm that is distinct 
from that of the high-potential complex (480 nm). The powerful combination of these 
two complexes allows the unambiguous detection of the products formed upon ground-
state electron transfer. The preparation of additional low-potential complexes, suitable 
for both incorporation into oligonucleotides and use in ET studies, will augment these 
results. 
A second hallmark of the Meade assembly is the use of 2'-modified nucleosides to 
facilitate ruthenium incorporation. The 2' position of the ribose ring is selected as the 
metal attachment point since metal complexes in this location do not directly interfere 
with the hydrogen bonding of the DNA bases. Additionally, metal attachment to the 
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Figure 1.10: Schematic structure of DNA assembly containing spectroscopically unique, 
non-intercalating ruthenium complexes. The ruthenium complexes are covalently 




ribose ring may afford an efficient pathway to the stacked array of n bonds present in the 
secondary structure of a duplex. This stacked array may prove ideal for enhancing the 
electronic coupling of a donor-acceptor pair. 34 
Scope of Thesis 
The design and subsequent oligonucleotide incorporation of redox-active probes 
is the focus of this thesis. These two activities form an iterative cycle, in that results 
obtained from initial incorporation attempts refine the design of the candidate ruthenium 
complexes. Likewise, newly designed ruthenium complexes become avenues to 
incorporation methods unavailable with other D/A candidates. Ultimately, the successful 
incorporation of a ruthenium complex elevates this candidate to further evaluation as a 
suitable probe. 
Site-specific incorporation of the candidate complexes is initially explored using 
post-synthetic modification. This method requires the preparation of nucleosides 
containing a metal-binding substituent. The synthesis of such nucleosides, their 
incorporation into oligonucleotides, and characterization of the resulting oligonucleotides 
is presented (Chapter 2). Because the insertion of the candidate complexes into the 
modified oligonucleotides using the post-synthetic modification method is unsuccessful 
(Chapter 3), an alternative method is explored. These efforts result in the first report of 
3' -metallated oligonucleotides prepared completely by automated solid-phase synthesis 
(Chapter 4). The electrochemical, absorption, and emissive features of the ruthenium-
modified oligonucleotides are unchanged from those of the precursor metallonucleoside 
(Chapter 4). The absence of any change in these properties upon incorporation into 
oligonucleotides and subsequent hybridization suggests that the incorporated 
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ruthenium(II) complex is a valuable probe for DNA-ET studies. Additional 
spectroscopic characterization of the ruthenium-modified nucleic acids prepared in this 
work documents the influence of the ligands that facilitate oligonucleotide attachment 
(Chapter 5). 
Work that is supplementary to the objectives of designing and incorporating 
redox-active probes into oligonucleotides represent avenues to future directions for this 
project: alternative nucleosides synthesis (Appendix A), model complex syntheses 
(Appendix B), oxidative and reductive quenching experiments with high-potential 
ruthenium-modified nucleic acids (Appendix C), and solid-phase synthesis of a bis-
metallated oligonucleotide (Appendix D). Relevant HPLC information is summarized 
(Appendix E). 
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Chapter 2 
2'-Modified Nucleosides for Site-Specific Labeling of Oligonucleotides 
62 
Introduction 
Nucleosides containing modifications in place of a hydroxyl group at the 2' ribose 
position are important structural and mechanistic probes of nuclease resistance and 
ribozyme catalysis.l-3 These nucleosides are used in the development of anti-sense 
therapeutics2 and in the rapid screening of oligonucleotide sequences displaying high 
affinity toward protein targets.4,5 Nucleosides containing a primary amine group at the 2' 
position also facilitate the incorporation of several reporter molecules or labels into 
oligonucleotides.6,7 This is achieved by (a) introducing the amine-containing nucleoside 
into an oligonucleotide using standard automated DNA synthesis, (b) purifying the 
resulting oligonucleotide, and (c) reacting the reporter group with the amine-containing 
oligonucleotide and isolating the conjugate (Chapter 1). Labels such as fluorescent 
dyes,6,8 aromatic and aliphatic isocyanates,7,9 and transition metal complexeslO have 
been successfully incorporated into oligonucleotides using this method. 
Our approach is to develop new methods of incorporating labels, namely 
transition metal complexes, into DNA site-specifically)! To this end we have designed 
nucleosides containing bidentate amine groups at the 2' ribose position to which 
transition metal complexes are chelated (Figure 2.1). The 2' position of the ribose ring is 
selected so that both solid support-bound and phosphoramidite forms of the nucleosides 
can be prepared. The solid support-bound nucleoside is used as the starting material in 
oligonucleotide synthesis, whereas the phosphoramidite monomer can be introduced at 
any later position in the oligonucleotide sequence. As a result, labels can be incorporated 
at the 3', intervening, or 5' locations of an oligonucleotides. Herein we report the 
63 
Figure 2.1: Structures of nucleosides modified at the 2' ribose position with metal-
binding ligands. The synthesis of nucleosides a-c is described in this chapter; the 























synthesis of 2'-modified nucleosides as both solid support-bound and phosphoramidite 
derivatives, and their incorporation into oligonucleotides via solid-phase methods. The 
characterization and thermal stability of the resulting oligonucleotides are discussed. 
Results 
Synthesis of 2'-Modified Nucleosides. Nucleosides with bidentate amine groups 
such as aminomethylpyridine (AMPy)l2 and aminoethylpyridine (AEPy) at the 2' ribose 
position were prepared as shown in Figure 2.2. This approach was based on methods 
developed recently for incorporating 2'-N-alkylamino substituents into nucleosides)3,14 
Nucleoside 1 was converted to the 3' N-alkyl carbamate upon prolonged treatment with 
carbonyl diimidazole in pyridine; this was followed by the addition of AMPy or AEPy in 
the presence of DIEA and dichloromethane. Subsequent cyclization in THF using the 
cyclization agent DBU produced either 2a or 2b in yields of 20% and 10%, respectively. 
Prolonged heating of 2a and 2b in a basic dioxane-methanol solution caused deprotection 
at the 2',3'-positions, giving 3a and 3b in high yield (92% and 88%, respectively). 
Derivatization of solid supports with 2'-modified nucleosides was achieved 
according to Figure 2.3. Nucleoside 4 was prepared according to previously published 
procedures.6,15,16 Both 3a and 4 were treated with succinic anhydride to give the 
corresponding hemisuccinates 5 and 6 in yields of 60% and 74%, respectively. l7,18 Solid 
supports such as controlled pore glass (CPG) containing long-chain alkyl amine groups 
were derivatized with 6 using p-nitrophenol and DCC. This method resulted in solid 
supports with low nucleoside loading. Subsequent attempts to prepare the nucleoside-
modified solid supports employed the coupling agent BOP in the presence of HOBT and 
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Figure 2.2: Synthesis of nucleosides containing bidentate ligands at the 2' ribose 
position: (a) (imid)zCO, pyridine, rt, 30 h; (b) NH2R (R = -CH2pyr, -CH2CH2pyr), DIEA, 
CH2Cl2, rt, 60 h; (c) DBU, THF, reflux, 46 h; (d) 6 N NaOH, dioxane, CH30H, 50 °C, 36 
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Figure 2.3: Synthesis of 2'-modified nucleosides as solid-support-bound and 
phosphoramidite derivatives: (a) succinic anhydride, pyridine, DMAP, rt, 16 h; (b) solid 
support, TEA, HOBT, BOP, CH2Cl2, rt, 16 h; acetic anhydride, N-methylirnidazole, 
pyridine, rt, 12 h; (c) amidite, DIEA, CH2Cl2, rt, 50 min. Abbreviation: R' = 4,4' -
dimethoxytrityl. 
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TEA.l9 The unreacted amine groups were treated with acetic anhydride, and the 
nucleoside loadings of the solid supports 7 and 8 were determined by spectrophotometric 
assay (60 and 52 ).!mol/gram, respectively).l7 
The preparation of phosphoramidite derivatives of nucleosides 3a and 4 relied on 
standard methods.6,16,17 As shown in Figure 2.3, 3a and 4 were treated with 2-
chlorocyanoethyl N,N-diisopropylaminophosphoramidite in the presence of DIEA to give 
9 and 10 in 57% and 65% yield, respectively. 
Oligonucleotide Synthesis. A series of oligonucleotides (Table 2 .1) were 
prepared from the support-bound and phosphoramidite nucleoside derivatives as outlined 
in Figure 2.4. To ensure maximum coupling, the reaction time for the first step was 
increased from 30 seconds to 2 minutes (yield> 95%). The reaction times for 9 and 10 
were 15 minutes in length, leading to coupling yields > 90%. 
All oligonucleotides were cleaved from the solid support with concentrated 
ammonia as a part of the automated synthesis routine, except in the case of 14, which was 
manually cleaved. The yield of purified oligonucleotide for 11-14 ranged from 30-40%, 
which was comparable to those values observed for 15-18. Results from matrix-assisted 
laser desorption-time of flight (MALDI-TOF) mass spectrometry on 11-14 were in 
excellent agreement with the calculated values. Further characterization of these 
oligonucleotides was achieved by enzymatic digestion.20 Analysis of the digestion 
products showed the expected distribution of nucleosides determined for each 
oligonucleotide sequence (Figures 2.5-2.8). 
Thermal Denaturation Studies. We investigated the thermal stability of 
duplexes containing 2'-modified nucleosides. Table 2.2 shows the transition melting 
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Table 2.1. Oligonucleotide Sequences.a 
sequence 

















a The symbol Ua denotes 2'-amino-2'-deoxyuridine; Ub 
denotes N2' -(2-pyridylmethyl)-2' -amino-2' -deoxyuridine. 
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Figure 2.4: Steps in the automated synthesis of oligonucleotide 14: (a) detritylation of 
7; monomer coupling; normal synthesis cycle; (b) coupling of 10; (c) cleavage and 






HOi Protected Oligo. )-P-o-~ II b 
0 
RO~ 




I 1-P -o-{,......-P-r-ot_e_ct_e_d_O_Ii-g-o.---}-P-0-~ 
'-f..IHR II II b 
0 0 I (c) 
o- o-
U-P-o-{ ___ 0~1:2-ig..:..:o. __ __.J}-P-o-U 
a II - II b 
0 0 
• = solid support 
U = l'f'-(2-pyridylmethyl)-
b 2'-amino-2'-deoxyuridine 
U = 2'-amino-2'-deoxyuridine 
a 
74 
Figure 2.5: Products of enzymatic digestion of 11 as analyzed by reverse-phase HPLC. 
Column: Prism C18. Gradient: 0-17% B over 15 minutes, then 17-75% B over 15 
minutes. Solvent A= 0.1 M triethylamine acetate, pH 7.0, 2% acetonitrile; Solvent B = 
acetonitrile. 
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Figure 2.6: Products of enzymatic digestion of 12 as analyzed by reverse-phase HPLC. 
Column: Prism C18. Gradient: 0-17% B over 15 minutes, then 17-75% B over 15 
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Figure 2.7: Products of enzymatic digestion of 13 as analyzed by reverse-phase HPLC. 
Column: Prism C18. Gradient: 0-17% B over 15 minutes, then 17-75% B over 15 
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Figure 2.8: Products of enzymatic digestion of 14 as analyzed by reverse-phase HPLC. 
Column: Prism C18. Gradient: 0-17% B over 15 minutes, then 17-75% B over 15 









Table 2.2. Thermal Denaturation Temperatures for 
Oligonucleotides containing 2' -Substituted Nucleosides. 
Duplex Tma (°C) Modification b 
15:16 48.2 ± 0.5 none 
11:15 46.6 ± 0.4 5' Ua 
12:16 46.7 ± 0.4 5' ub 
11:12 45.0 ± 0.5 5' Ua, 5' Ub 
17:18 47.6 ± 0.2 none 
13:18 45.8 ± 0.5 5' Ua, 3' Ua 
14:18 46.2 ± 0.5 5' Ua, 3' Ub 
a Values determined in 50 mM NaPi buffer (pH 7.0) containing 0.5 
M NaCl. The concentration of each oligomer was 2.7 !J.M. b The 
symbol Ua denotes 2' -amino-2' -deoxyuridine; Ub denotes N2' -(2-
pyridylmethyl)-2' -amino-2' -deoxyuridine. 
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temperatures (T rn) for each duplex prepared in 50 mM sodium phosphate buffer (pH 7.0) 
containing 0.5 M sodium chloride. The Tm of the 11-mer duplex formed by the 
unmodified olignucleotides 15 and 16 was 48 °C. When one 5' -terminal nucleoside from 
2' this duplex was substituted with either 2' -amino-2' -deoxyuridine (U3 ) or N -(2-
pyridylmethyl)-2' -amino-2' -deoxyuridine (Ub), the T m value remained essentially 
unchanged (Tm = 47 oc for duplexes 11:15 and 12:16). When both Ua and Ub were 
incorporated at the 5' ends of the same duplex (11:12), the T m value was decreased to 45 
This small change in the melting profile was similar to the results obtained with 
duplexes of identical length, GC content, and type of nucleoside modification, but of 
different sequence. This second set of duplexes contained 2' -modified nucleosides at 
both the 3' and 5' ends of the same strand. Duplex 13:18 contained Ua nucleosides at the 
5' and 3' termini, whereas duplex 14:18 contained Ua at the 5' end and Ub at the 3' end. 
The Tm values (46 °C) for duplexes 13:18 and 14:18 were decreased slightly m 
comparison to the value of the unmodified duplex 17:18 (Tm = 48 °C; Figure 2.9). 
Discussion 
Synthetic Strategy. This chapter describes the preparation of nucleosides 
containing 2' ribose substituents designed for incorporating reporter molecules into 
oligonucleotides. Two general methods exist for preparing oligonucleotides containing 
these labels. The post-synthetic modification method involves (a) the synthesis of 
nucleosides that possess reactive functional groups (such as a primary amine), (b) 
incorporation of these modified nucleosides into oligonucleotides, and (c) subsequent 
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labeling of the reactive functional groups with desired reporter molecules. The solid-
phase synthesis method entails the synthesis of label-containing nucleosides that are 
incorporated during solid-phase oligonucleotide synthesis. Both methods can be explored 
with the 2'-modified nucleosides described in this work.lO,ll 
The choice of 2' -substituents developed here are based on ligands that will bind 
transition metal complexes (Figure 2.1). These nucleoside ligands include AMPy and 
AEPy, and are contained in a variety of metal complexes.21 ,22 The first example of 
metalled 2' -modified nucleosides were prepared with a nucleoside containing a primary 
amine group at the 2' position.lO 
The site-specific labeling of oligonucleotides with metal reagents is of 
considerable interest. Experiments involving ruthenium-modified duplexes have shown 
that DNA can mediate energy and electron transfer reactions. l0,23-29 Additional work 
has led to the use of metal-modified primers in dideoxy DNA sequencing techniques.30 
The introduction of nucleosides containing metal-binding ligands can expand the use of 
metal complexes as probes of nucleic acid structure and function .lO, 11 
Synthesis of 2' -Modified Nucleosides. The synthesis of nucleosides containing 
2'-N-alkylamino substituents is an extension of methods developed by Sebesta, McGee, 
and coworkers.l3,14 The yields of isolation determined for 2a and 2b are lower than 
those observed for nucleosides containing similarly bulky substituents, and may be 
attributed to the purification conditions required for DMT-protected vs. silyl-protected 
intermediates.l3 The products 3a and 3b are isolated in yields comparable to the yields 
reported by Sebesta for similar 2' -modified nucleosides. 
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The preparation of supports derivatized with 2' -modified nucleosides is 
complicated, due to the poor accessibility of the 3' ribose site.31 The steric bulk at the 2' 
position hinders the reaction of the 3' hydroxyl with succinic anhydride. Succination of 
3a and 4 proceeds in reasonable yields and demonstrates that both small and large 
functional groups at the 2' position can be tolerated in succination step. High nucleoside 
loadings for 7 and 8 are achieved using the coupling agent BOP and an excess of 
nucleoside hemisuccinate in the derivatization step. While the solid support employed 
here is glass-based, the method is applicable to other solid supports containing a long-
chain alkylamine linker. 
Successful derivatization of supports with nucleosides like 3a and 4 now affords 
the synthesis of 3' oligonucleotide conjugates in which the label is incorporated on the 
ribose ring. Currently, the preparation of 3' oligonucleotide conjugates is achieved with 
supports containing either nucleosides with base-tethered primary amine groups32 or non-
nucleosidic amine derivatives.33-45 The ribose is an attractive attachment since labels 
introduced here may cause fewer perturbations to the secondary duplex structure than 
labels attached to the nucleoside base. The absence of a long linker between the 
attachment site and the incorporated label minimizes possible disruptions to the hydrogen 
bonding capacity of the oligonucleotide conjugate. 
Oligonucleotide Synthesis with 2'-Modified Nucleosides. The successful large-
scale synthesis of several 11-mer oligonucleotides validates the utility of 2'-modified 
nucleosides as support-bound and phosphorarnidite derivatives (Table 2.1). 
Oligonucleotide synthesis beginning with 7 or 8 proceeds with minor modification to the 
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automated protocol. The coupling yields of phosphoramidites 9 and 10 are suitable for 
routine oligonucleotide preparation. The purification of the several 11-mer modified 
oligonucleotides is straightforward. The isolation yields for 11-14 are comparable to 
values determined for oligonucleotides 15-18 under identical synthetic and purification 
conditions, implying that the use of 2' -modified nucleosides does not compromise the 
overall yield. 
Effect of 2'-Modified Nucleosides on Duplex Stability. The presence of 
nucleosides containing ribose substituents at the 2' position causes slight destabilization 
to the modified duplexes, as assessed by thermal denaturation studies. Interestingly, 
analysis of the transition melting (T m) temperatures listed in Table 2.2 suggests that the 
T m values are influenced by the number of 2'-modified nucleosides present in a duplex, 
not the size of the 2' substituent. For example, thermal denaturation of duplexes 11:15 
and 12:16 produces identical Tm values, despite the difference in the size of the 2' 
substituent (primary amine vs. AMPy). The Tm of 11:12 shows the effect of placing two 
2'-modified nucleosides at the 5' ends of the duplex. Similar results are obtained with a 
second set of duplexes identical in length, GC content, and type of nucleoside 
modification. The placement of two 2' -modified nucleosides at the 5' and 3' ends of the 
same strand results in duplexes destabilized by 1-2 °C (13:18 and 14:18 vs. 17:18). We 
conclude that the extent of duplex destabilization is the same when two 2' -modified 
nucleosides are introduced at either (1) the 5' and 3' ends of a one strand hybridized to its 
complement, or (2) the 5' ends of complementary strands. 
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2' -Aminonucleosides favor the 2' -en do conformation to a higher degree than 2'-
deoxynucleosides do.46 This observation suggests that 2' -aminonucleosides should 
stabilize DNA/DNA duplexes. However, T m data for a series of 9-mer duplexes 
containing a 2' -aminonucleoside in the middle of the sequence indicate that the presence 
of these modified nucleosides has a destabilizing effect. 6 Our work shows that placement 
of the 2' -modified nucleosides at the ends of the duplexes minimizes the destabilization 
imposed by the altered sugar conformation. 
Conclusion 
We report the synthesis of 2' -modified nucleosides designed specifically for 
incorporating reporter molecules into oligonucleotides. Because these nucleosides 
contain modifications to the ribose ring, as opposed to the nucleobase, they are important 
contributions to current library of nucleoside analogs. The introduction of metal-binding 
ligands at the 2' position is achieved after two steps. Conversion of these nucleosides to 
solid support-bound and phosphoramidite derivatives proceeds in good yield. The 
powerful combination of these derivatives affords the preparation of an entirely new class 
of oligonucleotides-those which contain label attachment sites at 3', intervening, and 5' 
locations of a duplex. 
Thermal denaturation studies indicate that the presence of 2' -modified nucleosides 
in 11-mer duplexes has a slight destabilizing effect on the duplex structure. This effect is 
limited by the selective placement of these nucleosides at the ends of the duplexes. 
Interestingly, the size of the metal-binding substituent does not influence the magnitude 
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of the destabilization. This characteristic makes these 2'-modified nucleosides attractive 
for use in the site-specific incorporation of reporter molecules into oligonucleotides. 
The methodologies employed here can be extended to other modified nucleosides. 
Succination yields for nucleosides containing metal-binding ligands at locations other 
than the 2' position are expected to be much higher, due to the absence of steric 
constraints. While the solid support is glass-based, the method is applicable to other solid 
supports containing any long-chain alkylamine linker. The library of solid supports 
containing modified nucleosides can be significantly expanded with the coupling 
conditions described here. These nucleoside reagents will enable the incorporation of 
labels that probe nucleic acid structure and function. 
Experimental Procedure 
General. 1H were acquired using Varian 300 and 500 spectrometers. Chemical 
shifts are reported in parts per million and referenced to the proton chemical shifts of 
deuterated solvent or trimethylsilane. Reagents and starting materials were used as 
received from Aldrich. Flash chromatography was performed on EM Science/Merck 
silica gel 60 (230-400 mesh). Thin-layer chromatography (TLC) was performed on 0.25 
mm Merck precoated silica plates (60 F254) . Combustion analysis was performed by 
Quantitative Technologies Inc. Enzymes were purchased from Pharmacia. Mass 
spectrometry was performed by the Caltech Peptide/Protein Microanalytical Laboratory. 
5' -0-( 4,4' -dimethoxytrityl)-2,2' -O-anhydro-l-(J3-D-arabinofuranosyl)uracil, 
1. This compound was prepared from reaction of 2,2'-0-anhydro-1-(,8-D-
arabinofuranosyl)uracil and 4,4' -dimethoxytrityl chloride as previously described.l5 
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5' -0-( 4,4' -dimethoxytrityl)-2' -N,3' -0-(2-oxooxazolidin)-2'-
aminomethylpyridyl-2' -deoxyuridine, 2a. To a solution of 1 (2.2 g, 4.2 mmol) in 
pyridine (40 mL) was added 1,1'-carbonyldiimidazole (1.01 g, 6.2 mmol). After 30 hours 
of stirring at ambient temperature, the solvent was removed and the residue was 
resuspended in dichloromethane (40 mL); DIEA (1.1 mL, 6 .3 mmol) and AMPy (649 J..IL, 
6.3 mmol) were delivered to the solution. After 60 hours of stirring at ambient 
temperature, the reaction was quenched with 5% citric acid, extracted with fresh 
dichloromethane, dried with Na2S04, and concentrated to an oil. The residue was 
dissolved in tetrahydrofuran (25 mL), DBU (628 J..LL, 4.2 mmol) was added to the flask, 
and the solution was refluxed for 46 hours. The solvent was removed and the residue 
was purified on silica (using 22% EtOAc in dichloromethane containing 1% TEA and 3% 
methanol) to afford 2a in 20% yield (548 mg, 828 J..lmol). 1H NMR (CDCh, 500 MHz; 
Figure 2.10) 8 3.48-3.58 (m, 2H), 3.78 (s, 6H), 4.35-4.40 (m, 1H), 4.54 (d, 1H), 4.75 (dd, 
2H), 5.14-5.17 (m, 1H), 5.41 (d, 1H), 6.06 (d, 1H), 6.82 (d, 4H), 7.21-7.30 (m, 9H), 7.33-
7.37 (m, 2H), 7.53 (d, 1H), 7.69 (t, 1H), 8.51 (d, 1H), 8.84 (s, 1H). ESI-MS mass 
calculated for C37H3sN40s [M+Ht: 663.24. Found: 663.2 (Figure 2.11). 
5' -0-(4,4' -dimethoxytrityl)-2' -N,3' -0-(2-oxooxazolidin)-2' -aminoethylpyridyl-
2'-deoxyuridine, 2b. To a solution of 1 (1.0 g, 1.9 mmol) in pyridine (30 mL) was added 
1,1'-carbonyldiimidazole (0.460 g, 2.8 mmol). After 30 hours of stirring at ambient 
temperature, the solvent was removed by rotary evaporation and the residue was 
resuspended in dichloromethane (30 mL); DIEA (500 J..IL, 2.85 mmol) and AEPy (340 
J..LL, 2.85 mmol) were delivered to the solution. After 60 hours of stirring at ambient 
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temperature, the reaction was worked up as described for 2a. The residue was dissolved 
in THF (11 mL), DBU (284 ~. 1.9 mmol) was added to the flask, and the solution was 
refluxed for 46 hours. The solvent was removed by rotary evaporation and the residue 
was purified on silica (eluting with 5-15% methanol in EtOAc) to afford 2b in 10% yield 
(127 mg, 188 J.-lmol). 1H NMR (CDCh, 300 MHz, Figure 2.12) 8 3.07-3.39 (m, 2H), 3.43-
3.60 (m, 2H), 3.74-3.77 (m, 6H), 3.93-4.04 (m, 1H), 4 .26-4.31 (m, 1H), 4.64 (dd, 2H), 
5.09-5.14 (m, 1H), 5.35 (d, 1H), 6.09 (d, 1H), 6.84 (d, 4H), 7.15-7.39 (m, llH), 7.59-7.69 
(m, 2H), 8.57 (d, lH). ESI-MS mass calculated for C3sH37N40s [M+Ht: 677.25. Found: 
677.2 (Figure 2.13). 
5' -0-( 4,4' -dimethoxytrityl)-2' -aminomethylpyridyl-2' -deoxyuridine, 3a. 
Compound 2a (242 mg, 0.36 mmol) was suspended in dioxane (6 mL), 4 M NaOH (4.7 
mL), and methanol (4.7 mL), and the mixture was stirred at 50 oc for 36 hours. The 
solvents were removed by rotary evaporation and the residue was dissolved in 
dichloromethane (55 mL). The solution was extracted with brine, dried over sodium 
sulfate, and evaporated to dryness to give 3a in 92% yield (216 mg, 0.34 mmol). 1H 
NMR (CDCh, 300 MHz, Figure 2.14) 8 3.3 (s(br), 4H), 3.73-3.78 (m, 6H), 3.94-4.02 (m, 
lH), 4 .1 (d, 1H), 4.2 (s, 1H), 5.3 (d, lH), 6.1 (d, 1H), 6.7 (dd, 4H), 7 .1-7.3 (m, llH), 7.5-
7.6 (m, 2H), 8.4 (s, 1H). ESI-MS mass calculated for C36H37N407 [M+Ht: 637.26. 
Found: 637.2 (Figure 2.15). 
5' -0-( 4,4' -dimethoxytrityl)-2' -aminomethylpyridyl-2' -deoxyuridine, 3b. 
Compound 2b (1.7 g, 2.51 mmol) was suspended in dioxane (43 mL), 4 M NaOH (26 
mL), and methanol (26 mL), and the mixture was stirred at room temperature for 20 hrs. 
The reaction was heated at 60 oc for an additional 2 hours, after which the solvents 
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Figure 2.15: ESI mass spectrum of 3a conducted in positive ionization mode. (Peak at 


































































































































































































































were removed by rotary evaporation. The residue dissolved in dichloromethane, 
extracted with brine, dried over sodium sulfate, and evaporated to dryness. The material 
was purified on silica (eluting with 23% ethyl acetate in dichloromethane containing 1% 
each of methanol and triethylamine) to give 3b in 88% yield (1.44 g, 2.21 mmol). 1H 
NMR (CDCh, 500 MHz, Figure 2.16) 5 3.03 (t, 2H), 3.12-3.25 (m, 2H), 3.43-3.53 (m, 
3H), 3.80 (s, 6H), 4.29 (s, 1H), 4.49 (d, 1H), 5.37 (d, 1H), 5.94 (d, 1H), 6.14 (s(br), 1H), 
6.85 (d, 4H), 7.18-7.33 (m, 10H), 7.40 (d, 1H), 7.67 (t, 1H), 7.74 (d, 1H), 8.49 (d, 1H). 
ESI-MS mass calculated for C37H39N407 [M+Ht: 651.27. Found: 651.2 (Figure 2.17). 
5' -0-( 4,4' -dimethoxytrityi)-N2' -trifluoroacetamido-2' -deoxyuridine, 4. This 
compound was prepared either from reaction of 2' -arnino-5' -0-( 4,4' -dimethoxytrityl)-2'-
deoxyuridine and ethyl trifluoroacetatel5 or from reaction N2'-trifluoroacetyl-2'-amino-
2' -deoxyuridine and 4,4' -dimethoxytrityl chloride as previously described.6 
5' -0-( 4,4' -dimethoxytrityl)-2' -aminomethylpyridyl -2' -deoxyuridine-3' -0-
succinate, 5 . Compound 3a (100 mg, 0.157 mmol), DMAP (9.4 mg, 0.5 eq), and 
succinic anhydride (17.3 mg, 1.1 eq) were suspended in dry pyridine (1 mL), and allowed 
to stir under argon for two hours, at which time an additional 0.2 equivalents of succinic 
anhydride were added. The reaction proceeded overnight at room temperature, after 
which the solvent was removed. The residue was dissolved in dichloromethane (20 mL) 
and stirred with an equal volume of 5% NaHC03 solution for two hours. The mixture 
was partitioned, and the organic phase was extracted with brine. Each phase was back-
extracted with fresh solutions once. The combined organic phases were washed with 
cold 5% citric acid, and concentrated to a small volume (3-5 mL). The sample was 
precipitated in stirring hexanes, and the white solid 5 was collected by filtration in 60% 
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Figure 2.16: 1H NMR spectrum of 3b in CDCh (500 MHz). 
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yield (69 mg, 0.094 mmol). ESI-MS mass calculated for C40H39N4010 [M-Hr: 735.27. 
Found: 735.2 (Figure 2.18). 
5' -0-( 4,4 '-dimethoxytrityl)-N2' -trifluoroacetamido-2' -deoxyuridine-3 '-0-
succinate, 6. Compound 4 (100 mg, 0.156 mmol), DMAP (9.4 mg, 0.5 eq), and succinic 
anhydride (17.2 mg, 1.1 equiv) were suspended in dry pyridine (2 ml) and stirred under 
argon for two hours. An additional 0.2-0.5 equivalents of succinic anhydride were added, 
and the reaction proceeded at room temperature overnight. The reaction was worked 
according to the procedure given for 5. A white powder 7 was isolated in 74% yield (85 
mg, 0.115 mmol). ESI-MS mass calculated for C36H33N30 11 [M-Hr: 740.21. Found: 
740.2 (Figure 2.19). 
5' -0-( 4,4' -dimethoxytrityl)-2' -aminomethylpyridyl-2' -deoxyuridine-3' -0-
succinated support, 7. Compound 7 was prepared by suspending the solid support 
(controlled pore glass derivatized with long-chain alkyl amine, 500 A. pore size, 350 mg) 
in dry dichloromethane (5 ml) and adding TEA (250 JJ.l) and 5 (180 mg, 245 J..lmol); 
HOBT (33 mg, 245 JJ.mol) and BOP (119 mg, 270 J..lmol) were added to the suspension. 
The mixture was agitated for 16 hours at room temperature, filtered, and washed with 
dichloromethane (2 x 10 ml). The solid was transferred to a separate flask and suspended 
in pyridine (7.5 ml). Acetic anhydride (1-2 ml) and N-methylimidazole (100 J..ll) were 
added to the flask, and the mixture was agitated overnight. The solid was filtered, and 
washed with pyridine (3 x 10 ml), methanol (3 x 10 ml), dichloromethane (3 x 10 mL), 
and diethyl ether (3 x 10 mL). The white solid 7 was dried under vacuum. The 
nucleoside loading was determined spectrophotometrically to be 60 JJ.mollg.l7 
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Figure 2.18: ESI mass spectrum of 5 conducted in negative ionization mode. Additional 



































































































































































































































































































































































































































5' -0-( 4,4' -dimethoxytrityl)-N2' -trifluoroacetamido-2' -deoxyuridine-3' -0-
succinated support, 8. Compound 8 was prepared using the same method described for 
7. The nucleoside loading for 8 was 52 J.tmol/g. 
5' -0-( 4,4 '-dimethoxytrityl)-2' -aminomethylpyridyl-2' -deoxyuridine-3' -0-(2-
cyanoethyl N,N-diisopropylaminophosphoramidite), 9. While under argon 3a (200 
mg, 0.314 mmol) was dissolved in dry dichloromethane (2 mL) containing DIEA (220 
J.tL, 4 eq). The reaction vessel was de-gassed several times prior to the addition of 2-
chlorocyanoethyl N,N-diisopropylarninophosphoramidite (105 J.tL, 1.5 eq) dropwise over 
5 minutes. A positive ninhydrin test indicated formation of the desired product. After 50 
minutes the reaction was diluted with 200 J.tL methanol and evaporated to dryness. The 
residue was applied to silica (eluting with 0-80% dichloromethane in hexane containing 
1% TEA) to give an off-white powder 9 in 57% yield (151 mg, 0.180 mmol). ESI-MS 
mass calculated for C45H52N60 8P [M-Hr: 835.37. Found: 835.4. 
5' -0-( 4,4' -dimethoxytrityl)-N2' -trifluoroacetamido-2' -deoxyuridine-3' -0-(2-
cyanoethyl N,N-diisopropylaminophosphoramidite), 10. Compound 10 was prepared 
using the same method described for 9, with the following workup procedure. After 90 
minutes the reaction was diluted with ethyl acetate which had been previously washed 
with cold 10% sodium carbonate. The organic layer was extracted twice with cold 10% 
sodium carbonate and once with brine. The organic fraction was dried over sodium 
sulfate and evaporated to an oil. The residue was purified on silica (eluting with 0-80% 
dichloromethane in hexane containing 1% TEA) to yield an off-white powder 10 in 65% 
yield (88 mg, 0.10 mmol). ESI-MS mass calculated for C41~6F3Ns09P [M-HT 840.31. 
Found: 840.4. 
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Oligonucleotide Synthesis. Protected deoxyribonucleoside phosphoramidites 
and other reagents required for solid-phase DNA synthesis were purchased from Applied 
Biosystems, Incorporated (ABI). All oligonucleotides were synthesized on a 1.0 Jlmole 
scale. Solid supports (7, 8) were packed in column assemblies purchased from ABI, and 
contained approximately 23 mg of derivatized resin, depending on the nucleoside 
loading. The initial coupling steps in each synthesis were increased from 30 seconds to 2 
minutes. The concentration of phosphoramidites (9, 10) typically ranged from 0.1-0.18 
Min dry acetonitrile. The coupling time for 9 and 10 was 15 minutes. 
Oligonucleotides 11, 13, and 14 were synthesized with the terminal 
dimethoxytrityl (DMT) group retained. Oligonucleotide 12 was prepared with the 5'-
DMT group removed prior to cleavage and deprotection. Oligonucleotides 11-13 were 
cleaved from the solid support with concentrated ammonia during the automated 
synthesis routine, and deprotected for either 16 hours at 55 °C or 4 hours at 65 °C. 
Oligonucleotide 14 was cleaved manually in 5 mL of concentrated ammonia for 16 hours 
at 55 °C. Oligonucleotides 15-18 were prepared by standard trityl-off procedures. 
Oligonucleotide Purification. Deprotected oligonucleotides containing a 5'-
DMT group were suspended in 20% triethylammonium bicarbonate buffer (1.0 M, pH 
8.5) in water and injected onto a reverse phase VYDAC 201HS1022 C18 column. 
Preparative HPLC was performed with a Waters 600E Controller and 994 Diode Array 
Detecter, using the following gradient: 0-100% B over 50 minutes, where A= 0.1 M 
triethylamine acetate, 2% acetonitrile; B = 0.05 M triethylamine acetate, 50% 
acetonitrile. The collected peaks were dried in vacuo and further purified using Waters 
C18 Classic SepPak cartridges. The amount of purified oligonucleotide was determined 
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spectrophotometrically, with ~::260 values given in parentheses: 11 (119,800 M-1 cm-1), 12 
(115,150 M-1 cm-1), 13 (95,900 M-1 cm-1), 14 (97,250 M-1 cm-1). 
Oligonucleotides 11, 13, and 14 were detritylated according to the procedure 
outlined by ABI manual and desalted using SepPak cartridges.20 The detritylated 
oligonucleotides were further purified using a weak anion exchange column purchased 
from SynChroPak (AX-100, analytical, semiprep), using the following gradient: 0-90% 
B over 35 minutes, where A= 50 mM sodium phosphate (pH 5.9), 30% methanol; B =50 
mM sodium phosphate (pH 5.9), 30% methanol, 1 M ammonium sulfate. The collected 
peaks were desalted using SepPak cartridges and assayed as described above. 
Oligonucleotide Yield. The overall yield of each modified oligonucleotide, 
following HPLC purification and workup, ranged from 30-40%, based on a 12-J,tmole 
synthesis. The detritylated, purified oligonucleotides 11-14 were characterized by 
MALDI-TOF mass spectrometry (Figures 2.20-2.23): 11, calculated, 3355 [M], found, 
3356.24 [M-Hr; 12, calculated, 3408 [M], found, 3407.17 [M-HL 13, calculated, 3230 
[M], found, 3228.38 [M-H]"; 14, calculated, 3320 [M], found, 3319.43 [M-Hr. 
Enzymatic Digestion of Oligonucleotides and HPLC Analysis. Approximately 
10-30 nanomoles of purified oligonucleotide was subjected to enzymatic digestion 
analysis. The digest cocktail (55 ~sample) contained bacterial alkaline phosphatase (4 
f.tL, 10 f.tUunit) and snake venom phosphodiesterase (2.4 f.tL, 1 rniJmg), in 1 M MgC}z 
(0.8 f.tL), 0.5 M Tris buffer, pH 7.5 (3.5 f.tL). The reaction mixture was incubated at 37 
oc for 8-16 hours. The reaction was stopped by adding 3 M sodium acetate (7 f.tL) and 
ethanol (155 f.tL) to the samples, which were then frozen on dry ice (10 minutes) and 
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centrifuged (10 minutes) at 4 °C. The supernatants were removed and transferred to new 
tubes, each containing 452 ~ ethanol. The samples were frozen and centrifuged; the 
resulting supernatants were removed and dried in vacuo. The samples were dissolved in 
water (200 J.!L) and injected onto a reverse phase Vydac (201HS54 4.6 mm x 25 em, 5 
micron, 90 angstrom) or Prism (Keystone Scientific, 4.6 x 250 mm, 5 micron, 100 
angstrom) C18 column. The product nucleosides were eluted within twenty minutes, 
according to either of the following gradients: (Vydac) 0-30% B over twenty minutes 
then 30-100% B over 10 minutes, where A = 0.1 M triethylamine acetate, 2% 
acetonitrile, B = 0.05 M triethylamine acetate, 50% acetonitrile; (Prism) 0-17% B over 
15 minutes then 17-75% B over 18 minutes, where A= 0 .1 M triethylamine acetate, pH 
7.0, 2% acetonitrile, B = 100% acetonitrile. The resulting peaks were compared against 
the appropriate set of nucleoside standards for a given oligonucleotide sequence. In all 
cases, the observed distribution of nucleosides matched the expected distribution (see 
Figures 2.5-2.8). 
Thermal Denaturation Measurements. Individual oligonucleotides were 
hybridized to their complementary strands in 50 mM NaPi buffer (pH 7.0), 0.5 M NaCl, 
to give solutions that were 2. 7 J.!M in each strand. The samples were heated for 20 
minutes at 70 oc and cooled to 4 oc overnight. Thermal denaturation profiles were 
measured at 260 nm with an Hewlett-Packard diode array UV -vis spectrophotometer 
equipped with a Peltier temperature controller and interfaced with a personal computer. 
Samples were equilibrated at 20 oc for 10-20 minutes prior to data collection. 
Absorbance values were taken over a temperature range of 20-70 °C, with measurements 
made every 0.5 oc with an equilibration time of 60 seconds for each point. Each hybrid 
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went through 2-4 separate heat-cool cycles, and the T m values obtained from these 
heating and cooling traces were averaged to give the final Tm value. Standard deviations 
were calculated for each duplex. 
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A general method for preparing oligonucleotides containing redox-active 
complexes was recently reported) This method employed oligonucleotides that 
contained 2'-amino-2'-deoxyuridine nucleosides at the 5' termini (Figure 3.1). These 
modified oligonucleotides were hybridized to complementary strands and subsequently 
treated with ruthenium(II) complexes. The extent of labeling at sites other than the 2' 
position of the terminal ribose was minimized by the presence of the complementary 
strand, which served as a large hydrogen-bonded blocking group. This strategy to protect 
reactive sites on the bases from metallation was an important advance in the preparation 
of metal-containing oligonucleotides. 
This post-synthetic modification method was employed to synthesize a series of 
ruthenium-modified oligonucleotides. The objective of this work was to prepare 
oligonucleotides containing the desired metal complex at a single, pre-determined 
location. Several oligonucleotides containing 2' -modified nucleosides were prepared as 
described in Chapter 2. The 2'-modified nucleosides and their positions in the target 
oligonucleotides are shown in Figure 3.2. Several unmodified oligonucleotides 
containing a single guanine base were also prepared for metallation reactions. 
The following ruthenium(II) reagents were used: [Ru(bpyh(C03], 
[Ru(NH3)5(0H2) ]
2
+, and [Ru(acac)2(CH3CN)2], where bpy = 2,2'-bipyridine, acac = 
acetylacetonate. The first two reagents have been used extensively in the modification of 
redox-active proteins at reactive histidine sites.2-7 The third reagent has not been used to 
label biological structures; however, the substitution chemistry of [Ru(acach(CH3CNh ] 
has been described in several reports .8-10 These metal complexes were selected based on 
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Figure 3.1: Reaction scheme for preparing metal-containing oligonucleotides as 
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ACGTAGCUa 








Figure 3.2: Structures of 2' -modified nucleosides and their positions m 11-mer 
oligonucleotides. 
137 
s·a UCTCCT ACACUa 
1J 1J 










the absorption and electrochemical features displayed by the anticipated products after 
metallation (Table 3.1).ll-l4 The metal-containing oligonucleotides were expected to 
have features similar to the model complexes shown in Figure 3.3. 
The remainder of Chapter 3 contains three sections summarizing results from 
metallation reactions involving and 
[Ru(acac)2(CH3CN)2]. For each section, the target oligonucleotides are given in figures 
and the reaction procedures are described schematically. Several parameters (reaction 
duration, temperature, pH) were investigated in the course of the metallation studies. The 
conditions leading to substantial metallation are summarized in the Experimental 
Procedure. Sample HPLC traces showing the distribution of products are given for each 
metal reagent. HPLC columns and buffers are summarized in Appendix E. 
Results: Metallation Reactions with [Ru(bpy)2C03) 
The target 11-mer oligonucleotides contained 2'-arnino-2'-deoxyuridine 
nucleosides at either 5' or 3' termini or both (Figure 3.4). Typically, the oligonucleotide 
was hybridized to its complementary strand in buffer containing 0.5 M sodium chloride. 
The duplex solution was deaerated under argon and the metal reagent was added (Figure 
3.5). The reaction proceeded at room temperature or slightly elevated temperatures. 
Several reaction conditions were explored to maximize the yield of 
oligonucleotide metallation (Table 3.2). The reactions were monitored by analytical 
HPLC to determine optimal reaction conditions. Substantial metallation ( -60%) was 
observed under the following conditions: 0.2 mM DNA, 2.0 mM [Ru(bpy)2C03), 50 mM 
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Table 3.1. Electrochemical and Absorption Data for Model Complexes. 
Complex E112• ya Amax. nma Refs. 
vs. NHE (EX 10"3, M"1 cm"1) 
[Ru(bpy h(im)(NH2R) ]
2+ 1.266 4806 11 
[Ru(NH3)s(pyr)] 2+ 0.35 407 (7.7) 12 
[Ru(NH3)4(ampy)] 2+ 0.30 414 (6.3) 12 
[Ru(NH3)4(impy)] 2+ 0.56 520 (6.1) 12 
378 (4.4) 
[Ru(acach(impy)] 0.23c 576 (4.6) 13 
402 (4.6) 
[Ru(NH3)s(N
7(G))] 2+ 0.15 565 (0.44) 14 
























t = 2-3 days 
room temp. 
t = 12 hours 
room temp. 
(a) Run(bpy )2C03 





Table 3.2. Summary of Conditions for Metallations with [Ru(bpyh(C03]. 
rxn # sample 









workup procedure yield 
C18 RP HPLC low 
C18 RP HPLC low 
gel filtration; C18 RP HPLC low 
SepPak; ion exchange HPLC moderate 
SepPak; ion exchange HPLC moderate 
SepPak; ion exchange HPLC moderate 
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HEPES (pH 8.5), 35 °C, 48 hours. A sample HPLC trace is shown in Figure 3.6. The 
yield after HPLC purification was <10%. 
Reactions with oligonucleotides containing a single 2'-amino-2'-deoxyuridine 
nucleoside at either the 5' or 3' end (aUT, TUa) highlighted the need for a complementary 
strand serving as a large blocking group. Experiments involving separate reactions of 
aUT and TUa with [Ru(bpyhC03] showed the formation of a multi-ruthenated 
oligonucleotide. HPLC and mass spectrometry indicated the presence of two ruthenium 
complexes attached to each oligonucleotide. A sample HPLC trace of the aUT 
metallation reaction is shown in Figure 3.7. 
Efforts to isolate the desired metal-containing oligonucleotide were hindered by 
the large amounts of unreacted metal reagent in the reaction mixture. Attempts to 
remove the excess metal included: (a) HPLC purification, (b) gel filtration, (c) dialysis, 
and (d) SepPak Cl8 elution. The most effective means of eliminating excess metal 
reagent was achieved by the last method. 
Further isolation of the metal-containing oligonucleotides employed both reverse-
phase and ion-exchange HPLC methods. Two reverse-phase columns were used: Cl8 
201HS54 (Vydac) and OligoR3 Cl8 (Perseptive Biosystems). Since the complementary 
strand was present in some of the reaction samples, it was necessary to separate it from 
the modified oligonucleotide. This was achieved by pre-heating the sample prior to 
injection into the HPLC system and by heating the column to 60 oc during the course of 
the chromatography. Heating the column proved effective for separating the two 
complementary strands when Cl8 RP columns were used. However, purification of the 
reaction mixture with Cl8 RP columns produced very small amounts of product. 
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Figure 3.6: HPLC trace of metallation reaction involving aUUa and [Ru(bpy)zC03]. 
Column: AX-100 weak anion exchange. Gradient: 0-90% B over 35 minutes. Buffer 
A: 50 mM sodium phosphate (pH 5.9), 30% methanol. Buffer B: 50 mM sodium 
phosphate (pH 5.9), 30% methanol, 1 M ammonium sulfate. Wavelength monitored: 








































































































































































Figure 3.7: HPLC trace of metallation reaction involving aUT and [Ru(bpy)2C03]. 
Column: AX-100 weak anion exchange. Gradient: 0-90% B over 35 minutes. Buffer 
A: 50 mM sodium phosphate (pH 5.9), 30% methanol. Buffer B: 50 mM sodium 
phosphate (pH 5.9), 30% methanol, 1 M ammonium sulfate. Wavelength monitored: 































































































































Ion-exchange HPLC columns were more effective than C18 RP columns for 
separating the metallated oligonucleotides from the unmetallated strands. Three weak-
anion exchange columns were used: AX-100 (SynchroPak), MonoQ (Pharmacia), and 
NucleoPac PA-100 (Dionex). Initially, the AX-100 column provided product separation 
that was far better than any results obtained with C18 columns. Further purification of 
metallation reactions was achieved with several solvent systems using the Dionex 
column. 
Experimental Procedure. For all metallation reactions involving duplex DNA, 
the individual oligonucleotides were quantitated and combined in the desired ratio (target 
strand:complementary strand). The solution of DNA contained either 100 mM Tris (pH 
7.2) or 100 mM HEPES (pH 8.5), plus 900 mM NaCl. Hybridization of the 
complementary strands involved heating the solution at 70-80 °C for 20 minutes and 
gradually cooling it to 4 oc over 6 hours in the cold room. The sample was deaerated 
under argon and equilibrated to the reaction temperature prior to the addition of the metal 
reagent. 
Metallation with [Ru(bpy)2C03]•4H20 of duplexes aUUa typically involved a 
final solution of 0.2 mM DNA and 2.0 mM Run. The metal complex was added 
dropwise under argon to the reaction vessel over thirty minutes. The reaction proceeded 
for approximately 48 hours at 35 °C, with aliquots removed periodically and reacted with 
10-fold excess of imidazole for 12 hours. The reaction's progress was monitored by RP 
HPLC performed at 60 oc to prevent any duplex formation. Unreacted metal complex 
was removed using a C18 SepPak cartridge (0.35g). The resulting metal-DNA fractions 
were injected on a Synchropak AX100 weak anion exchange column using the following 
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gradient: 0-90% B over 35 minutes, where A= 50 mM sodium phosphate (pH 5.9), 30% 
methanol; B = 50 mM sodium phosphate (pH 5.9), 30% methanol, 1 M ammonium 
sulfate. The collected fractions were dried down and desalted using a C18 SepPak 
cartridge. The amount of ruthenated aUUa was determined spectrophotometrically (20-
100 nmol). An analytical sample of ruthenated aUUa analyzed by electrospray mass 
spectrometry indicated the presence of two [Ru11(bpy)z(im)] fragments covalently 
attached to aUUa. 
Metallation reactions involving unduplexed aUUa were conducted in 50 mM 
HEPES (pH 8.5) at 35 oc at the DNA/Ru concentrations given above. An analytical 
sample of ruthenated aUUa analyzed by MALDI-TOF mass spectrometry indicated the 
presence of two [Ru11(bpy)z(im)] fragments covalently attached to aUUa: 3641, [M-
imidazolef and 4193, [M-(imidazoleh + matrixf. 
Separate metallation reactions of aUT and TUa (each unduplexed) followed the 
same procedure described above for unduplexed target strands, with the following 
modifications: 10 eq. of [Ru(bpy)zC03], 100 nmol of oligonucleotide, 2-day reaction 
time, T = 40 °C; 12 eq. of imidazole, 2-day reaction time; workup by SepPak; AX-100 
HPLC purification. The samples were preheated for 10 minutes at 60 oc prior to 
injection. The column was heated to 60 oc during the chromatography. An analytical 
sample of ruthenated aUT analyzed by MALDI-TOF mass spectrometry indicated the 
presence of two [Ru11(bpy)z(im)] fragments covalently attached to aUT: 3640, [M-
imidazole]", and 4194 [M-(imidazole)z + matrixf. Likewise an analytical sample of 
ruthenated TUa indicated two [Ru11(bpy)z(im)] fragments covalently attached to the oligo: 
3640, (M-imidazole]", and 4195 [M-(imidazoleh + matrixf. 
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Results: Metallation Reactions with [Ru(NH3)s(OHz)i+ 
Modified Oligonucleotides. The oligonucleotides targeted for metallation by 
[Ru(NH3) 5(0H2)]
2
+ are shown in Figure 3.8. They consist of 11-mer strands containing 
2' -modified nucleosides, as well as oligonucleotides that contain a single guanine over-
hang at the 5' terminus when hybridized to its complement. All reactions with 
[Ru(NH3) 5(0H2)]
2
+ contained the target oligonucleotides hybridized to complementary 
strands to minimize ruthenium labeling at multiple sites. Overall, this blocking method 
was ineffective and the ruthenium reagent was incorporated at several locations on the 
target oligonucleotides. 
Metallation reactions with [Ru(NH3) 5(0H2)]
2+ of samples containing duplexed 
aUUb and llB took place at neutral pH, lasting for 3-16 hours at room temperature under 
an argon atmosphere (Figure 3.9). During this time, the solution changed from yellow to 
orange-brown. Exposure to air caused the solution to become a dark purple. Subsequent 
workup and HPLC purification produced an oligonucleotide pellet that was purple. A 
solution of the sample displayed broad absorption bands at 330 and 545 nm (Figure 3.10). 
Mass spectral analysis of this material gave results suggestive of an oligonucleotide 
modified with one or more Ru-amrnine complexes (data not shown). However, the 
precise identity of the metal-containing oligonucleotide was not clear. 
Model Complexes. Model reactions were conducted with N-(isopropyl)-
aminomethylpyridine and [Ru(NH3) 5(0H2)f+ under conditions similar to the 
oligonucleotide metallation (Figure 3.11). The reaction was monitored by absorption 
spectroscopy; an aliquot from the reaction taken after 12 hours of stirring at room 
temperature displayed absorption bands at 206, 254, and 402 nm (Figure 3.12). (The 
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Figure 3.11: Reaction scheme for the synthesis of [Ru(NH3) 4(impy)]





50 mM: Tris, pH 7.2 






Figure 3.12: Absorption spectra of (a) [Ru(NH3) 4(ampy')]
2
+ (solid line) and (b) 
[Ru(NH3) 4(impy')]
2
+ (dashed line) in 50 mM Tris, pH 7.2. Abbreviations: ampy' = N-











high-energy bands represent internal 7t-7t* ligand transitions; the feature at 402 nm is a 
MLCT from the Ru(II) to the pyridine ligand.)l2 Exposure of the sample to air caused 
several changes in the absorption spectrum. The band at 402 nm disappeared, and the 
spectrum was marked by the appearance of two additional bands with maxima at 366 and 
502 nm (Figure 3.12). Kinetic analysis of the changes at/.. = 402 nm and/..= 528 nm 
gave virtually equivalent rate constants (k402 = 3.4 x 104 s-1; k528 = 5.0 x 10-4 s-1) . 
Isosbestic points were observed at 386 and 455 nm. 
These results were consistent with reports describing the products from the 
oxidative dehydrogenation of amine ligands coordinated to ruthenium)2,15-19 Ford and 
coworkers showed that air-exposure of [Ru(NH3)4(ampy)]
2+ (ampy = 
aminomethylpyridine) leads to the formation of [Ru(NH3) 4(impy)f+ (impy = 
iminomethylpyridine).l2 Subsequent work by Keene and Meyer outlined the mechanism 
of oxidative dehydrogenation for a related complex, [Ru(bpy)2(ampy)]
2+ (Figure 3.13).17-
19 The key intermediate in this mechanism is the Ru(IV) species that is formed upon 
disproportionation of the initial product of air-exposure, Ru(Ill) . The high oxidation state 
facilitates a low-energy pathway for the transfer of two electrons needed for the 
dehydrogenation reaction.l8 
Additional model complex reactions involving oxidative dehydrogenation of 
coordinated ligands are described in Appendix B. 
G-containing Oligonucleotides. Additional metallation reactions involved 
oligonucleotides containing a single guanine base overhanging on one end of the duplex 
(Figure 3.14). The guanine base was used as a metal attachment site. Reports by Clarke 
and coworkers describe the selective coordination of [Ru(NH3)5(0H2) ]
2+ to N7 of guanine 
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Figure 3.13: Scheme showing the mechanism of oxidative dehydrogenation of amines 




H2N 2+ H2N 3+ 









Figure 3.14: Reaction scheme for metallation of duplexes containing an overhanging 
guanine base at the 5' end. 
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Guanine as Metal Attachment Site 
5' .. 9 bp .. 5' -----G 12 bp -------G 
8 bp 11 bp 
5-' ---9 _bp---G [Ru(NH3)5]
3
+ 




bases contained in calf-thymus DNA.20-22 Studies of ruthenium(II) guanine complexes 
have demonstrated this selectivity.23-26 
Metallation of G-containing oligonucleotides was pursued to avoid preparing 
oligonucleotides modified with a metal-binding ligand. The discouraging results 
obtained from metallations of aUUb and llB motivated this change in the type of 
oligonucleotides targeted. The reactions were conducted according to the procedure 
described for metallation of aUUb and llB. However, metallations of G-containing 
oligonucleotides failed to be selective for the single guanine. This conclusion is 
supported by the number of metallated products indicated in the HPLC traces. Attempts 
to control the metallation of duplexed G-containing oligonucleotides by limiting the 
amount of [Ru(NH3) 5(0H2)]
2+ present in the reaction did not minimize the complexity of 
the resulting solution (Figure 3.15). Reactions lasting as short at 15 minutes resulted in 
multi-ruthenated oligonucleotides. 
unsuccessful. 
Separation of these products by HPLC was 
Experimental Procedure. Metallation of aUUb hybridized to its complementary 
strand involved a final solution of 0 .1 mM DNA duplex and 1 mM [Ru(NHJ)s(OHz)]Ch 
that had been freshly reduced over Zn!Hg amalgam in 100 mM Tris buffer (pH 7.2). The 
reaction mixture turned from yellow to an orange-brown over 3 hours under argon at 
room temperature, at which time the reaction vessel was opened up to air. Within 15 
minutes the reaction solution changed to a dark purple. The solution was dried down or 
desalted right away by gel filtration, followed by ion exchange HPLC analysis. 
Metallation of G-containing oligonucleotides proceeded as follows. Duplexes 
were prepared in 100 mM Tris (pH 7.2) containing 900 mM sodium chloride. Typical 
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Figure 3.15: HPLC trace of metallation reaction involving duplexed 9G and 
[Ru(NH3) 5(0H2)]
2
+ (1:1.5 DNA:Ru, t = 35 minutes, 50 mM Tris (pH 7.2), 900 mM 
sodium chloride). Column: Dionex NucleoPac 100. Gradient: 0-15% B over 4 minutes, 
15-30% B over 33 minutes. Buffer A: 25 mM Tris (pH 8.0), 0.5% acetonitrile. Buffer 
B: 25 mM Tris (pH 8.0), 0.5% acetonitrile, 1.5 M ammonium chloride. Wavelength 
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reactions contained 0.95 mM DNA and 0.95-4.8 mM [Ruf+ and were stirred at room 
temperature for 30-60 minutes. Air was bubbled through the solution until the solution 
was purple. The sample was dialyzed, dried to a pellet, and purified by ion-exchange 
HPLC methods (Dionex column). A sample HPLC trace showing the reaction after 30 
minutes is given in Figure 3.15. 
Results: Metallation Reactions with Ruthenium( II) Acetylacetonate Reagents 
The oligonucleotides targeted for metallation with [Ru(acac)3], 
[Ru(acac)z(CH3CN)z], and [Ru(acac)z(tmen)t (where tmen = tetramethylethylene 
diamine) included aUUb and llB (see Figure 3.8). Metallations of aUUb took place in 
absence of a complementary strand; therefore, these solutions did not contain sodium 
chloride. Metallations of llB contained duplexed samples of this target oligonucleotide, 
thus requiring that a high concentration of sodium acetate be present in the solution. All 
reactions were conducted under an argon atmosphere. Typically [Ru(acach] and 
[Ru(acac)z(tmen)t were reduced over Zn/Hg and then transferred under argon to the 
oligonucleotide sample. Some reactions took place in the presence of solid Zn/Hg. 
Metallations performed with [Ru(acac)z(CH3CN)z], did not require reduction prior to 
addition to the DNA. 
Model Complexes. Reactions with a 2' -modified nucleoside assisted in 
designing suitable oligonucleotide metallation conditions (Figure 3.16). The 5'-DMT 
protected form of N2' -(2-pyridylmethyl)-2' -amino-2'-deoxyuridine was reacted with 
either [Ru(acac)3] or [Ru(acac)z(CH3CN)z] to give the metallonucleoside shown in Figure 
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Figure 3.16: Reaction scheme for the synthesis of [Ru(acac)z(impy')] (where acac = 








3.16. Details of the model complex synthesis are given in Appendix B. Full 
characterization of the metallonucleoside is given in Chapter 5. 
Modified Oligonucleotides. Several reactions were performed with aUUb under 
different conditions (Table 3.3). Metallations conducted with [Ru(acac)2(CH3CNh] were 
more successful than those using [Ru(acac)3] or [Ru(acach(tmen)t. Solutions 
containing [Ru(acach(CH3CNh] remained a clear yellow or yellow-brown throughout 
the course of the metallation. Analytical HPLC was used to monitor the progress of the 
reactions and employed both ion-exchange and reverse-phase columns. Sample 
chromatograms for metallations of aUUb and llB are shown in Figures 3.17 and 3.18. 
Because the peaks displaying absorption spectra suggestive of Ru(acach-containing 
oligonucleotides eluted closely to other unmetallated peaks, separation of the desired 
peaks was difficult. Mass spectral results for such peaks are given in Figures 3.19 and 
3.20. Overall, approximately 15-25 nmoles of Ru(acac)2-modified aUUb were isolated. 
Experimental Procedure. Metallation of aUUb and duplexes llB involved final 
solutions of 0.17 rnM DNA and 0.17-3 rnM ruthenium(II) reagent. [Ru(acach] and 
[Ru(acac)2(tmen)t were reduced over Zn/Hg amalgam in 25-50 rnM Tris buffer (pH 7.2) 
and transferred via syringe to the reaction vessel. The solutions were deaerated under 
argon or degassed by the freeze-pump-thaw method. Reaction mixtures were typically 
red-pink in the presence of [Ru(acac)3] or [Ru(acac)2(tmen)t. Reactions containing 
[Ru(acach(CH3CNh] were yellow, yellow-brown, or orange. Aliquots were desalted by 
dialysis or SepPak elution. HPLC purification was performed by either ion-exchange 
(Dionex column) or reverse-phase (Oligo R3, T = 60 °C) chromatography. The collected 
fractions were dried down and desalted by SepPak elution. 
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Table 3.3. Conditions for Metallation Reactions involving Ruthenium(II) 
Acetylacetonate Reagents 













Ru(acac )z(CH3CN)2 1.2:1 
a Buffer concentration: 25-50 rnM. 
aUUb Tris, pH 7.2 25 
50% EtOH25 
aUUb Tris, pH 7.2 80 
50% EtOH 
aUUb Tris, pH 7.2 90 
aUUb Tris, pH 7.2 25 
aUUb Tris, pH 7.4 75 
aUUb Tris, pH 7.4 75 
aUUb Tris, pH 7.4 75 
aUUb Tris, pH 7.4 75 
aUUb Tris, pH 7.4 65 
aUUb Tris, pH 7.4 65 
a UUb Tris, pH 7.4 65 
aUUb Tris, pH 7.4 70 
a UUb Tris, pH 7.4 70 
llBb Tris, pH 7.4 40 
0.9MNaOAc 
b 11B hybridized to its complementary strand. 
















Figure 3.17: HPLC trace of metallation reaction involving aUUb and 
[Ru(acac)z(CH3CN)z] (1:3 DNA:Ru ratio, 25 mM Tris (pH 7.4), T = 65 °C, t = 26 hours). 
Column: Dionex NucleoPac 100. Gradient: 10-60% B over 3 minutes, 60-67% B over 
25 minutes. Buffer A: 10% acetonitrile. Buffer B: 10% acetonitrile, 1.5 M ammonium 
acetate. Wavelength monitored: 260 nm. Absorption spectra for the peaks are given in 

































































































































































































Figure 3.18: HPLC trace of metallation reaction involving duplexed 118 and 
[Ru(acac)2(CH3CNh] (1:1.2 DNA:Ru ratio, 50 mM Tris (pH 7.4), 900 mM sodium 
acetate, T = 40 °C, t = 5 days). HPLC sample was pre-heated at 65 oc for 15 minutes. 
Column: Oligo R3, T = 65 °C. Gradient: 10-60% B over 3 minutes, 60-67% B over 25 
minutes. Buffer A: 100 mM ammonium acetate (pH 8.5), 2% acetonitrile. Buffer B: 
100% acetonitrile. Wavelength monitored: 260 nm. Absorption spectra for the peaks 
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Figure 3.19: MALDI-TOF mass spectrum of fractions collected after HPLC purification 
of reaction involving aUUb and [Ru(acac)z(CH3CN)z]. See Figure 3.17 for HPLC trace. 
The molecular weight calculated for the desired metal-containing oligonucleotide { [M] = 














































Figure 3.20: MALDI-TOF mass spectrum of fractions collected after HPLC purification 
of reaction involving duplexed llB and [Ru(acach(CH3CNh]. See Figure 3.18 for 
HPLC trace. The molecular weight calculated for the desired metal-containing 























































Metallations with [Ru(bpy)2C03} 
Attempts to incorporate [Ru(bpy)2C03] into oligonucleotides modified with 
amine ligands were complicated by several factors. Effective purification methods were 
difficult to develop due to the multiple components in the reaction mixture. 
Commercially available resins provided inadequate separation of the metallated 
oligonucleotides from unreacted starting materials. Identification of product fractions 
was hampered by the lack of high-recovery methods suited for desalting short 
oligonucleotides containing cationic metal complexes. These issues thwarted efforts to 
properly optimize the reaction conditions. 
The lengthy reaction times needed for significant metallation further exacerbated 
efforts to optimize the reaction conditions. The substitution chemistry of the Ru(ll) 
center was hindered by the presence of the near-molar quantities of sodium chloride 
required to stabilize the short duplex. However, conditions of low ionic strength did not 
lead to selective modification of the target oligonucleotide. 
Metallation of oligonucleotides with [Ru(bpyhC03] is a complicated reaction for 
several reasons. The desired "ligand"- the 2' amine group on the terminal nucleoside of 
an oligonucleotide-is attached to a highly charged oligonucleotide. It is not intended for 
this oligonucleotide to participate in the substitution reaction. However, single-stranded 
oligonucleotides-such as aUT and TVa--containing a single "ligand" are modified with 
more than one metal complex upon metallation with [Ru(bpyhC03]. These results 
confirm that metal complexation is not exclusive for the targeted ligand. 
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These results are consistent with those reported by Netzel and coworkers for 
incorporating [Ru(bpyh(OH2h]
2+ into oligonucleotides using post-synthetic modification 
methods (Chapter 1). An equimolar amount of this ruthenium reagent was incubated in 
the presence of a bpy-bearing oligonucleotide that was unhybridized. This led to multiple 
ruthenium-containing oligonucleotides despite the fact that the DNA bases are poor 
ligands compared to bpy in this context. The lack of selective labeling precludes the 
wide-spread applicability of this method to certain metal complexes. 
Metallation Reactions with [Ru(NH3)5(0Hz)/+ 
Reactions with [Ru(NH3)s(OH2)]
2+ provided additional insight into the challenges 
of incorporating ruthenium complexes at single sites within several oligonucleotides. 
Oligonucleotides containing the nucleoside Ub were targeted initially, since the 
anticipated product would display features characteristic of the model complex, 
[Ru(NH3) 5(pyr)]
2+. However, the results indicated the formation of a species displaying 
absorption features different from those of the expected product. Observations from a 
reaction between [Ru(NH3) 5(0H2)]
2+and a small molecule analogue of Ub-type 
oligonucleotides aided in understanding these results. A comparison of the absorption 
features of the products isolated from both reactions suggested that the metallated 
oligonucleotide contained a metal complex at the desired Ub site; however, the nature of 
the complex was of the type [Ru(NH3) 4(impy)]
2+. While a metallated oligonucleotide in 
this form has many desireable features, we concluded that the absorption bands displayed 
by this species were too broad and weak for the transient absorption studies we 
envisioned. 
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In addition to this result, there were several reasons why metallation with 
[Ru(NH3) 5(0H2)]
2
+ was unsuccessful. Efforts to minimize ruthenation at multiple sites 
by using the complement as a blocking group were ineffective. We predicted that the 
multi-metallated oligonucleotides contained guanine bases modified with this ruthenium 
reagent. This assessment was based on the work by Clarke involving the selective 
coordination of [Ru(NH3) 5(0H2)]
2
+ to N7 of guanine.20-22 The presence of these other 
metal-containing oligonucleotides complicated the isolation of the [Ru(NH3) 4(impy)]
2
+-
modified oligonucleotide. Additionally, mass spectral characterization of such 
oligonucleotides was unreliable since the metallated species were not stable in the 
conditions of MALDI-TOP analysis. Efforts to characterize the products using a more 
gentle mass spectral method (ESI-MS) were hindered by the presence of salt 
unsuccessfully removed from the HPLC fraction. 
The likelihood of guanine labeling by [Ru(NH3) 5(0H2)]
2
+ motivated further 
attempts to obtain oligonucleotides containing a single metal complex. Since unmodified 
strands of any sequence could be prepared commercially, we investigated using duplexes 
containing an overhanging guanine at the 5' end in subsequent metallation reactions. If 
prepared, these metal-containing oligonucleotides would serve as complementary strands 
to oligonucleotides separately metallated with [Ru(bpyh C03] . (The sequence of the G-
containing oligonucleotide was constrained by the sequence of complementary 
oligonucleotides already containing [Ru(bpyhC03]).27 However, the results from 
metallations of G-containing oligonucleotides showed that controlling the substitution of 
[Ru(NH3)s(OH2)]
2
+ was difficult. At 1:1 Ru:DNA concentrations, substantial metallation 
was observed after only a few minutes. HPLC traces indicated that multiple products 
189 
were formed under these conditions. After several attempts to limit the metallation to the 
single guanine base in solution, experiments with [Ru(NH3)5(0H2)]
2
+ were discontinued. 
Metallation Reactions with Ruthenium( II) Acetylacetonate Reagents 
Reactions involving three Ru(II) acac reagents demonstrated the difficulty of 
incorporating redox-active complexes into oligonucleotides. Metallations of aUUb with 
[Ru(acach] were unsuccessful due to the extreme oxygen sensitivity of the reduced metal 
complex. [Ru(acach(CH3CNh] was a desireable reagent for metallation since (a) it was 
not as air-sensitive as [Ru(acac)3t, (b) it did not require reduction over Zn/Hg prior to 
addition to the oligonucleotide solution, and (c) the substitution chemistry of 
[Ru(acac)2(CH3CNh] could be managed by the reaction temperature. Model complex 
reactions performed with [Ru(acac)2(CH3CN)2] assisted in designing optimal reaction 
conditions for oligonucleotide metallation. Reactions involving [Ru(acach(CH3CNh] 
and 118 provided the desired metal-containing oligonucleotide, although there were 
several metallated oligonucleotides also produced in the course of the reaction. 
Conclusion 
Overall, incorporating ruthenium(II) complexes into the oligonucleotides using 
the post-synthetic modification method was unsuccessful. While this method originally 
provided metallated oligonucleotides under conditions similar to those described here,l 
its application to oligonucleotides of different length and sequence proved ineffective. 
The systematic variation of several reaction parameters (reaction time, temperature, pH, 
ionic strength, concentration, ratio of reactants, presence of complement, presence of 
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reductant, oligonucleotide sequence) did not yield large amounts of metallated 
oligonucleotides. 
Despite these disappointing results, the insight gained from these studies has 
value. There are multiple factors controlling the successful incorporation of metal 
complexes into oligonucleotides using post-synthetic modification. One important factor 
is the association of the ruthenium complex with oligonucleotides, whether they be 
single- or double-stranded. The overall charge of the complex and the affinity of the 
ruthenium center for the binding sites available within DNA contribute to this 
association. Since multiple ruthenium-containing oligonucleotides were generated in 
reactions involving both dicationic and neutral ruthenium reagents, no correlation 
between yield of labeling and overall charge on the ruthenium complex emerges from 
these experiments. 
Examining these factors contributes to our understanding of how metal complexes 
interact with nucleic acids. Such an understanding can aid in the design and development 
of metal reagents as drug candidates. For instance, promising candidates would behave 
like [Ru(NH3)5(0H2)]
2
+, as opposed to [Ru(bpyhC03], due to the different rates of 
substitution displayed by these complexes in the presence of DNA. Unlike the conditions 
of solid-phase incorporation of metal complexes, the metallation experiments like those 
described in this chapter more closely mimic the biological setting in which metal-DNA 
interactions become important. 
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Chapter 4 
Automated Synthesis of 3' -Metallated Oligonucleotides 
194 
Introduction 
Recent studies of electron transfer (ET) through DNA have employed redox-
active probes bound to single- and double-stranded oligonucleotides.l-8 An important 
objective in this area continues to be the facile and site-specific incorporation of metal 
complexes into DNA. One method to achieve this involves the synthesis of 
oligonucleotides possessing metal-binding ligands, followed by incorporation of the 
metal complexes at these sites.8-21 While this method enables the preparation of various 
metal-containing oligonucleotides from the same strand, it requires large amounts of 
metal reagent, lengthy reaction times, and multiple chromatographic separations. A 
second method entails the preparation of metal-containing monomers that can be 
incorporated during solid-phase DNA synthesis using standard phosphorarnidite coupling 
techniques.22-32 Advantages of this method include: rapid preparation of metal-
containing oligonucleotides, high yields of metal incorporation, and routine product 
isolation. The success of this approach depends on the construction of individual 
metallated monomers that are compatible with automated DNA synthesis techniques. 
Several groups have introduced metal complexes into DNA using metallated 
phosphonate and phosphoramidite monomers, where the metal complex (containing 
either Ptn, Run, or Os11) is attached to the nucleoside base (Chapter 1).23,24,27,28,32,33 
Other examples include nonnucleosidic phosphoramidite monomers where the metal 
complex is tethered to the terminal phosphate group of the oligonucleotide.25,29 We 
designed two modified nucleosides containing low- and high-potential metal complexes, 
as introduced in Chapter 1 (Figure 4.1 ).31 Because the site of modification is the 2' 
position (as opposed to other ring positions), it is possible to 
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Figure 4.1: Synthesis of metallonucleosides and metal-containing solid support: (a) 2-
pyridinecarboxaldehye, EtOH, 2h; (b) Ru(acac)2(CH3CN)z, EtOH, 1h, 79% yield; (c) 
Ru(bpy)2Cl2, EtOH, 4 h, 19% yield; (d) succinic anhydride, DMAP, pyridine, 18 h, 54% 
yield; (e) solid support, TEA, HOBT, BOP, CH2Cl2, rt, 16 h; acetic anhydride, N-
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prepare these metallonucleosides as monomers that can be delivered during automated 
DNA synthesis. 
We predicted that the presence of a metal complex at the 2' ribose position would 
decrease the coupling of phosphoramidite derivatives of 2 and 3. Therefore, we prepared 
customized solid supports containing the desired metallonucleoside and used these solid 
supports to initiate DNA synthesis. Because oligonucleotide synthesis proceeds step-
wise in a 3' ---7 5' direction beginning with the nucleoside pre-derivatized to the solid 
support, all products isolated from the DNA synthesizer contain the metal complex. This 
method enables the rapid production of 3' -metallated oligonucleotides. The overall yield 
is not compromised by the coupling of a metallated phosphoramidite. Most importantly, 
the combination of both phosphoramidite and solid support-bound metallonucleosides 
affords the synthesis of an oligonucleotide containing metal complexes at the 3' and 5' 
ends (Appendix D). 
Here we report the first synthesis of a metallonucleoside bound to a solid support 
and subsequent oligonucleotide synthesis with this precursor. Due to its stability in both 
the mildly acidic and strongly basic solutions that are routinely encountered during solid-
phase DNA synthesis, 3 is an excellent candidate for conjugation to the solid support. 
However, the acid sensitivity of 2 precludes its use as a solid support-bound 
metallonucleoside. Large-scale syntheses of metal-containing oligonucleotides are 
achieved with the solid support modified with 3. Interestingly, the yield is comparable to 
the values obtained for oligonucleotides synthesized with unmodified solid supports. A 
duplex formed with the purified metal-containing oligonucleotide exhibits superior 
thermal stability when compared to the corresponding unmetallated duplex. The 
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spectroscopic properties of the single- and double-stranded metal-containing 
oligonucleotides are unchanged from those of the metallonucleoside. 
Results 
Synthesis of Ruthenium-Containing Solid Support. The metal-binding 
nucleoside 1, 5' -0-( 4,4' -dimethoxytrityl)-2' -iminomethylpyridyl-2' -deoxyuridine, was 
prepared in situ by condensation of 5'-0-(4,4'-dimethoxytrityl)-2'-amino-2'-deoxyuridine 
and 2-pyridinecarboxaldehyde (Figure 4.1). The ruthenated nucleoside 2 was synthesized 
by addition of Ru(acach(CH3CN)2 to 1 and isolated in 79% yield (see Chapter 5 for 
synthetic details and full characterization). Addition of Ru(bpyhClz to the intermediate 1 
gave 3, which was isolated in 19% yield. 
The preparation of the ruthenium-containing solid support was based on our work 
involving the derivatization of solid supports with 2' -substituted uridine nucleosides 
(Chapter 2). Treatment of 3 with succinic anhydride in the presence of DMAP34 yielded 
the hemisuccinate 4 in 43% yield.35 Derivatization of the solid support with an excess of 
4 using the coupling agent BOP, followed by capping of the unreacted sites, produced the 
ruthenium-containing solid support 5 with high nucleoside loading (- 30 J..tmol/g).36 The 
derivatization yield was comparable to those observed in the preparation of solid supports 
with similar 2' -modified nucleosides (Chapter 2). 
Oligonucleotide Synthesis with 5. The preparation of 10- and 11-mer 
oligonucleotides containing the Ru-modified nucleoside at the 3' terminus was done on a 
1.0 J..tmol scale. Automated DNA synthesis with 5 is illustrated in Figure 4.2; the length 
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Figure 4.2: Oligonucleotide synthesis with the metal-containing solid support: (a) 
detritylation of 5; monomer coupling; normal synthesis cycle; (b) detritylation of nascent 
oligonucleotide, monomer coupling; normal synthesis cycle; (c) cleavage of 
oligonucleotide from solid support and removal of protecting groups. Oligonucleotides 6 







5' CTCCTACACU Ru 
!(c) ~ 
6 5' CT CCT ACA CU Ru 3' 
7 5' TCT CCT ACA CU Ru 3' 
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of the first coupling step lasted from 2-10 minutes. Cleavage of the products from the 
solid support was performed manually using concentrated aqueous ammonia. Incubation 
at room temperature for 15 hours followed by 3 hours at 55 oc provided optimal cleavage 
and deprotection conditions. Figure 4.3 shows the HPLC profile of the crude mixture of 
deprotected oligonucleotide 7. The purity and composition of oligonucleotides 6 and 7 
were verified by mass spectrometry and enzymatic digestion. MALDI-TOF (matrix-
assisted laser desorption ionization/time-of-flight) mass spectra of 6 and 7 showed a 
single peak representing the singly charged species and having m/e ratios equal to 
3425.73 (calc. 3425.56) and 3728.55 (calc. 3730.76), respectively (Figure 4.4). HPLC 
analysis of the enzymatic digestion products of 6 and 7 confirmed the presence of a 
single metallonucleoside 3 in each oligonucleotide (Figures 4.5 and 4.6). 
Absorption. The electronic spectrum of 3 displays intense UV transitions (210, 
238, 256, 284 nm) and a broad absorption band in the visible region (480 nm). The high-
energy bands represent the bipyridine- and nucleoside-based n-n* transitions. The 
feature at 480 nm represents multiple metal-to-ligand charge-transfer (MLCT) transitions 
due to the presence of the bipyridine and iminomethylpyridine groups coordinated to the 
ruthenium center (Chapter 5).37-39 The electronic spectra of 6 and 7 display the same 
broad band in the visible region, verifying that 3 was successfully incorporated into these 
oligonucleotides (Figure 4.7). The n-n* transitions of the oligonucleotide bases are 
unaffected by the presence of the metal complex. 
Thermal Denaturation Studies. We investigated the thermal stability of a 
ruthenium-containing duplex to assess the influence of the metal complex on the overall 
DNA structure. Table 4.1 contains the sequences of the duplexes prepared in 50 mM 
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Figure 4.3: Ion-exchange HPLC trace of the crude mixture following synthesis, 
cleavage, and deprotection of oligonucleotide 7 (denoted by *; A = 260 nm). Column 
type: Dionex NucleoPac 100. Gradient: 10-33% B over 1 minute, 33-44% B over 17 
minutes (A = 10% acetonitrile; B = 10% acetonitrile, 1.5 M ammonium acetate). Flow 













Figure 4.4: MALDI-TOF mass spectra for ruthenium-containing oligonucleotides, 6 
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Figure 4.5: Products of enzymatic digestion of 6 as analyzed by reverse-phase HPLC. 
Sequence: 5'-CTCCTACACURu· Integration of the peak areas gives 5C:2T:2A:1URu (A. 
= 260 nm). The peaks observed at t = 18.57 and 19.07 minutes display identical 
absorption spectra and represent the diastereomers of the ruthenium-containing 
nucleoside generated after complete digestion. See Experimental Section for additional 
information. The extinction coefficient for URu at 260 nm is 23300 M-1 cm-1• Column: 
Prism C18. Gradient: 0-17% B over 15 minutes, then 17-75% B over 15 minutes. 
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Figure 4.6: Products of enzymatic digestion of 7 as analyzed by reverse-phase HPLC. 
Sequence: 5'-TCTCCTACACURu· Integration of the peak areas gives 5C:3T:2A:lURu 
(A. = 260 nm). The peaks observed at t = 18.85 and 19.45 minutes display identical 
absorption spectra and represent the two diastereomers of the ruthenium-containing 
nucleoside generated after complete digestion. See Experimental Section for additional 
information. The extinction coefficient for URu at 260 nm is 23300 M-1 cm-1. Column: 
Prism C18. Gradient: 0-17% B over 15 minutes, then 17-75% B over 15 minutes. 




0 . 55· 











• .'oo , :oo 1.'oo 14 . 00 
210 
Figure 4.7: Absorption spectra of 3 (top; methanol) and 7 (bottom; 0.05 M sodium 
phosphate, pH 7.0, 0.5 M sodium chloride) at room temperature. Amax (£, M-1 cm-1) for 7: 

























Table 4.1. Thermal Denaturation Temperatures for Metallated and Modified 
Oligonucleotides. a 
sequence abbreviation modification duplex Tm (°C)b 
5' -TCTCCTACACURu 7 3'URu 7•9 49.5 ± 0.6 
5' -TCTCCT ACACT 8 none 8•9 47.6 ± 0.2 
5' -AGTGTAGGAGA 9 none 
5'-8 UCTCCTACACUa 10 3' U8 , 5' Ua 10•9 45.8 ± 0.5 
5' -3 UCTCCTACACUb 11 3' Ub, 5' Ua 1h9 46.2 ± 0.5 
a The symbol Ua denotes 2'-amino-2'-deoxyuridine; Ub denotes N2,-(2-pyridylmethyl)-2'-
amino-2'-deoxyuridine. b Values were determined in 0.05 M sodium phosphate buffer 
(pH 7 .0) containing 0.5 M sodium chloride. 
213 
sodium phosphate buffer (pH 7.0) containing 0.5 M sodium chloride. The melting 
temperature (T m) of the duplex formed by the unmodified oligonucleotide 8 and its 
complement 9 is 47.6 oc (Figure 4.8). The ruthenium-containing duplex formed by 7 and 
9 exhibits a single, cooperative melting transition similar to the transition observed for 
the unmodified duplex. The T m of 7·9 is 50.0 °C, 2 °C higher than that of 8·9. 
Differences of a few degrees in the T m values of metal-containing vs. unmodified 
duplexes are observed for duplexes containing other metal complexes)2,19,27,32,33 
Electrochemistry. Voltammograms of 3 in dichloromethane display a reversible 
one-electron oxidation (1.6 V vs. normal hydrogen electrode, NHE), which represents the 
Ru(IIIIII) couple. This reduction potential compares well with that reported for the 
model system [Ru(bpy)z(impy)]2+ , where impy = iminomethylpyridine (1.5 V vs. NHE, 
acetonitrile))? The Ru(IIIIII) reduction potential for 3 is slightly more positive than that 
of the model complex, suggesting that the proximity of the nucleoside to the metal center 
may be responsible for the small positive shift. This effect is observed for 
metallonucleoside 2 (E112 = 0.29 V vs. NHE, ethanol) and Ru(acac)z(impy), where acac = 
acetylacetonate (E112 = 0.23 V vs. NHE, ethanol).31 Incorporation of 3 into an 
oligonucleotide, 7, results in a Ru(IIIIII) couple of 1.3 V in aqueous solution (Figure 4.9). 
Multiple ligand-centered reductions are observed (-0.8, -1.1 , -1.3 V vs. NHE) for 
3; the most positive reduction is irreversible. Similar results have been reported for a 
series of Ru(bpy)z(a,a'-diimine)2+ complexes.37 Based on these values, estimates of the 
excited-state potentials of 3 are (£3+12+*) - -0.18 V and (E2+*fl+) - 1.0 V vs. NHE, 
respectively. 40 
Additional discussion of these electrochemistry results can be found in Chapter 5. 
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Figure 4.8: Thermal denaturation curves for duplex 8·9 (0) and metal-containing 
duplex 7·9 ( • ). Sequences are given in Table 4.1. Buffer: 50 mM sodium phosphate 
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Figure 4.9: Square-wave voltammogram of oligonucleotide 7 m 50 mM sodium 
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Emission. Steady-state emission spectra of metallonucleoside 3 and oligonucleotide 7 
show similar profiles. Excitation of either 3 or 7 at 480 nm produces an emission 
maximum at 730 nm, with a shoulder near 810 nm (Figure 4.10). The excited-state 
lifetimes are strictly monoexponential and are independent of solvent: 44 ns for 3 
(aqueous methanol) and 42 ns for 7 (phosphate buffer). However, the quantum yield of 3 
is slightly greater than that of 7 (Table 4.2). These observations support the assertion that 
the lowest electronically excited state is the same for both the metallonucleoside and 
ruthenium-containing oligonucleotide (Chapter 5).31 
The absence of any significant differences in the lifetimes of 3 and 7 demonstrates 
that the bases contained in 7 (adenine, cytosine, thymine) do not quench the luminescent 
MLCT state. The addition of the guanine-rich complementary strand 9 to 7 does not 
alter the excited-state lifetime, suggesting that (1) hybridization does not influence the 
emissive properties of the incorporated ruthenium complex and (2) the photoexcited 
species does not oxidize guanine, the most easily oxidized base (E+•to = 1.3 V vs. NHE, 
pH 7).41 Absorption spectra recorded at various time points after initial excitation 
confirm this assessment. Data collected at multiple wavelengths did not indicate guanine 
oxidation (Appendix C). 
The addition of quenchers known to generate potent Ru(ill) oxidants from 
photoexcited Ru(II) polypyridyl species does not lead to detectable guanine oxidation.42 
For example, oxidative quenching of photoexcited 7·9 by [Ru(NH3)6]3+ is described by 
linear plots of the observed decay rate constant (kobs) vs. quencher concentration under 
conditions of high ionic strength (bimolecular quenching constant, kq =1.1 x 108 M-1 s-1) . 
However, high concentrations of quencher (150-1500-fold excess of [Ru(NH3)6]
3+ or 
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Figure 4.10: Steady-state emission spectrum of 3 in aerated methanol (Aexc = 480 nm, 
Amax = 730 nm). 
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Table 4.2. Absorption and Emission Data for Ru(bpy)z(impy)2+ 
Derivatives at Room Temperature.a 
compd Amax (absl Amax (em)c "Cd <!>erne X 10-3 
Ru(bpy)z(impy)2+ 470 
3 480 730 44 0.53 
7 480 725 42 0.11 
7•9 480 725 42 
a Concentrations ranged from 10-40 J.tM. b Measured in aqueous 
solution or methanol. c Emission maxima determined from 
steady-state emission spectra collected with aerated solutions (in 
MeOH for 3, in water for samples containing 7). d Lifetimes 
determined from monoexponential fits of the luminescence 
decay observed at 720 nm in degassed solutions (in 25% MeOH 
for 3, in 0.05 M sodium phosphate, pH 7.0, 0.5 M NaCl for all 
samples containing 7). e Quantum yields for emission 
calculated using Ru(bpy)3Cl2 as an actinometer. 
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methyl viologen) are required to effect a- 10% decrease in the excited-state lifetime of 7. 
Absorption spectra recorded 5 /-lS after excitation indicate that the yield of generating 
Ru(III) following oxidative quenching is low (Appendix C). 
Discussion 
Incorporation Strategy. The solid-phase incorporation of nucleoside monomers 
containing metal complexes attached directly to the ribose ring has gone unexplored until 
recently_31,32 This is primarily due to the difficulty of introducing substituents to the 
ribose ring of the nucleoside (Chapter 2). Nevertheless, this site is an attractive location 
for modifications since reporter molecules incorporated here may cause fewer 
perturbations to the secondary duplex structure than those attached to the nucleoside 
base. Additionally, the selective placement of metal complexes at various locations on 
the nucleoside (base and ribose positions) allows for comparative studies regarding 
electron transfer pathways in nucleic acids. 
There are numerous constraints associated with incorporating modified 
nucleosides during automated solid-phase DNA synthesis.43-46 The most demanding of 
these include the mildly acidic and strongly basic conditions to which the solid support is 
repeatedly exposed during synthesis. The choice of metallonucleoside 3 is motivated by 
its observed stability under these conditions. While higher yields (60-74%) for 
succination are observed for unmetallated nucleosides containing 2' substituents (Chapter 
2), the modest yield for succination of 3 ( 43%) indicates that the metal complex inhibits 
this reaction (Figure 4.1). The successful derivatization of the solid support with the 
succinated metallonucleoside demonstrates that a large, cationic metal complex can be 
tolerated in the conjugation reaction. 
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The utility of solid supports pre-derivatized with metallonucleosides is validated 
by the rapid, large-scale synthesis of 10- and 11-mer oligonucleotides containing 
[Ru(bpy)2(impy')]
2
+ (impy' = nucleoside 1) complexes at the 3' termini. Analysis of the 
crude oligonucleotide mixture following cleavage from the solid support reveals an 
efficient synthesis (integration at 260 nm indicates a yield of 70% prior to HPLC 
purification, as shown in Figure 4.3). Clearly, this methodology may be extended to 
other transition metal complexes incorporated into nucleosides at either ribose or base 
positions, provided that the metal complex is stable to the conditions of oligonucleotide 
synthesis. 
Effect of Metal Complexes on Duplex Stability. Thermal denaturation studies 
serve as an indication of how the incorporated label influences the duplex stability. In the 
case of metal-containing duplexes, it is difficult to ascertain from the T m value if the 
cationic nature of a non-intercalating metal complex partially offsets the destabilization 
caused by the modification. For the metal-containing duplex 7·9, the T m value is slightly 
higher than the T m of the unmodified duplex 8·9 (50 °C vs. 48 °C, respectively). 
Modified duplexes of similar sequence serve as a useful comparison to duplex 7·9; they 
contain nucleosides with unmetallated substituents at the same ribose position (Table 
4.1). The duplexes 10·9 and 11·9 contain the modified nucleosides at both the 3' and 5' 
ends of the strands, whereas duplex 7·9 contains a single metal complex at the 3' end. 
Despite the fact that the nucleosides with unmetallated 2'-substituents favor the same 
sugar conformation adopted by 2' -deoxynucleosides, the T m values of the resulting 
duplexes are slightly below the melting temperature of the unmodified duplex (Chapter 
224 
2).47 This companson suggests that the presence of the cationic metal complex 
compensates for some of the destabilizing effects induced by the 2' modification. 
Our observation that the T m for duplex 7·9 is two degrees higher than the T m of 
the unmodified duplex 8·9 contrasts with reports describing T m values of duplexes end-
labeled with other metal complexes (Chapter 1).12.19,27,32,33 All of these duplexes 
contain metallonucleosides at the 5' end, as opposed to the 3' end. The T m values are 
either essentially unchanged or lower by a few degrees relative to the melting 
temperatures of the unmodified duplexes.21,27,29,32,48 An exception to this trend occurs 
when [Ru(bpy)z(bpy')]2+ is tethered to the 5'-terminal phosphate group: the Tm of the 
metal-containing duplex is 18 degrees lower than the value of the unmodified duplex (42 
oc vs. 60 °C).29 This result suggests that tethering a cationic metal complex to the 5'-
terminal phosphate group has a large destabilizing influence on the duplex; the absence 
of a nucleoside at the end of the duplex may be responsible for the lowered duplex 
stability. 
Absorption. The electronic spectrum of metallonucleoside 3 displays a broad 
absorption band with maximum at 480 nm (E = 9100 M-1 cm-1) that is red-shifted from 
Amax = 470 nm (E = 13600 M-1 cm-1) for the model complex [Ru(bpy)z(impy)f+ (Table 
4.2).38 The slight difference in Amax for the model complex and the metallonucleoside 
reveals the effect of replacing the impy ligand with an impy derivative possessing a 
ribose substituent on the imino nitrogen. The metal-containing oligonucleotides 6 and 7 
display visible absorption bands identical to those of 3, demonstrating that incorporation 
does not alter the electronic properties of the metallonucleoside. 
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Similar trends are observed for oligonucleotides containing derivatives of 
[Ru(bpy)3]
2+. Changes in the absorption maximum occur when the model complex (i.e., 
[Ru(bpy)3f+) is modified to accommodate linkers required for oligonucleotide 
attachment (Table 4.3). The resulting monomer complex (i.e., [Ru(bpy)z(bpy)]2+, where 
bpy' denotes a substituted bipyridine ligand containing the linker) displays an absorption 
maximum that is unchanged or slightly red-shifted from Amax for [Ru(bpy)/+] .49 
Typically, incorporation of the monomer complex into an oligonucleotide does not alter 
Amax for the metal-containing oligonucleotides (Table 4.3). 
Emission. The emission spectra of 7 and 7·9 are virtually identical to that of the 
precursor 3, indicating that both incorporation into an oligonucleotide and hybridization 
of the metal-containing strand do not alter the emissive properties of the metal complex 
(Table 4.1). This result is in contrast to the changes in the emissive behavior of monomer 
complexes based on [Ru(bpy)3f+ (Table 4.3). In most cases, these complexes exhibit 
emission maxima shifted from 628 nm to lower energy (660-675 nm). When the 
monomer complexes are incorporated into oligonucleotides, the emission maxima are 
unchanged or shifted to lower energy. An exception to this trend is a 16-mer 
oligonucleotide containing a [Ru(bpy)z(bpy')]2+ complex attached to the base of a 
nucleoside located mid-strand; the emission maximum is centered at 660 nm, blue-shifted 
from the corresponding value of the monomer complex (675 nm).28,48 
The excited-state lifetime of 3 does not change upon incorporation into an 
oligonucleotide and subsequent duplex formation. This result contrasts with observations 
made for many of the metal-containing oligonucleotides in Table 4 .3. The lifetimes of 
both single- and double-stranded oligonucleotides are dramatically different from those 
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Table 4.3. Absorption and Emission Data 
Incorporated into Oligonucleotides.a 
compd 
Ru(bpyh + 
Ru(bpy )z(impy )2+ 
Ru(bpy )z(bpy')2+ 
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a Values measured in buffered aqueous solution (pH 7.0) at room temperature unless 
otherwise noted. X denotes metal attachment to oligonucleotide via linker to nucleoside 
base, ribose, or phosphate. Please see individual references for details of metal 
attachment for each system. b Measured in aqueous methanol solution. c Measured in 
unbuffered aqueous solution. d Monomer complex values measured in acetonitrile. 
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of the monomer complexes, despite identical experimental conditions. Lewis and 
coworkers observe a decrease in the lifetime of single-stranded oligonucleotides 
containing a [Ru(bpy)z(bpy')]2+ label.30 The lifetimes of two short strands are within 
10% of the value for the monomer complex; a third strand forms a hairpin structure at 
high ionic strength and exhibits a lifetime that is 30% shorter compared to the lifetime of 
the monomer complex. Conversely, Grinstaff and coworkers report an increase in the 
lifetime values upon both incorporation and hybridization of three separate 
[Ru(bpyh(bpy')]2+ derivatives, regardless of the attachment linkage or placement of the 
metal complex within the duplex.29,32,48 
A rationale for the contrasting changes in the excited-state lifetime values of the 
metal-containing oligonucleotides summarized in Table 4.3 is unclear. The decrease in 
excited-state lifetime reported by Lewis for the single-stranded vs. hairpin 
oligonucleotides could be attributed to structural differences between the conformations 
available to the strands. The two 8-mer strands do not form well-defined hairpin 
structures at high ionic strength; therefore, the emission lifetimes for these 
oligonucleotides are expected to resemble that of the monomer complex.30 The 16-mer 
oligonucleotide forms a stable hairpin structure, and this structural difference may cause 
the observed decrease in the excited-state lifetime.SO However, the increase in lifetime 
values upon both incorporation and hybridization reported by Grinstaff may be due to 
interactions between the metal complex and the duplex not operative in Lewis' hairpin 
assembly. Subtle factors involving duplex conformation and ionic strength may be 
responsible for these trends. 
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Guanine Oxidation. The absence of any significant differences in the lifetimes 
of 3, 7, and 7·9 demonstrates that the bases contained in 7 or 9 do not quench the 
photoexcited [Ru(bpy)z(impy')]2+ . Although guanine is the most facile electron donor of 
the DNA bases (E+•IO = 1.3 V vs. NHE, pH 7),41 oxidation by photoexcited 7 is not 
favored thermodynamically (E2+*/I+ - 1 V vs. NHE). Even the addition of oxidative 
quenchers fails to result in any oxidative damage to the DNA bases of 7·9, despite 
generating a Ru(III) species that is a powerful oxidant (£112 = 1.3 V). 
Modest decreases in the excited-state lifetimes of 7 and 7·9 are observed in the 
presence of large excess of oxidative quenchers. In the case of [Ru(NH3)6]
3
+, the 
bimolecular quenching constant determined for the quenching of photoexcited 7·9 is one 
order of magnitude smaller compared to the value measured for the quenching of 
[Ru(bpy)3]
2+ (1.1 x 108 vs. 2 x 109 M-1 s-1, respectively).42 However, the driving force 
estimate (~Gq) for the single electron transfer from [Ru(NH3)6]
3
+ to photoexcited 7·9 is 
approximately -0.24 eV, much smaller than the value calculated for [Ru(bpy)3]2+* (-0.92 
eV).42,51 Oxidative quenching by methyl viologen is thermodynamically unfavorable 
(~Gq = 0.26 e V). Despite the large difference in ~Gq for the two quenchers, the addition 
of either quencher in large excess to 7 or 7·9 generates small amounts of oxidized 
product. 
Conclusion 
We report the first method of synthesizing a metal-containing solid support for 
use in automated DNA synthesis. This achievement represents a significant advance in 
the development of metal-containing oligonucleotides. While the solid support employed 
here is glass-based, the method is applicable to other solid supports containing any long-
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chain alkylamine linker. Succination yields for nucleosides containing metal complexes 
at locations other than the 2' position are expected to be much higher, due to the absence 
of steric constraints. This methodology may be extended to other transition metal 
complexes, provided that the metal complex is stable to the conditions of oligonucleotide 
synthesis. The preparation of a metal-containing solid support provides the opportunity 
to generate oligonucleotides with metal complexes placed at 3', intervening, and 5' 
positions of the duplex when combined with other solid-phase incorporation methods 
(Appendix D).21-25,27-29,32 
Thermal denaturation studies of the modified duplexes indicate that the presence 
of metallonucleoside 3 at the 3' terminus compensates for part of the destabilizing effects 
induced by placing a chelating ligand at the 2' ribose position. The metal-containing 
strands exhibit electrochemical and spectroscopic features nearly identical to those of the 
individual metallonucleoside. The absence of any change in these properties upon 
metallonucleoside incorporation into oligonucleotides and subsequent hybridization 
suggests that the Ru(bpy)z(impy)2+ chromophore is a valuable probe for DNA-mediated 
ET studies. 
Experimental Section 
General Materials and Methods. All reagents were of the highest purity available from 
commercial sources and used as received. All solvents were of spectrophotometric 
quality or better. Aqueous solutions were prepared from Millipore purified water with 
resistivity of 18 MQ-cm. Flash chromatography was performed on alumina (basic, 
activated Brockmann I, 150 mesh) from Aldrich. Thin-layer chromatography (TLC) was 
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performed on Merck precoated silica plates (60 F254, 5 x 7.5 em). Analytical HPLC was 
performed using reverse phase Prism C18 column (Keystone Scientific, 4.6 x 250 mm, 5 
f.!m, 100 angstrom), using one of the following gradients: (1) 0-17% B over 15 minutes, 
then 17-75% B over 15 minutes; (2) 0-100% B over 30 minutes; (3) 0-40% B over 15 
minutes (where A = 0.1 M triethylamine acetate, pH 7 .0, 2% acetonitrile; B = 
acetonitrile). Controlled pore glass (LCAA-CPG, 500-angstrom pore size) was obtained 
from Peninsula Laboratories. Oligonucleotide synthesis was carried out on an Applied 
Biosystems Incorporated 394 DNA synthesizer using standard protocols. DNA synthesis 
reagents were purchased from Glen Research. Enzymes were purchased from Pharmacia. 
Instrumentation. Steady-state absorption spectra were obtained using a Hewlett-
Packard HP8452A diode array spectrophotometer. HPLC was performed using a Waters 
600E Controller equipped with a 994 Diode Array Detecter. Steady-state emission 
spectra were obtained with a Hitatchi F-4500 Fluorescence Spectrophotometer using aXe 
arc lamp as the light source and the following instrumental parameters: 10 nm slits, 750 
V PMT, 480 nm excitation, and 500-900 nm observation range. All spectra are blank-
subtracted. Quantum yield measurements were calculated using [Ru(bpyhf+ as an 
actinometer. Time-resolved measurements (emission and transient absorption) were 
conducted in the Beckman Institute Laser Resource Center as previously described.52 
Electrochemical measurements were conducted at room temperature with a CH 
Instruments 660 electrochemical workstation. Data were collected in a traditional two-
compartment cell using a polished and sonicated 3 mm-diameter glassy carbon or 
platinum disk working electrode, Pt wire auxiliary electrode, and Ag/ AgCI reference 
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electrode. Solutions for electrochemical measurements were performed either in 
dichloromethane containing 0.1 M n-tetrabutylammonium hexafluorophosphate or m 
sodium phosphate buffer (50 mM, pH 7.0, 0.5 M sodium chloride, nanopure water), and 
were deaerated under argon. 
Approximately 10-30 nanomoles of purified oligonucleotide was subjected to 
enzymatic digestion analysis. The digest cocktail (55 Jll.lsample) contained bacterial 
alkaline phosphatase (4 J!L, 10 J..IL/unit) and snake venom phosphodiesterase (2.4 J!L, 1 
rnUmg), in 1 M MgClz (0.8 J!L), 0.5 M Tris buffer, pH 7.5 (3.5 J!L). The reaction 
mixture was incubated at 37 °C for 8-16 hours. The reaction was quenched by the 
addition of 200 J.!L of Buffer A (see HPLC section above). The products were analyzed 
by reverse-phase HPLC. The resulting peaks were compared against the appropriate set 
of nucleoside standards for that given oligonucleotide sequence. Two peaks with 
identical absorption spectra were observed for the ruthenium-containing nucleoside; the 
sum of the integrated areas of these peaks corresponds to one ruthenium-containing 
nucleoside relative to the other nucleosides (£260 for 3 = 23300 M-
1 em-\ This 
observation of two peaks is explained by the fact that the isomers of 3 and 4 were not 
separated prior to coupling to the solid support. Independent synthesis of the detritylated 
form of 3 produced two diastereomers that elute as two peaks upon HPLC injection under 
similar conditions (see Appendix B for synthetic details). 
Thermal denaturation curves were collected using a Hewlett-Packard HP 8452A 
diode array spectrophotometer equipped with a Peltier temperature controller (20-70 oc 
range). Individual oligonucleotides were hybridized to their complementary strands in 50 
mM sodium phosphate (pH 7.0) containing 0.5 M sodium chloride, to give solutions that 
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were 2. 7 J.tM in each strand. The samples were heated for 20 minutes at 70 oc and 
slowly cooled to 4 oc overnight. Thermal denaturation values were calculated from 
absorbance changes at 260 nm as the average of the heating and cooling traces collected 
for each hybrid; values were obtained from 2-4 separate heat-cool cycles. 
Synthesis of [Ru(bpy)z(1)](PF 6h (3): 2'-amino-5'-0-(4,4'-dimethoxytrityl)-2'-
deoxyuridine (1.8 g, 3.31 mmol) was dissolved in ethanol (30 mL) containing molecular 
sieves, and the solution was flushed with argon for 15 minutes. 2-
pyridinecarboxaldehyde (295 uL, 3.1 mmol) was added incrementally, and the reaction 
was refluxed for 6 hours. The solution was cooled, filtered to remove the molecular 
sieves, and evaporated to dryness under reduced pressure to give the intermediate 
nucleoside 1. (Electrospray mass spectral analysis of an aliquot of crude 1 found 635.2 
[M+Ht; calculated for [M+Ht, 635.14. See Appendix A for additional details.) The 
residue was re-dissolved in EtOH (180 mL) and Ru(bpy)2Ch (1.6 g, 3.31 mmol) was 
added to the solution. The reaction was refluxed over molecular sieves for 4 hours under 
argon. The solution was filtered, and the solvent was removed under reduced pressure. 
The residue was purified by flash chromatography [(a) silica, 2% saturated aqueous 
KN03, 7% water in acetonitrile; (b) basica alumina after conversion to the PF6- salt, 
0.5% saturated aqueous KPF6, 2.5% water in acetonitrile]. The product fractions were 
concentrated, dissolved in dichloromethane, and filtered to remove excess salt. The 
product was obtained as a red film (yield 19%). 1H-NMR (500 MHz, CD3CN, Figure 
4.11) 8 7.15-8.5 (mm, 31H), 6.89 (d, 4H), 6.60 (d, 1H), 6.35 (d, 1H), 5.39 (d, 1H), 4.77 
(d, 1H), 4.18-4.20 (m, 2H), 3.79-3.84 (m, 6H), 2.87-3.04 (m, 2H). UV-vis (MeOH) nm 
233 
Figure 4.11: 500 MHz NMR spectrum of 3 in CD3CN. (Asterisks denote peaks for 
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(E, M-1 cm-1): 210 (70100), 238 (38900), 256 (25800), 284 (51900), 480 (9100). ESI-MS 
calculated for C56H50Ns07RuPF6 [Mt 1193.08, found 1193.0 [Mt (Figure 4.12). 
Analytical HPLC with gradient 3: t = 24.09 minutes (Figure 4.13). 
Synthesis of Ru(bpyh(l-succinate)(PF6) 2 (4): To a solution of 3 (46.5 mg, 35 ~-tmol) 
and dimethylaminopyridine (2.1 mg, 17.5 ~-tmol) in 0.5 mL anydrous pyridine was added 
succinic anhydride (3.1 mg, 31.5 ~-tmol) . The reaction was stirred for 19 hours at room 
temperature under an argon atmosphere. The solvent was removed under reduced 
pressure and the residue was co-evaporated with toluene. The residue was purified by 
flash chromatography (basic alumina, 1% saturated aqueous KN03, 19% water m 
acetonitrile). The product fractions were combined and the acetonitrile was removed. A 
saturated aqueous solution of ammonium hexafluorophosphate was added to the resulting 
solution to precipitate the product. The red solid was collected by filtration and dried 
under vacuum (yield 54%). ESI-MS calculated for C6oH5~s010RuPF6 [Mt 1293.26, 
found 1293.2 [Mt (Figure 4.14). Several attempts to obtain a 1H NMR spectrum of 4 
were unsuccessful due to the presence of trace amounts of 3 in the sample. Preliminary 
results showed peaks diagnostic of the protons on the succinate arm in the region 2.6-2.95 
ppm (CD3CN, 500 MHz). 
Synthesis of Ru-Solid Support (5): To a solution of 4 (179 mg, 125 ~-tmol) in 4 mL of 
anhydrous dichloromethane was added anhydrous triethylamine (350 1-tL), HOBT (22.6 
mg, 166 ~-tmol), and BOP (91, 205 ~-tmol) . This solution was transferred to a flask 
containing long-chain alkylamine-controlled pore glass (LCAA-CPG) (250 mg, 500 A 
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Figure 4.13: Analytical HPLC trace of 3. Column: Prism C18. Gradient: 0-40% B 
over 15 minutes. Solvent A = 0.1 M triethylamine acetate, pH 7.0, 2% acetonitrile; 
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Figure 4.14: ESI mass spectra of 4 obtained in positive ionization mode. 
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pore size) and agitated gently overnight at room temperature. The resin was filtered and 
washed with fresh dichloromethane. A portion of the rinsed CPG was removed, washed 
with methanol and ether, and assayed for nucleoside loading (38-47 !J.mollg resin). The 
remaining resin was rinsed with methanol and ether and dried under vacuum. The 
washed resin was resuspended in 2 mL of acetic anhydride/pyridineffHF solution 
(supplied by ABI) and 1 mL 1-methyl-imidazoleffHF solution (ABI) and was agitated 
for 30 minutes. The resin was filtered, washed with pyridine (3 x 20 mL), methanol (3 x 
20 mL), dichloromethane (3 x 20 mL), and ether (3 x 20 mL), and dried under vacuum. 
The nucleoside loading of the solid support after capping was 28 !J.mol/g resin. 
Synthesis of CT CCT ACA CUimpyRu(bpyh (6) and TCT CCT ACA 
CUimpyRu(bpyh (7): Ru-solid support (40 mg, 1 !J.mol) was packed into an ABI 
column; two-four columns were used for each oligonucleotide synthesis. The reaction 
time for the first coupling was 2-10 minutes: the yield of the first coupling step was 
routinely > 95%. Upon completion of the synthesis (trityl off), the contents of the 
columns were transferred to two glass tubes and suspended in 30% aqueous ammonia (5 
rnUtube). The oligonucleotide solutions were incubated either at room temperature for 
15 hours followed by 3 hours at 55°C. The solvent was evaporated in a speed vacuum 
and the red pellets were purified by ion-exchange HPLC (Dionex NucleoPac PA-100 
column; A= 10% acetonitrile in water, B = 10% acetonitrile in water, 1.5 M NJ40Ac, 
pH = 6, 37-47% B over 17 minutes). The product fractions were collected and the 
solvent was removed under vacuum. The resulting pellets were desalted using Waters 
CIS SepPak cartridges. Yield of 6 after isolation: 30%. MALDI-TOF mass 
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spectrometry: found: 3425.73 [M-H]-; calculated: 3425.56 [M-Hf (Figure 4.4) Yield 
of 7 after isolation: 28%. MALDI-TOF mass spectrometry: found: 3728.55 [M-H]-; 
calculated: 3730.76 [M-Hf (Figure 4.4). 
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Chapter 5: 
Spectroscopy of Ruthenium-Modified Nucleic Acids 
249 
Introduction 
Several reports have described the preparation of mixed-chelate ruthenium(II) 
polypyridine complexes bound at specific sites in single- and double-stranded 
oligonucleotides.l-15 Typically, these ruthenium complexes contain two types of ligands: 
an unmodified polypyridine ligand (pp) and a substituted polypyridine ligand containing 
a linker required for oligonucleotide attachment (pp'). These [Ru(pp)2(pp')]
2+ complexes 
attain relatively long-lived (triplet) metal-to-ligand charge-transfer eMLCT) excited 
states upon excitation.2,3,5,6,10,16,17 In a few cases, the Ru(pp)z(pp')f+ complexes 
incorporated into oligonucleotides have been used in studies investigating DNA-mediated 
energy and electron transfer reactions_ll ,l2,18-21 
Further tuning of the probes for such reactions depends on a detailed 
understanding of both the ground- and excited-state properties of these complexes. 
Extensive correlations between photophysical and electrochemical data for mixed-
chelated complexes demonstrate the dependence of these properties on the n* energies of 
the pp and pp' ligands.22-24 Multiple charge-transfer transitions from the filled dn(Rurr) 
levels to the low-lying n* (ligand) orbitals are expected.25 Emission energies reflect the 
population of then* orbital that is lowest in energy.26-28 Likewise, the redox behavior of 
mixed-chelate Ru(II) complexes is influenced by the n* energies of the ligands. The 
absorption, emission, and electrochemical properties correlate well since the metal-
centered and ligand-centered orbitals involved in MLCT transitions are also the orbitals 
involved in the redox processes. 
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We have prepared mixed-chelate Ru(ll) complexes for use in ground-state 
electron transfer studies involving DNA.l ,21 These complexes consist of low-(1) and 
high-potential (2) metallonucleosides (Figure 5.1). Their absorption and electrochemical 
features are similar to those of the closely related complexes, [Ru(acach(bpy)] and 
[Ru(bpy)3]
2
+, respectively (acac = acetylacetonate, bpy = 2,2'-bipyridine).23,29 However, 
subtle differences in these properties are observed for 1 and 2 relative to the reference 
complexes. These changes reflect the presence of the substituted iminomethylpyridine 
(impy') ligand present in the coordination sphere of the metallonucleosides. We utilized 
resonance Raman spectroscopy to document the influence of the impy' ligand on the 
ground-state properties of 1 and 2. 
Results 
Electrochemistry. Cyclic voltammograms of 1 in ethanol show a reversible one-
electron oxidation ( 48 m V vs. SCE) that represents the Ru(IIIIII) couple (Table 5.1 ). 
This value is slightly more positive than the reduction potentials measured for the model 
system [Ru(acac)2(impy)], and the closely related complexes, [Ru(acach(bpy)] and 
[Ru(acach(dppz)] (Table 5.1)_1,30-32 These differences in E 112 suggests that the presence 
of the nucleoside is responsible for the positive shift in the reduction potential for 1. 
Voltammograms of 2 in dichloromethane display a reversible one-electron 
oxidation at 1.38 V attributable to the Ru(III/11) couple (Table 5.2). The oxidation 
process is not completely reversible at slow scan rates (0.1 - 1.0 V/sec). Studies of the 
electrochemical behavior of a series of [Ru(bpyh(a,a'-diimine)]2+ complexes show that 
fast scan rates (> 5 V/sec) are required in order for these complexes to display reversible, 
or nearly reversible, one-electron oxidation processes in acetonitrile.33 The reduction 
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Figure 5.1: Structure and sequence of ruthenium-modified nucleic acids. 
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1 : LL = acetylacetonate 
2: LL = 2,2'-bipyridine 
3: 5'-TCT CCT ACA CU (impy)RJ'(bpy)2 
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Table 5.1: Reduction Potentials and Absorption Data for 
Ru(II) Acetylacetonate Complexes. 
Compd £ 112, m ya 
vs. SCE 
1 48 
[Ru( acac )z(impy)] -11 
[Ru( acac )z(bpy)] 
[Ru(acac)z(dppz)] -9 
Amax. nmb Ref. 














278 (sh) (33.7) 
257 (sh) (38.9) 





a EtOH containing 0 .1 M N:I-4PF6 at room temperature (unless otherwise 
noted). 
b EtOH (unless otherwise noted); Amax values ± 2 nm; £values± 5%. 
c CH2Cl2 containing 0.5 M TBABF4, 20 °C. 
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Table 5.2. Ground and Excited State Properties in Acetonitrile at Room Temperature. 
2 
3 
El/2, v VS . SCEa Amax. nm (±2 nm) Aem c!>em '! (ns) 
oxidn redn (E x 10·3, M-1 cm-1) nm (±5 nm) x 103 (±5%) ns (±%) 
+1.386 -1.08 480(9.1) c 730 c 0.53 c 44 c 
+1.12 d 
-1.39 284 (51.9) 






[Ru(bpyh (impy)]2+ e +1.27 470 (13.0) 
[Ru(bpyh(ampy)]2+ " +1.12 



















628 4.5 650 
" Values obtained in acetonitri le containing 0.1 M [N(n-C4H9) 4]PF6 unless otherwise noted. b CH2Ch. 
'"CH30H. "SO mM sodium phosphate buffer (pH 7.0), 500 mM sodium chloride. • Reference 33. 
1 I M 
HC104 . 8 Reference 35. h Reference 34 . 
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potential of 2 is more positive than E 112 for the model system [Ru(bpy)z(impy)]
2+ as well 
as E 112 for [Ru(bpy)J]
2+ (Table 5.2).33,34 
Multiple ligand-centered reductions are observed in acetonitrile for 2 ( -1.08, -
1.39, -1.61 V). The most positive reduction potential is irreversible and represents 
reduction of the impy' ligand, by analogy to the [Ru(bpy)z(a,a'-diimine)f+ complexes 
described above.33 The other two ligand-centered potentials observed for 2 are shifted to 
more positive values relative to the ligand-based reductions observed for [Ru(bpy)3]
2+ 
(Figure 5.2).34 
Absorption. The visible absorption features of 1 and 2 are shown in Figure 5.3. 
The electronic spectrum of 1 in ethanol displays maxima at 234, 276, 396, and 592 nm 
(Table 5.1). The high-energy bands represent acac- and nucleoside-based n-n* 
transitions. The transitions in the visible region shift slightly in dichloromethane (392 
nm, E = 3600 M-1 cm-1; 602 nm, E = 3700 M-1 cm-1) . These bands are similar to the 
maxima reported for [Ru(acac)2(impy)] m ethanol: 206, 274, 402, and 576 nm.l 
Comparison of the absorption maxima of 1 and of the closely related complexes, 
[Ru(acac)z(bpy)] and [Ru(acac)z(dppz)], reveals notable differences (Table 5.1).29,32 
Two visible absorption maxima are observed for [Ru(acac)z(bpy)] at lower energy (416, 
621 nm), whereas [Ru(acac)2(dppz)] displays a single band (547 nm). 
The absorption maxima of 2 in methanol are 210, 238, 256, and 284, with a broad 
absorption band at 480 nm (E = 9100 M-1 cm-1) (Table 5.2). The high-energy bands 
represent bpy- and nucleoside-based n-n* transitions. For comparison, 
[Ru(bpy)z(impy)]2+ exhibits a maximum in the visible region at 470 nm (E = 13600 M-1 
cm-1) with a shoulder at 430 nm,33.35 The slight difference in Amax for the model 
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Figure 5.2: Differential pulse voltammograms showing ligand centered reductions of 3 
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Figure 5.4: Resonance Raman spectrum of 1 in dichloromethane (441.6 nm excitation). 
Solvent peaks are noted in parentheses. Laser source: He-Cd Liconix. Dwell time of 10 
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complex and 2 shows the effect of replacing the impy ligand with an impy derivative 
possessing a ribose substituent on the imino nitrogen. 
Resonance Raman. Ground-state resonance Raman spectra of 1 in 
dichloromethane were recorded at multiple excitation wavelengths (441.6, 457.9, and 
514.5 nm). Spectra obtained at the first two excitation frequencies both display peaks at 
1234 and 1527 cm·1 (Figures 5.4-5.6). An exception occurs upon 514.5 nm excitation: 
the peak observed at 1234 cm·1 is absent, with peaks at 1249 and 1286 cm-1 observed 
instead (Figure 5.6). Multiple vibrational modes are enhanced despite the weak 
absorption of 1 at this excitation frequency. 
Ground-state rR spectra of 2 (c4-methanol) and 3 (water) were recorded at 441.6 
nm excitation and displayed nearly identical peaks (Figures 5.7 and 5.8). The rR spectra 
of [Ru(bpy)3]2+ and 3 in water are shown in Figure 5.8 (441.6 nm excitation). 
Comparison of these two spectra enables the identification of bpy-associated vibrations 
observed in the spectrum of 3 at 1023, 1173, 1276, 1315, 1488, 1552, and 1604 cm·1• 
However, additional vibrations at 1471 and 1242 cm·1 are observed. The feature at 1552 
cm·1 is broader than the corresponding vibration in the spectrum of [Ru(bpy)3f+. 
Additional rR spectra of 2 were obtained with 457.9 and 488.0 nm excitation 
wavelengths (Figures 5.9 and 5.10). These rR spectra resemble the spectra obtained with 
441.6 nm excitation. However, significant changes in the intensity of peaks were 
observed between 1400-1700 cm·1• Figure 5.11 shows the striking changes in the 
intensity of two modes (1470 and 1488 cm-1) as a function of excitation wavelength. In 
addition to these changes, the broad feature at 1552 cm·1 observed with 441.6 nm 
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Figure 5.5: Resonance Raman spectrum of 1 in dichloromethane (457.9 nm excitation). 
Solvent peaks are noted in parentheses. Laser source: Ar+ Coherent Innova 70. Dwell 
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Figure 5.6: Resonance Raman spectrum of 1 in dichloromethane (514.5 nm excitation). 
Solvent peaks are noted in parentheses. Laser source: Ar+ Coherent Innova 70. Power at 
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Figure 5.7: Resonance Raman spectrum of 2 in deuterated methanol (441.6 nm 
excitation). Solvent peaks are noted in parentheses. Laser source: He-Cd Liconix. 300 
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Figure 5.8: Resonance Raman spectrum obtained with 441.6 nm excitation of 
[Ru(bpy)3]
2+ (top) and 3 (bottom) in water. Laser source: He-Cd Liconix. Dwell time of 
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Figure 5.9: Resonance Raman spectrum of 2 in deuterated methanol (457.9 nm 





























Figure 5.10: Resonance Raman spectrum of 2 in deuterated methanol (488.0 nm 
excitation). Solvent peaks are noted in parentheses. Laser source: Ar+ Coherent Innova 
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Figure 5.11: Resonance Raman spectrum of 2 in deuterated methanol at three excitation 
wavelengths: 441.6 (bottom), 457.9 (middle), and 488.0 nm (top). Laser sources: He-











Figure 5.12: Steady-state emission spectrum of 2 in aerated methanol (480.0 nm 
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excitation becomes resolved at longer excitation wavelengths. A weak feature at 1580 
em·' becomes apparent with 488.0 nm excitation. 
Emission. Steady-state emission spectra of metallonucleoside 2 and 
oligonucleotide 3 show similar profiles at room temperature. Irradiation of 2 and 3 at 480 
nm produces an emission maximum at 730 nm, with a shoulder near 810 nm (Figure 
5.12). The excited-state lifetimes are strictly monoexponential and are independent of 
solvent: 44 ns for 2 (aqueous methanol) and 42 ns for 3 (phosphate buffer). However, 
the quantum yield of 2 is slightly greater than that of 3 (Table 5.2). 
Variable-temperature emission spectra were obtained with 2 suspended in a 
polymer matrix. While the shape of the emission spectrum of the solid sample closely 
resembles that of the solution sample, the emission maximum is shifted to higher energy 
(707 nm). However, lowering the temperature does not appreciably alter the position of 
A.(em). The emission maximum at 181K and 64K is 700 nm. 
Discussion 
Electrochemistry. The reduction potentials of 1 and 2 are more positive than 
those of the corresponding impy model complexes by 60 and 110 mV, respectively 
(Tables 5.1 and 5.2). While this comparison isolates the contribution of the impy' ligand 
to the reduction potential, it does not explain why the shift in E 112 is larger for 2 than for 
1. Reduction of the imine linkage in 2 and in [Ru(bpy)z(a,a'-diimine)f+ complexes 
occurs at potentials more positive than bpy-based reductions; this implies that the n* 
orbital energy for impy is lower than that of bpy.36 
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Based on the values measured for metal- and ligand-centered processes (Table 
5.2), estimates of the excited-state couples for 2 can be made using equations (1) and (2): 
.....3+!2+*- E - E 1!., ~ - ox em (1) 
E2+*tl+ E E = rect+ em (2) 
For values of Eem, E0.0 measured at 64K in a polymer matrix was used. These values give 
estimates for g+tZ+* - -0.4 and £ 2+*/l+ - 0.7 V vs. SCE. For comparison, the reduction 
and oxidation potentials for *[Ru(bpy)3]
2+ are 0.77 and -0.81 V (acetonitrile).23 The 
differences in the reduction potentials of these complexes is highlighted by inspecting the 
Latimer diagrams in Figure 5.13. This comparison reveals the effect of replacing one bpy 
ligand with impy'. 
Absorption of 1. Assigning the transitions of 1 by comparison with other 
complexes is difficult since only a limited number of Ru(II) acetylacetonate complexes 
have been prepared. The low-energy feature at 621 nm in the spectrum of 
[Ru(acac)z(bpy)] has been assigned as a dn(Ru)---77t*(bpy) transition.29 A tentative 
assignment of MLCT was given to the band at 416 nm for [Ru(acac)z(bpy)], although the 
nature of the n* orbital of this transition was not specified.29 Transitions in other Ru(II) 
acetylacetonate complexes- such as cis- and trans-[Ru(acac)z(Lh] complexes (where L 
= CH3CN, pyrazine, Cl) - appear near 400 nm, which have been described as 
dn(Ru)---77t*(acac) transitions.37 The single absorption band at 547 nm exhibited by 
[Ru(acac)z(dppz)] was assigned as a dn(Ru)---77t*(dppz) transition based solely on its 
energy and intensity.32 
Based on the assignments given for the reference complexes above, the absorption 
bands at 592 and 396 nm displayed by 1 can be described as dn(Ru)---7n*(impy') and 
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Figure 5.13: Latimer diagrams for [Ru(bpy)z(impy')]2+ (top) and [Ru(bpy)3]
2+ (bottom). 
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(All potentials vs. SCE, in acetonitrile.) 
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dn(Ru)~n*(acac) transitions, respectively. An analogous assignment is given for the 
visible bands displayed by [Ru(acac)z(impy)]. Such a description is consistent with the 
relative ordering of the ligand reduction potentials. Reduction of impy' occurs at a -1.08 
V, with reduction of the acac ligand expected to occur at more negative potentials due to 
the electron-rich nature of this ligand. 
Interestingly, the energy of the dn(Ru)~n*(ligand) transition increases over the 
series: [Ru(acac)z(bpy)] (621 nm), [Ru(acac)z(impy')] (592 nm), [Ru(acac)z(impy)] (576 
nm), [Ru(acac)2(dppz)] (547 nm). This trend suggests that impy' and impy ligands 
stabilize the dn(Ru) level to a greater degree than the bpy ligand in Ru(ll) acetylacetonate 
complexes. Furthermore, it appears that the dn(Ru)~n*(acac) transition in 
[Ru(acac)z(dppz)] complex has been blue-shifted to lie under the dppz intraligand (1t-1t*) 
transition. 
Similar to the low-energy bands in [Ru(acac)(bpy)2t and [Ru(acac)z(bpy)], the 
visible absorption maxima for 1 vary with solvent polarity.29 However, these two bands 
do not shift in the same direction with increasing solvent polarity. For 1, the absorption 
maxima are centered at 602 and 392 nm in dichloromethane, and at 592 and 396 nm in 
ethanol. This observed shift from 602 to 592 nm is not consistent with the MLCT 
description given to this transition. 
Typically, MLCT bands of complexes like [Ru(bpy)3]
2
+ exhibit a positive 
solvatochromism, wherein Amax shifts to lower energy as a function of increasing solvent 
polarity.25 This trend is consistent with the molecule having a nonpolar ground state and 
a more polar excited state, consequences brought about by the removal of an electron 
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from a ruthenium-centered dn orbital and subsequent population of an empty n* orbital 
of the bpy ligand. Thus, a shift of Amax to higher energy in solvents of increasing 
polarity indicates a negative solvatochromism. This effect implies that the ground state is 
polar and that the dipole moment of the molecule is reversed or reduced upon excitation. 
Negative solvatochromism is a hallmark of ligand-to-ligand charge-transfer 
(LLCT) transitions displayed by several metal diimine complexes. 38,39 The CT 
transition is directed to the vacant n* orbital of the diimine ligand, as verified by 
electrochemistry,40,41 molecular orbital calculations,42 resonance Raman 
spectroscopy,43,44 and emission studies.42,45 Of these LLCT complexes, 
Pt(diimine)(dithiolate) complexes have been studied by Eisenberg and coworkers, who 
present computational results indicating substantial metal character in the HOMQ.42 
These findings support a revised assignment of the charge-transfer band to include the 
contribution of the Pt, which is described as follows: { d(Pt)/p(S)--77t*(diimine)}. It is 
possible that the charge-transfer band in 1 near 600 nm represents a similarly metal-
mixed LLCT transition. That this band exhibits negative solvatochromism suggests that 
it may originate in a mixed Ru/acac orbital and be directed to the n* orbital of the impy' 
ligand. 
Resonance Raman of 1. Probing the visible transitions of 1 by resonance Raman 
spectroscopy provides support for this revised description. The peaks observed at 1234 
and 1528 cm-1 (441.6 nm excitation) have been recorded for other metal-acac complexes 
and represent v(C-C) and v(CO) vibrations, respectively.46,47 No other modes are 
observed at this excitation frequency, implying that the transition near 400 nm involves 
only the acac ligand. 
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The rR spectrum of 1 obtained with 514.5 nm excitation shows enhancement of 
multiple vibrational modes (Figure 5.6). The vibrations at 1286, 1461, 1499, 1552, and 
1595 cm·1 can be attributed to the presence of the impy' ligand, based on comparisons 
with similar Ru(II) polypyridine complexes (see discussion of 2 below).48 Interestingly, 
the mode at 1529 cm· 1 is not observed in the rR spectra of these reference complexes. 
This mode experiences significant distortion upon low-energy excitation. Similarities 
between the rR spectra obtained at both 441.6 and 514.5 nm excitation suggest that this 
mode represents a v(CO) vibration. 
The origin of the mode at 1249 cm·1 observed upon 514.5 nm excitation is not 
immediately clear. Given the appearance of the strong Raman signal at 1529 cm·1 
tentatively assigned as a v(CO) vibration, the presence of an accompanying v(C-C) 
vibration in the region of 1234 cm·1 is expected. However, the rR spectrum of 2 shows 
bpy- and impy'-associated vibrations in the same region (see discussion below). 
Therefore, the peak at 1249 cm·1 could represent an acac- or impy'-associated vibration. 
The presence of modes characteristic of both acac- and impy' -associated 
vibrations in the 514.5 nm rR spectrum supports the LLCT assignment suggested earlier 
in the discussion. This description for the band near 600 nm in 1 -
{ d(Ru)/p(acac)-7n*(diimine) }- is consistent with the observed negative 
solvatochromism. Regardless of the degree of metal involvement, a 
d(Ru)/p(acac)-77t*(diimine) transition would be expected to cause resonance 
enhancement of vibrational modes on both ligands involved. 
Absorption and Resonance Raman of 2. For mixed-chelate Ru(II) complexes, 
separate transitions to then* orbital of each ligand may occur, resulting in an absorption 
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spectrum that is a composite of MLCT transitions. The broad absorption feature of 2 
represents multiple MLCT transitions due to the presence of the bipyridine and 
iminomethylpyridine groups coordinated to the metal center_33,35,49 
Resonance Raman data confirm this description (Figures 5.7-5.11). The rR 
spectra of both 2 and 3 show striking similarities with the spectrum obtained for 
[Ru(bpy)3]2+ upon 441.6 nm excitation (Figures 5.7 and 5.8). The peaks characteristic of 
bpy-associated vibrations are observed at 1023, 1173, 1276, 1316, 1488, 1552, and 1604 
cm·1 for both 2 and 3, which confirms the dn(Ru)-m*(bpy) nature of the transition in 
this region. Additional peaks at 1242 and 1471 cm·1 represent distortions that are absent 
in [Ru(bpy)3]2+ and can be attributed to the presence of the impy' ligand. 
Typically, ground-state rR spectra of mixed-chelate Ru(II) complexes show 
features characteristic of the types of ligands present.26,27 For example, the Raman 
signals reported for [Ru(bpy)z(Br2bpy)]
2+ are a combination of those observed for the 
homoleptic complexes, [Ru(bpy)3]
2
+ and [Ru(Br2bpy)3f+, at identical excitation 
frequency.27 The relative intensities of the observed features reflect the number and type 
of pp ligand present in the complex.26 Therefore, it is expected that the rR spectra of 2 
and 3 to contain Raman signals characteristic of both bpy and impy' vibrations. 
Changes in the rR spectra of 2 (457.9 and 488.0 nm excitation) suggest that the 
low-energy side of the broad MLCT band is dominated by a dn(Ru)-m*(impy') 
transition (Figures 5.9 and 5.10). This assignment is supported by the variation in the 
relative intensities of modes in the region of 1400-1700 cm·1• The 1471 and 1488 cm·1 
modes undergo a striking reversal in intensity as a function of excitation wavelength 
(Figure 5.11). While the peak at 1605 cm·1 remains essentially unchanged, the broad 
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peak at 1552 cm-1 (441.6 nm excitation) sharpens upon 488.0 nm excitation. The 
appearance of a peak at 1580 cm-1 implies that absorption at this excitation frequency 
involves a dn(Ru)~n*(impy') transition in addition to the dn(Ru)~n*(bpy) transition. 
Emission of 2. Irradiation of 2 at 480 nm yields an emission spectrum with a 
maximum at 730 nm, which is red-shifted from the emission maximum of [Ru(bpy)3]
2+ 
(625 nm) (Figure 5.12). This substantial shift to lower energy suggests that the emitting 
state is based on the impy' ligand. Electrochemical data show that this ligand has the 
most positive reduction potential; consequently, impy' is the ligand in 2 with the n* 
orbital that is lowest in energy_36 This assertion that the excited electron is localized on 
the most easily reduced ligand is consistent with the literature.27 
The excited-state lifetime of 2 is 44 nsec, much shorter than those of similar 
complexes (Table 5.2). The decrease in the lifetime values over the series-[Ru(bpy)3]2+ 
(650 nsec), [Ru(bpy)z(ampy)]2+ (192 nsec), 2 (44 nsec)-reveals the effect of the ampy 
and impy linkages. The differences in the lifetime and quantum yield for [Ru(bpy)3]
2
+ vs. 
2 correspond to an increase in the nonradiative rate constant (knr) from 1.54 x 106 s-1 to 
2.38 x 107 s-1, respectively. This increase is consistent with the additional vibrational 





We utilize several methods to investigate the visible transitions displayed by 
metallonucleosides 1 and 2. Comparison of the ground-state properties of these 
complexes with those of reference complexes shows the effect of replacing one 
bipyridine ligand with a substituted impy ligand. The presence of the nucleoside 
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substituted on the impy ligand increases the metal-centered reduction potentials displayed 
by 1 and 2. Resonance Raman spectroscopy assists in analyzing the absorption spectrum 
of each metallonucleoside. The rR results suggest that the low-energy transition 
displayed by 1 involves both the acac and impy' ligands, tentatively assigned as a metal-
mixed LLCT transition. 
The broad visible band displayed by 2 represents multiple charge-transfer 
transitions, namely MLCT transitions to the n* orbtials of the bpy and impy' ligands. A 
description of this broad band as a composite of ligand-localized MLCT transitions is 
supported by rR data obtained at multiple excitation frequencies.25 The electrochemical, 
absorption, and emission data of 2 indicate that the lowest energy n* orbital available for 
occupation by an excited electron is that of the impy' ligand. 
The replacement of one bpy ligand with a substituted impy ligand causes minor 
alterations to the ground-state properties of the resulting mixed-chelate complex, 2. 
However, profound changes in the excited-state properties are observed upon this bpy--7 
impy' synthetic substitution. While the impy' ligand enables facile incorporation of the 
ruthenium complex into oligonucleotides by solid-phase DNA syntheis,l it dominates the 
emissive behavior of the Ru(II) complex. This result illustrates how ligand replacements 
imposed for synthetic purposes can cause significant alterations in the excited-state 
properties of the resulting mixed-chelate complex. 
Experimental Section 
Synthesis of Ru(acac)l(impy') (1): 2'-amino-5'-0-( 4,4'-dimethox ytri tyl )-2'-
deoxyuridine (93 mg, 0.17 mmol) was dissolved in ethanol (5 mL) containing molecular 
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sieves, and the solution was flushed with argon for 15 minutes. 2-
pyridinecarboxaldehyde (15 J.l.L, 0.16 mmol) was added incrementally, and the reaction 
was refluxed for 2 hours. The solution was cooled, filtered to remove the molecular 
sieves, and evaporated to dryness under reduced pressure to give the intermediate 
nucleoside impy'. (Electrospray mass spectral analysis of an aliquot of crude impy' 
found 635.2 [M+Ir], as compared to 634.2 calculated for [M].) The nucleoside was 
redissolved in ethanol (5 mL) and the solution was deaerated. In a separate flask 
Ru(acac)2(CH3CN)2 (0.17 mmol) was dissolved ethanol (25 mL) and the solution was 
deaerated. The two solutions were combined and heated to reflux for 1 hour. The 
solvent was removed under reduced pressure and the green residue was purified by flash 
chromatography on silica using 1.5:1 THF/hexanes mobile phase (yield 79%). 1H-NMR 
(500 MHz, CDC13, Figure 5.14) 8 8.93 (s, lH), 8.74 (d, 1H), 7.81 (d, lH), 7.73 (d, 1H), 
7.48 (t, 1H), 7.43 (d, 2H), 7.20-7.34 (mm, 7H), 7.11 (t, 1H), 6.81 (dd, 4H), 5.36 (dd, lH), 
5.28 (s, 1H), 5.02 (s, 2H), 4.88-4.92 (m, 1H), 4 .84 (s (br), 1H), 4.68-4.76 (m, 1H), 3.79 
(d, 6H), 3.41-3.56 (m, 2H), 2.20 (s, 3H), 2.12 (s, 3H), 1.82 (s, 3H), 1.60 (s, 3H). UV-vis 
(EtOH) nm (E): 234 (33400), 276 (27000), 396 (3600), 592 (3600). ESI-MS calculated 
for C46~sN40ttRu [M+H+] 934.96, found 934.4 [M+H+] (Figure 5.15). 
Synthesis of Ru(acac)z(impy): The model complex was prepared by first reducing 
Ru(acac)3 (99.6 mg, 0.25 mmol) over Zn!Hg amalgam under argon in 6:1 ethanol/water 
solution.SO Following reduction, 2-(aminomethyl)pyridine (28.4 J.l.L, 0.25 mmol) was 
added dropwise in 1 mL EtOH and the solution was refluxed for 2 hours. The reaction 
mixture was cooled, filtered and purified by flash chromatography on silica under argon 
using 1.5:1 THF/hexanes mobile phase (yield 58%). UV-vis (EtOH) nm (E): 206 
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Figure 5.15: ESI mass spectrum of 1 in positive ionization mode (top) and MALDI-TOF 
mass spectrum of 1 showing isotopic distribution (bottom). 
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(21,800), 274 (16,800), 402 (4600), 576 (4600). ESI-MS calculated for C16H20N20 4Ru 
[M+H+] 406.41, found 406.2 [M+H+] (Figure 5.16). 
The ruthenium(II) compounds 2 and 3 were prepared and characterized as 
previously described in Chapter 4.1 
Instrumentation 
Electrochemical data were collected in a traditional two-compartment cell using a 
polished and sonicated 3 mm-diameter glassy carbon or platinum disk working electrode 
(BAS), Pt wire auxiliary electrode, and Ag/AgCl reference electrode. Values in the text 
are referenced to the saturated calomel electrode (SCE). Measurements were conducted 
at room temperature with a CH instruments 660 electrochemial workstation after the 
solutions were deaerated under argon. Data for 1 and [Ru(acach(impy)] were recorded in 
ethanol containing 0.1 M ammonium hexafluorophosphate (Aldrich); measurements of 2 
were collected in either acetonitrile or dichloromethane (Burdick and Jackson) containing 
0.1 M n-tetrabutylammonium hexafluorophosphate (SACHEM). Square-wave 
voltammograms of 3 were recorded in phosphate buffer (50 mM, pH 7.0, 0.5 M NaCl) in 
nanopure water. Absorption spectra were obtained using a Hewlett-Packard 8452A diode 
array spectrophotometer. 
Excitation of the rR samples was provided by 441.6 nm (He:Cd Liconix) or 514.5 
nm (Ar+ Coherent Innova 70) and scattered light was dispersed with a Spex 1403 Double 
Monochromator and intensities were measured by single-photon counting. Samples were 
prepared in NMR tubes and contained either water, ~-methanol, or dichloromethane. 
The Raman signal was collected at 90° during irradiation with dwell times of 10 sec/cm-1 
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at 1 cm-1 intervals. 
Emission spectra were collected with a Hitachi F-4500 Fluorescence 
Spectrometer with the following instrumental parameters: 10 nm slits, 750 V PMT, 480 
nm excitation, 500-900 nm scan wavelengths. Quantum yield measurements were 
calculated using [Ru(bpy)3]2+ as an actinometer. Lifetimes were collected as previously 
described.51 Variable-temperature emission spectra were collected with 2 suspended in 
polymer matrix by Dr. Jeffrey J. Rack. 
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Appendix A: 
Additional Nucleoside Synthesis 
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Part A. Synthesis of 2' -Modified Nucleoside, 3a. 
An alternate approach to preparing nucleoside 3a (Chapter 2) was pursued that 
utilized the 5' -protected form of 2' -amino-2' -deoxyuridine (A1). Condensation of A1 
with 2-pyridinecarboxaldehyde in absolute ethanol gave the 2'-imine nucleoside 
(nucleoside 1, Chapter 4) in approximately 70% yield. Attempts to purify nucleoside 1 
by flash chromatography were unsuccessful. Subsequent reduction of 1 with sodium 
cyanoborohydride gave 3a in high yield as indicated by TLC. However, attempts to 
isolate 3a by flash chromatography resulted in low yields (5-10% ). 
0 0 0 
L1H 0 L1H L1H 
DMTO~ 0 H~ DMTO~ 0 DMTO~ 0 N -& 
0 r{) NaBH4 o(--0 
EtOH HO ~ N # HO HN N # HO NH2 
A1 1 3a 
Chapter 4 Chapter 2 
Experimental Notes 
5' -0-(4,4' -dimethoxytrityl)-2' -aminomethylpyridyl-2' -deoxyuridine (3a). 
Compound A1 was prepared as described.l A1 (1.9 g, 3.5 mmol, 1.5 eq) was dissolved 
in absolute ethanol (25 mL) over molecular sieves; the reaction vessel was flushed with 
argon for 20 minutes while heated to reflux temperature. 1 eq of 2-
pyridinecarboxaldehyde (220 )..l.L, 2.3 mmol) was delivered to the solution in 1 mL of 
ethanol, and the solution was refluxed for 2-16 hours. 
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An aliquot from the reaction was filtered and evaporated to dryness by rotary 
evaporation. ESI-MS calculated for 1 [M-Hr (negative mode): 633.24. Found: 633.2.; 
calcd for 1 [M+Ht (positive mode): 635.24. Found: 635.2. Additional peaks were 
observed in positive mode: [M+Nat 657.2, [M+Kt 673.2, (unassigned) 724.4. Data are 
shown in Figures A.l and A.2. Purification on silica was unsuccessful; 1H NMR analysis 
of the crude product was complicated by impurities. 
The remaining solution was cooled and excess sodium borohydride was added to 
the solution. The reaction was stirred at room temperature for 12 hours and refluxed for 
an additional 2 hours. The solvent was removed and the residue was dissolved in 
dichloromethane and extracted with: 5% ammonia solution, saturated sodium chloride, 
water, and cold 5% citric acid. The organic phase was dried over sodium sulfate and the 
solvent evaporated to give 3a. Purification on silica (45-45-10 dichloromethane-
methanol-triethylarnine) was unsuccessful and resulted in impure fractions of 3a. 
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Part B. Deprotection of 2' -Modified Nucleoside, 3b. 
There are two methods for removing the trityl protecting group at the 5' position. 
The first method involves stirring the solid in 80% acetic acid for 16-24 hours, followed 
by removal of the solvent and coevaporation with methanol. The residue is extracted in 
dichloromethane with water. The aqueous fraction is evaporated to dryness to give the 
deprotected nucleoside. The second method uses trichloroacetic acid and is complete in a 
very short period of time. The solid is dissolved in a 1:4 mixture of ethanol and 
dichloromethane, to which is added an equal volume of aqueous 5% trichloroacetic acid 
(para-toluene sulfonic acid may also be used). The mixture is shaken well and the 
reaction is complete within 15 minutes (as monitored by TLC). The organic phase is 
removed and the resulting solution is neutralized with 4 M sodium hydroxide. The 
remaining solvent is removed and the residue is dissolved in water, followed by 
extraction with either ethyl acetate or dichloromethane. The aqueous phase was 
evaporated to dryness to give the deprotected nucleoside. 
Nucleoside 3b from Chapter 2 was detritylated using the second method. ESI-MS 
calculated for C 16HzoN40s: [M+Ht: 349.14. Found: 349.2. Additional peaks were 
found: [M+Nat 371.2, (unassigned) 393.2. The deprotected nucleoside was used in the 
model complex reactions summarized in Appendix B. 
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Part C. Synthesis of Modified Oligonucleotides. 
Oligonucleotides containing the 2' modified nucleosides shown below were 
synthesized and purified. The sequences of these oligonucleotides are tabulated. 





Abbreviation Oligonucleotide Sequence 
8A 5' -UaGCATCGA-3' 
8B 5' -UaCGATGCA-3' 
llA 5' -UaCAGCTGTAGA-3' 
liB 5' -UbCT ACAGCTGA-3' 
14A 5' -UaGTGCTCCTGAGGA-3' 
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Synthesis of Ruthenium Model Complexes 
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Summary 
Several ruthenium model complexes were evaluated as possible donor-acceptor 
candidates for use in DNA-ET studies (see Chapter 1 for discussion of criteria). The 
types of complexes considered included Ru(ll) acetylacetonate, bipyridine, and amine 
complexes. Once prepared, the model complexes were evaluated for subsequent 
incorporation into oligonucleotides by either post-synthetic modification or solid-phase 
synthesis methods (Chapter 4). The synthesis and characterization of these complexes is 
summarized below. 
Experimental Section 
Ru(acac)2(impy). The model complex was prepared by first reducing Ru(acac)3 
(99.6 mg, 0.25 mmol) over Zn/Hg amalgam under argon in 6:1 ethanol/water solution. 
Following reduction, 2-(arninomethyl)pyridine (28.4 f..LL, 0.25 mmol) was added 
dropwise in 1 mL EtOH and the solution was refluxed for 2 hours. The solution was a 
deep orange. The reaction mixture was cooled and filtered. Upon exposure to air, the 
solution became a deep purple. The solution was evaporated to dryness and purified by 
flash chromatography on silica under argon using 1.5:1 THF/hexanes mobile phase (yield 
58%). UV-vis (EtOH) nm (£): 206 (21,800), 274 (16,800), 402 (4600), 576 (4600); 
(CH2Cl2) 232 (7800), 276 (11,800), 398 (4700), 592 (4800). ESI-MS calculated for 
C 16H20N20 4Ru [M+H+] 406.05, found 406.2 [M+H+]. See Chapter 5 for mass spectral 
data shown in Figure 5.15. Electrochemical data: E 112 = 33 mV vs. Ag/AgCI in EtOH, 
0.1 MN~PF6. 
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Ru(acac)2(impy'). 5'-0-(4,4'-dimethoxytrityl)-2'-amino-2'-deoxyuridine (93 mg, 
0.17 mmol) was dissolved in ethanol (5 rnL) containing molecular sieves, and the 
solution was flushed with argon for 15 minutes. 2-pyridinecarboxaldehyde (15 JJL, 0.16 
mmol) was added incrementally, and the reaction was refluxed for 2 hours. The solution 
was cooled, filtered to remove the molecular sieves, and evaporated to dryness under 
reduced pressure to give the intermediate impy-modified nucleoside. (Electrospray mass 
spectral analysis of an aliquot of the crude nucleoside found 635.2 [M+W], as compared 
to 634.2 calculated for [M].) The nucleoside was redissolved in ethanol (5 rnL) and the 
solution was deaerated. In a separate flask Ru(acac)2(CH3CNh (0.17 mmol) was 
dissolved ethanol (25 rnL) and the solution was deaerated. The two solutions were 
combined and heated to reflux for 1 hour. The solvent was removed under reduced 
pressure and the green residue was purified by flash chromatography on silica using 1.5:1 
THF/hexanes mobile phase (yield 79%). 1H-NMR (500 MHz, CDC13, see Chapter 5, 
Figure 5.13) B 8.93 (s, 1H), 8.74 (d, 1H), 7.81 (d, 1H), 7.73 (d, 1H), 7.48 (t, 1H), 7.43 (d, 
2H), 7.20-7.34 (mm, 7H), 7.11 (t, 1H), 6.81 (dd, 4H), 5.36 (dd, 1H), 5.28 (s, 1H), 5.02 (s, 
2H), 4.88-4.92 (m, 1H), 4 .84 (s (br), 1H), 4.68-4.76 (m, 1H), 3.79 (d, 6H), 3.41-3.56 (m, 
2H), 2.20 (s, 3H), 2.12 (s, 3H), 1.82 (s, 3H), 1.60 (s, 3H). UV -vis (EtOH) nm (E): 234 
(33400), 276 (27000), 396 (3600), 592 (3600); (CH2Ch) 234 (21,500), 276 (18,600), 392 
(3600), 602 (3700). ESI-MS calculated for C46~sN40ttRu [M+H+] 934.96, found 
934.4 [M+H+] (see Figure 5.14). E 112 = 92 mV vs. Ag/AgCl in EtOH, 0.1 M NRJ'F6. 
See Chapter 5 for additional characterization. 
Ru(acac)2(aepyt. The model complex was prepared by reducing Ru(acac)3 (100 
mg, 0.25 mmol) over Zn!Hg amalgam under argon in 6:1 ethanol/water solution. 
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Following reduction 2-(aminoethyl)pyridine (29 ~, 0.25 rnmol, d = 1.049) was added 
dropwise in 1 mL EtOH and the solution was refluxed for 18 hours. The reaction mixture 
was cooled, filtered, and evaporated to dryness by rotary evaporation. An absorption 
spectrum of the crude material in ethanol showed bands at 332, 396, and 580 nm; the UV 
region was broad and ill-defined. ESI-MS (crude material) calculated for C17H24N20~u 
[M] 422, found 422.2 [M], in addition to other peaks at 474.2, 5l1.4, 562.4, and 835.4. 
The isotope pattern of the peak at 422.2 matched the predicted pattern for C17H2~204Ru. 
[Ru(acach(tmen)](N03). Method 1. The model complex was prepared by 
reducing Ru(acac)3 (100 mg, 0.251 rnmol) over Zn/Hg amalgam under argon in 100:1 
THF/water solution. The tmen ligand (38 ~' 0.251 rnmol, d = 0.77) was added and the 
solution was refluxed overnight. The progress of the reaction was monitored by TLC 
using a 3:1 THF:hexanes solvent system. The reaction was filtered and evaporated to 
dryness by rotary evaporation to give 135 mg of crude materal. This residue was 
resuspended in a minimal amount of THF, and a saturated solution of TBAH in THF was 
added to the sample and the solution was chilled overnight. 
Method 2. The model complex was prepared by dissolving Ru(acac}z(CH3CNh 
(20 mg, 0.052 rnmol) in ethanol under argon and adding the tmen ligand (7 .9 ~' 0.052 
mmol, d = 0.77) to this solution. The reaction was heated to reflux and monitored by 
TLC using a 90:10 CH3CN:water solvent system. Initially the solution was orange; 30 
minutes after heating commenced, the solution was a dark orange-red. TLC showed a 
new spot near the origin. The reaction was cooled to room temperature after 10 hours of 
refluxing, evaporated to dryness (35 mg crude material), and purified by column 
chromatography on silica gel (80:20 CH3CN:water containing 0.1% saturated KN03). 
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The sample was resuspended in ethanol and evaporated to dryness. UV-vis (EtOH, 0.1 
M Nl4PF6): 226, 284, 332, 514 nm. ESI-MS calculated for C16H30N20 4Ru [M] 416, 
found 416.4 [M]. Electrochemical data: E 112 = -0.415 V vs. Ag/AgCl in EtOH, 0.1 M 
Nf4PF6. 
[Ru(bpy)z(Uimpy)](N03)z. 2'-amino-2'-deoxyuridine (0.5 g, 2.05 mmol) was 
dissolved in ethanol (140 mL) containing molecular sieves, and the solution was flushed 
with argon for 15 minutes. 2-pyridinecarboxaldehyde (196 uL, 2.05 mmol) was added 
dropwise, and the reaction was refluxed for 11 hours. The reaction was monitored by 
TLC using the following solvent systems: 70:30 CH2Cl2:MeOH; 85:12:3 
CH2Cl2:MeOH:TEA; 3:1 EtOH:TEAAc. The solution was filtered and evaporated to 
dryness by rotary evaporation, giving - 700 mg of crude material. (ESI-MS (crude 
material) calculated for C1sH16N405 [M] 332.3, found 333.0 [M+Ir], 355.0 [M+Na+], in 
addition to small peaks at 304.2, 387.0, 422.2, 476.0, and 490.0.) The crude nucleoside 
was resuspended in ethanol (40 mL) and the solution was flushed with argon for 10 
minutes. Ru(bpy)2Cl2 (0.904 g, 1.87 mmol) was dissolved in ethanol (40 mL) and stirred 
for 10 minutes prior to being delivered to the nucleoside solution. The combined 
solutions were flushed with argon for 10 minutes and heated to reflux for 4 hours. The 
reaction was monitored by TLC using a 90:8:2 CH3CN:water:saturated KN03 solvent 
system. The reaction was cooled, filtered, and stripped to dryness by rotary evaporation 
to give 1.5 g of crude material, which was purified on basic alumina using a 88:10:2 
CH3CN:water:saturated KN03 solvent system. ESI-MS showed impurities 
contaminating the product, so the material was re-purified as follows. The sample was 
dissolved in MeOH, the excess KN03 was removed by filtration, the resulting solution 
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was stripped to dryness, and the residue was purified on alumina using a 90:8:2 
CH3CN:water:saturated KN03 solvent system. Fractions containing the product were 
evaporated to dryness, redissolved in MeOH to remove excess salt, and evaporated to 
dryness to give a red film (-500 mg). MALDI-TOF MS calculated for C35H32N80 5Ru 
[M] 746.35, found 746.14 [M+W]. Additional peaks were observed at 633.11, which 
corresponds to the loss of the uracil base; the complex was deemed unstable in the 
absence of the matrix. Electrochemical data: E 112 = 1.38 V vs. Ag/AgCl in CH3CN 
containing 0.1 M TBAH (scan rate, 1.0 V/sec). Emission decay at 720 nm O"exc = 480 
nm): 't = 60 nsec (50 mM sodium phosphate, pH 7.0, 500 mM sodium chloride). 
[Re(C0)3(phen)(Ua))(OS02CF3). The model complex was prepared (by Dr. 
Jeffrey J. Rack) by heating [Re(C0)3(phen)(OS02CF3)t in water at 80 oc for 3 hours. 
The supernatant was removed and a portion of this solution (1 mL, -0.4 mM) was added 
to a buffered solution (50 mM HEPES, pH 8.5) containing 2'-amino-2'-deoxyuridine (27 
mg, 0.11 mrnol). The solution was stirred for 24 hours. ESI-MS identified peaks at 
239.0, 694.0 and 478.5, which correspond to Uimpy. Re(C0)3(phen)(Uimpyt. and 
Re(CO)J(phen)(H20t, respectively. The excited state lifetimes of the two Re(l) 
complexes were determined using the crude solution (Figure B.l). 
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Figure B.l: Emission decay of a solution containing Re(C0)3(phen)(OH2t and 
Re(C0)3(phen)(2'-arnino-2'-deoxyuridinet (50 rnM HEPES, pH 8.5; Aexc = 396 nrn; Aobs 
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Results and Discussion 
Ru(II) acetylacetonate Complexes. Synthesis of the Ru(II) acetylacetonate 
complexes employed either Ru(acac)3 or Ru(acac)z(CH3CN)z as starting reagents (Figure 
B.2).1-3 Both complexes provided convenient routes to the model complexes that might 
qualify as donor-acceptor complexes suitable for DNA electron transfer experiments. 
Initially, Ru(acac)z(ampy)1+ was selected as one of these targets, based on our 
interest in preparing ruthenium complexes that would bind the 2' -modified nucleosides 
previously synthesized (Chapter 2, Appendix A). We predicted that this particular 
complex would display a low reduction potential, due to the presence of the electron 
donating acac ligands. The tris-chelate nature of this complex made it an attractive 
candidate because of the enhanced stability that bidentate ligands confer on a metal 
complex. 
Preparation of this complex was adapted from methods developed by Bennett and 
coworkers for synthesizing alkene derivatives of Ru(II) and Ru(ll) acetylacetonate 
complexes (Figure B.3).4 However, exposure to air resulted in a dramatic change in the 
solution color, reminiscent of the model complex work performed with 
Ru(NH3)4(ampy')
2
+ in Chapter 3. Results with this acac derivative were consistent with 
reports describing the products from the oxidative dehydrogenation of amine ligands 
coordinated to ruthenium.S-10 Ford and coworkers showed that air-exposure of 
[Ru(NH3) 4(ampy)]
2+ leads to the formation of [Ru(NH3) 4(impy)]2+.7 Subsequent work by 
Keene and Meyer outlined the mechanism of oxidative dehydrogenation for a related 
complex, [Ru(bpy)2(ampy)]
2+ (see Chapter 3, Figure 3.13).8-10 Ru(acac)z(impy) and 
Ru(acac)z(impy') can also be prepared from Ru(acac)z(CH3CN)z (Chapters 3 and 5). 
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A second target complex, Ru(acac)2(aepyt, was selected based on the availability 
of a nucleoside containing a bidentate substituent at the 2' position (3b, Chapter 2). The 
preparation of Ru(acac)2(aepyt relied on the method devised for synthesizing 
Ru(acac)2(impy). Although preliminary mass spectral data indicated formation of the 
desired product, the crude material was difficult to purify and the expected air-sensitivity 
of the product complicated these purification efforts. Synthesis of this complex using 3b 
and a detritylated version of 3b (Appendix A) were unsuccessful. 
Synthesis of [Ru(acac)z(tmen)](N03) was pursued since this complex was a 
desireable precursor for use in the post-synthetic modification of oligonucleotides 
(Chapters 2 and 3). The complex was prepared from both Ru(acac)3 and 
Ru(acac)z(CH3CN)z in reasonable yields (values not reported). However, metallation 
reactions employing this precursor were unsuccessful (Chapter 3). 
Acid treatment of Ru(acach(impy) and Ru(acac)2(impy'). To assess the 
stability of these complexes in the mildly acidic solution used in automated DNA 
synthesis, samples of each were dissolved in dichloromethane and treated with 
dichloromethane containing 0.15-3% trichloroacetic acid. Solutions of Ru(acac)2(impy) 
displayed absorption maxima at 398 and 592 nm prior to treatment; the addition of the 
acidic solution immediately caused changes in the absorption spectrum of each complex, 
such that no distinct absorption maxima were observed. Rather, a broad featureless band 
was observed in the visible region, suggestive of significant decomposition. 
Likewise, treatment of Ru(acac)2(impy') resulted in rapid changes in the 
absorption spectrum of the sample. The absorption maxima at 392 and 602 nm decrease 
after acid treatment; the growth of two intense bands at 414 and 504 nm is observed. 
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These bands are identical to a dichloromethane solution of dimethoxytrityl chloride, 
which indicates that acid treatment of Ru(acac)2(impy') causes removal of the DMT 
protecting group on the nucleoside appended to the metal. The results obtained for 
Ru(acac)2(impy) and Ru(acac)2(impy') indicate that these complexes are not stable in the 
mildly acidic conditions employed during automated DNA synthesis. 
Synthesis of Ru(bpy)2(Uimpy)2+. The metallonucleoside 3 prepared in Chapter 4 
proved to be an attractive candidate for use in DNA electron transfer studies; this 
prompted interest in having a water-soluble version of the complex (Ru(bpy)2(Uimpy)2+) 
on-hand for additional study. The synthesis was achieved using a non-tritylated 
nucleoside, Uimpy• that was prepared in situ by condensing 2-pyridinecarboxaldehyde and 
2'-amino-2'-deoxyuridine. Addition of Ru(bpy)zC12 produced the desired complex. 
Purification, however, was lengthy and reduced the overall yield of the synthesis. HPLC 
analysis of the purified complex using a reverse-phase C18 column revealed the presence 
of two diastereomers, each eluting as separate peaks. This result clarified the identity of 
the products obtained upon enzymatic digestion of oligonucleotides containing 
metallonucleoside 3 (Chapter 4; Figures 4.5 and 4.6). 
Interestingly, the excited-state lifetime of Ru(bpy)2(Uimpy)2+ in buffered aqueous 
solution is 60 nsec O"exc = 480 nm; Aobs = 720 nm), which is slightly longer than the 
lifetime determined for the tritylated complex in aqueous methanol (-r(3) = 42 nsec; 
Chapter 5). 
Synthesis of Re(CO)J(phen)(Uat· The Re(I) complex prepared with a 2' 
modified nucleoside was investigated due the high reduction potential the target complex 
was expected to exhibit (- 1.8 V vs. NHE). The limited solubility of the Re(I) precursor 
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in conditions conducive to complexation with 2'-amino-2'-deoxyuridine resulted in a low 
yield. That this result precluded further characterization of the target complex is 
unfortunate, especially since the complex displayed a long excited-state lifetime in 
buffered aqueous solution (Figure B.1). 
Conclusion 
The complexes described in this Appendix are representative of our efforts to 
develop ruthenium complexes that might qualify as promising candidates for use in 
DNA-mediated electron transfer studies. 
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Appendix C: 
Fluorescence Quenching Experiments 
with Ruthenium-Modified Nucleic Acids 
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Introduction 
Inherent in the process of designing donor-acceptor complexes for use in DNA-
ET studies is the evaluation of such candidates for their viability in the bimolecular 
quenching method (Figure C.l). Of the methods available to measure ET rate constants 
in biological assemblies, this method is attractive since it facilitates the determination of 
rate constants that vary over several orders of magnitude.! It also allows the 
experimenter to study ET reactions that have large thermodynamic driving forces. A 
potent oxidant (or reductant) is generated upon excited-state quenching by an exogenous 
quencher. The products of this quenching include the oxidized complex and reduced 
quencher. In the absence of an electron donor, the oxidized complex recombines with the 
quencher to form the starting reagents and the cycle is repeated. In the presence of an 
electron donor, ET from the donor to the oxidized complex (electron acceptor) takes 
place in competition with the charge recombination step. Thus, driving force values are 
estimated from the difference in the ground-state reduction potentials of the electron 
donor and electron acceptor. 
The design and synthesis of donor-acceptor candidates involves evaluating these 
complexes under conditions that mimic the bimolecular quenching scheme described 
above. Suitable acceptor complexes must display an emission lifetime that is long 
enough to allow oxidative or reductive quenching. Additionally, the excited-state 
quenching must generate products that are detectable using transient absorption 
spectroscopy. There must be enough quenched product to undergo ET when the donor 
complex is present. This amount can be modulated by the concentration of exogenous 
quencher. 
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Figure C.l: Scheme outlining the bimolecular quenching cycle designed for studying 
electron transfer reactions in biological systems. The bis-metallated DNA duplex is 
excited at 480 nm in the presence of an added quencher, which oxidatively quenches the 
newly formed excited state. Quenching generates the mixed-valence intermediate that 
then undergoes electron transfer depending on the overall driving force for the ET step. 
Recombination of the ET product with the reduced quencher gives the initial starting 
materials. Abbreviations: acac = acetylacetonate, bpy = 2,2' -bipyridine. 
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Recombination 
(bpy) 2Ru3+>-.-~~ Ru2+(acac) 2 
l Obse.-vation of ET 
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Some of the results from oxidative quenching experiments with ruthenium-
modified nucleic acids are presented in Chapter 4. Included here is a summary of the 
quenching studies conducted with metallonucleoside 3, oligonucleotide 7 (or 6), and 
duplex 7:9. The specialized reaction scheme shown in Figure C.2 outlines the 
experiments performed with these samples. Nanosecond transient absorption and 
emission spectroscopy were used to probe the nature of both oxidative and reductive 
quenching of the Ru-containing complexes by a variety of quenchers in aqueous solution. 
Results 
Samples were approximately 40 f...t.M and included either the metallonucleoside 3 
in methanol (25-100%) or Ru-oligonucleotides (6 or 7 alone; or 7 hybridized to its 
complement 9) in phosphate buffer (0.05 M sodium phosphate, pH 7.0, 0.5 M sodium 
chloride). The preparation of 3, 6, and 7 is described in Chapter 4. A non-tritylated 
version of 3 was prepared as described in Appendix B. Figure C.3 shows the structure 
and sequences of these ruthenium-modified nucleic acids. The abbreviation impy' will be 
used throughout this section to denote either the impy-containing nucleoside or impy-
containing oligonucleotides, where impy = iminomethylpyridine. 





-, and [Ru(acach(tmen)t (Figure C.4). A single reductive 
quencher, [W(CN)g]4-, was investigated. Changes in the optical density at 450 nm were 
monitored for the Rulli species generated upon oxidative quenching of the *Run-excited 
state, due to the differential absorbance of Rulli- vs. Run-diimine complexes at this 
wavelength. The isosbestic point determined in the absence of quencher was 406 nm 
(Figure C.5). Formation and decay of [Ru(bpyh(impy')t was monitored at 510 nm, 
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Figure C.2: Scheme for Stem-Volmer analysis of quenching reactions. 
' Ruii(bpy) 2(impy') 
334 
kq = bimolecular quenching constant 
kct = emission lifetime decay rate in the absence of quencher 
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Figure C.3: Structure of ruthenium-containing nucleoside 3 and sequences of 
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Figure C.S: A sample Stem-Volmer plot derived from quenching experiments involving 
photoexcited 7:9 (35 ~) in the presence of [Ru(NH3) 6]
3
+ (12-52 mM). Buffer: 50 mM 




































































































































































































































based on the intense absorption features of the Ru1 species at this wavelength.2 Other 
wavelengths diagnostic of the reduced/oxidized quencher were employed where possible. 
Reduction Potentials. £ 112 (vs. NHE) values are given for the following 
quenchers: [Ru(NH3) 6]




-, 0.36 V; 




-, 0.50 V. 
Emission Lifetimes. The excited-state lifetimes of 3, 6, 7, and a non-tritylated 
version of 3 were determined by monitoring the emission decay at 720 nm. All decay 
traces are monoexponential, and no indications of decomposition were observed. The 
lifetimes are as follows: 43.7 nsec (3), 42.1 nsec (6 or 7), 42.1 nsec (duplexed 7), 60 nsec 
(non-tritylated 3 in buffer). 
Oxidative Quenching. The oxidative quenching of duplexed *Ru-oligonucleotide 
7 by [Ru(NH3) 6]
3+ gave linear plots of kobs• the observed decay rate constant, vs. 
[Ru(NH3) 6]
3+ under conditions of high ionic strength (Figure C.6). The average 
bimolecular quenching rate constant (kq) derived from these plots was 1.1 x 108 M-1 s·1. 
In all cases the presence of oxidative quenchers resulted in only modest reductions in the 
lifetime of [*Ru(bpy)z(impy')]2+. High concentrations of quencher (150-1500-fold 
excess) were required to effect a - 10% decrease in the lifetime values. Figure C.7 
displays the lifetime of photoexcited 7:9 in the presence of 0, 30, and 52 mM 
[Ru(NH3) 6]
3+ (-r = 45, 41, and 37 nsec, respectively). An exception to this general trend 
was observed with 3 (25% methanol) in the presence of [Fe(CN)6]
3+ (1.8 mM), for which 
the lifetime decrease was greater than 50%. 
Transient difference spectra showed rapid bleaching of the [Ru(bpy)z(impy')f+ 
MLCT absorbance as observed at 450 nm, and the subsequent decay back to zero ~OD 
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Figure C.6: Plot of excited-state lifetime of 7:9 (35 J.1M) in the presence of [Ru(NH3) 6] 3+ 
(0, 30, and 52 mM). Buffer: 50 mM sodium phosphate (pH 7.0), 500 mM sodium 





























Figure C.7: Transient absorption difference spectrum constructed for oligonucleotide 6 
(35 J..tM) following irradiation at 480 nm. The spectrum was generated by plotting the 
~OD at t = 5 J..tSec at wavelengths 350-550 nm, excluding the wavelengths overlapping 



































































































































was complete within nearly 5 J..tseconds in most samples. Only in samples of 3 with high 
concentrations of oxidative quencher was a detectable amount of the Rum product 
observed within this 5-J..tsecond window. The highest apparent yield of 
[Ru(bpy)z(impy')]3+ product was recorded in 25% methanol with [Ru(NH3) 6]
3
+ (27 mM) 
present. 
A sample of non-tritylated 3 (0.1 mM) was suspended in 50 mM sodium 
phosphate (pH 7.0) containing 500 mM sodium chloride, to which was added 
[Ru(acac)2(tmen)t (- 1mM). Determination of the lifetime of the non-tritylated 3 in the 
presence and absence of the oxidative quencher gave identical values (60 nsec). 
Reductive Quenching. The nature of reductive quenching of *[Ru(bpy)2(impy')]2+ 
by [W(CN)8t· was unclear. Samples of 6 in the presence of [W(CN)8]
4
. (1.8 mM) 
exhibited a modest decrease in the lifetime(- 13%); transient difference spectra collected 
at 350 and 510 nm 5 J..tseconds after excitation were suggestive of a Ru1 species. Parallel 
experiments with 3 and [W(CN)8]
4
- (1 mM) in 25% methanol revealed a significant 
reduction in the lifetime (- 30%) and gave similar spectra. However, the positive ~OD 
change observed at 510 nm persisted longer than 5 J..tseconds and did not return to zero at 
longer time points (50 J..lS - 1 ms), suggestive of an irreversible reaction between 
photoexcited 3 and [W(CN)st-. 
Discussion and Conclusion 
The absence of any significant differences in the lifetimes of 3, 7, and 7·9 
demonstrates that the bases contained in 7 or 9 do not quench the photoexcited 
[Ru(bpy)z(impy')]2+. Although guanine is the most facile electron donor of the DNA 
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bases (E+•to = 1.3 V vs. NHE, pH 7), 3 oxidation by photoexcited 7 is not favored 
thermodynamically (E2+*tl+- 1 V vs. NHE; Chapter 4). Even the addition of oxidative 
quenchers fails to result in any oxidative damage to the DNA bases of 7·9, despite 
generating a Ru(III) species that is a powerful oxidant (£112 = 1.3 V). 
Modest decreases in the excited-state lifetimes of 7 and 7·9 are observed in the 
presence of large excess of oxidative quenchers. In the case of [Ru(NH3) 6]
3+, the 
bimolecular quenching constant determined for the quenching of photoexcited 7·9 is one 
order of magnitude smaller compared to the value measured for the quenching of 
[Ru(bpy)3]
2+ (1.1 x 108 vs. 2 x 109 M.1 s·1, respectively).4 However, the driving force 
estimate (~Gq) for the single electron transfer from [Ru(NH3) 6]
3+ to photoexcited 7·9 is 
approximately -0.24 eV, much smaller than the value calculated for [Ru(bpy)Jf+* (-0.92 
eV).4,5 Oxidative quenching by methyl viologen is thermodynamically unfavorable (~Gq 
= 0.26 e V). Despite the large difference in ~Gq for the two quenchers, the addition of 
either quencher in large excess to 7 or 7·9 generates small amounts of oxidized product. 
Interestingly, the largest percentage decrease in the excited-state lifetime of 3 was 
generated by the addition of [Fe(CN)6]
3
-. The driving force for oxidative quenching by 
this complex is -0.54 eV, the largest value for the series of oxidative quenchers 
examined. 
It is difficult to reconcile the value of the bimolecular quenching constant 
determined for the oxidative quenching of photoexcited ruthenium-modified 
oligonucleotides by [Ru(NH3)6]
3+ and the low amount of oxidized product following 
quenching. These results suggest perhaps that a large percentage of the geminate pairs 
generated in the quenching reaction recombine to form the ground-state reactants. While 
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this assessment is preliminary, it may explain the observations. Very little Ru(III) 
product is generated in the presence of oxidative quenchers for samples containing 3; 
even less is observed for the oligonucleotide samples. Perhaps the low yield is 
attributable to the nature of the [Ru(bpyh(impy')]2+ complex. We can speculate that the 
negatively charge environment of the oligonucleotide may accelerate the geminate pair 
recombination. Based on the results described above, we can conclude that the 
[Ru(bpy)2(impy')]2+ complex is not suitable for use in the bimolecular quenching method. 
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Appendix D: 
Automated Synthesis of an Oligonucleotide Containing 
Ruthenium(ll) Complexes at 3' and 5' Ends. 
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Summary 
The preparation of a bis-metallated 11-mer oligonucleotide entirely by solid-
phase methods was attempted. The reagents and oligonucleotide sequence used in the 
synthesis are shown in Figure D.l. The preparation of the ruthenium-containing solid 
support is described in Chapter 4. Synthesis and characterization of the phosphitylated 
[Ru(acac)z(Timpy)] complex was performed by Dr. Natia L. Frank (Timpy = thymidine 
modified at the 5' position with iminomethylpyridine) (N. L. Frank, unpublished results). 
Oligonucleotide synthesis was initiated with the ruthenium-containing solid 
support (compound 5 in Chapter 4) using standard coupling procedures as dictated by the 
automated protocol for a 1 J..lmole scale. A 0 .15 M solution of the ruthenium-containing 
phosphoramidite was delivered and allowed to couple for 30 minutes. The contents of 
the column were transferred to a test tube, and the crude oligonucleotide was manually 
cleaved in concentrated aqueous ammonia for 9 hours at room temperature. The resulting 
orange solution was filtered and evaporated to dryness using a SpeedVac. 
Analytical samples of the crude oligonucleotide were analyzed by HPLC using 
ion-exchange methods (Figure D.2). The peaks labeled B, C, D in Figure D.2 were 
collected, desalted, and analyzed by ESI-MS techniques. The results are summarized 
below: 
MS Sample Calculated Found Assignment 
Peak B, t = 9.5-9.85 min. 4117.9, [M-Hr 4130.94, [M-Hr target plus 13 
"n-1" oligonucleotide: 
Peak C, t =10.15-10.3 min. 3425.5, [M-Hr 3425.73, [M-Hr 5' -CTCCT ACACURu(bpy)2 
Peak D, t = 10.35-10.6 min. 4145.4, [M-Hr tar_g_et _Qlus 28 
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Figure D.l: Sequence of target 11-mer oligonucleotide prepared by solid-phase methods 
using the metal-containing monomers indicated. Abbreviations: acac = acetylacetonate, 






Figure D.2: HPLC trace of the crude mixture from the synthesis of 5'-
RuTCTCCTACACURu achieved by solid-phase methods. Column type: Dionex 
NucleoPac 100. Gradient: 10-33% B over 1 minute, 33-44% B over 17 minutes (A = 
10% acetonitrile; B = 10% acetonitrile, 1.5 M ammonium acetate). Flow rate: 1.0 


































The mass spectral results for Peak B strongly suggest the presence of the 11-mer 
oligonucleotide containing both ruthenium complexes. The fact that the target strand 
contains an additional 13-14 mass units is consistent with results obtained by Frank for 
oligonucleotides prepared from the phosphitylated [Ru(acac)z(Timpy)] complex. The 
putative species (M + 13 amu) is the product of the oxidation step that follows 
phosphoramidite coupling and subsequent cleavage in concentrated aqueous ammonia. 
The isolated oligonucleotides likely possess a ruthenium complex that has experienced 
further oxidation of the impy ligand to give a hydroxylated species: 
R, JcJOH HN 
I 'I '\:: 
(acachRu1~N _ 
R = nucleoside 
(Later experiments led to a revised workup procedure that involves reduction of 
Ru(acac)z(impy)-modified oligonucleotides with dithionite prior to cleavage in ammonia. 
Mass spectral data of oligonucleotides thus treated were consistent with the calculated 
values for the intact ruthenium-containing oligonucleotides.) 
The assignment of Peak C is based on the synthesis of the 10-mer oligonucleotide, 
5' -CTCCT ACACURu(bpy)2 (Chapter 4 ). The mass spectral results support this assignment 
and confirm that Peak C in the chromatogram is the oligonucleotide resulting from 
inefficient coupling of the phosphitylated [Ru(acac)z(Timpy)] complex. The identity of 
Peak D is unclear. It may represent an oligonucleotide containing both metal complexes 
but that possesses impy nucleosides that have oxidized in the presence of concentrated 
356 
ammonia to give an OH addition product. Additional characterization by enzymatic 
digestion was not performed to confirm this suggestion. 
Since the additional reduction step prior to cleavage in ammonia have been 
incorporated into the workup for Ru(acac)2(impy)-modified oligonucleotides, attempts to 
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